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Abstract
Background: Proteinaceous toxins are observed across all levels of inter-organismal and intra-genomic conflicts.
These include recently discovered prokaryotic polymorphic toxin systems implicated in intra-specific conflicts.
They are characterized by a remarkable diversity of C-terminal toxin domains generated by recombination with
standalone toxin-coding cassettes. Prior analysis revealed a striking diversity of nuclease and deaminase domains
among the toxin modules. We systematically investigated polymorphic toxin systems using comparative genomics,
sequence and structure analysis.
Results: Polymorphic toxin systems are distributed across all major bacterial lineages and are delivered by at least
eight distinct secretory systems. In addition to type-II, these include type-V, VI, VII (ESX), and the poorly
characterized “Photorhabdus virulence cassettes (PVC)”, PrsW-dependent and MuF phage-capsid-like systems.
We present evidence that trafficking of these toxins is often accompanied by autoproteolytic processing catalyzed
by HINT, ZU5, PrsW, caspase-like, papain-like, and a novel metallopeptidase associated with the PVC system.
We identified over 150 distinct toxin domains in these systems. These span an extraordinary catalytic spectrum to
include 23 distinct clades of peptidases, numerous previously unrecognized versions of nucleases and deaminases,
ADP-ribosyltransferases, ADP ribosyl cyclases, RelA/SpoT-like nucleotidyltransferases, glycosyltranferases and other
enzymes predicted to modify lipids and carbohydrates, and a pore-forming toxin domain. Several of these toxin
domains are shared with host-directed effectors of pathogenic bacteria. Over 90 families of immunity proteins
might neutralize anywhere between a single to at least 27 distinct types of toxin domains. In some organisms
multiple tandem immunity genes or immunity protein domains are organized into polyimmunity loci or
polyimmunity proteins. Gene-neighborhood-analysis of polymorphic toxin systems predicts the presence of novel
trafficking-related components, and also the organizational logic that allows toxin diversification through
recombination. Domain architecture and protein-length analysis revealed that these toxins might be deployed as
secreted factors, through directed injection, or via inter-cellular contact facilitated by filamentous structures formed
by RHS/YD, filamentous hemagglutinin and other repeats. Phyletic pattern and life-style analysis indicate that
polymorphic toxins and polyimmunity loci participate in cooperative behavior and facultative ‘cheating’ in several
ecosystems such as the human oral cavity and soil. Multiple domains from these systems have also been repeatedly
transferred to eukaryotes and their viruses, such as the nucleo-cytoplasmic large DNA viruses.
Conclusions: Along with a comprehensive inventory of toxins and immunity proteins, we present several testable
predictions regarding active sites and catalytic mechanisms of toxins, their processing and trafficking and their role
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in intra-specific and inter-specific interactions between bacteria. These systems provide insights regarding the
emergence of key systems at different points in eukaryotic evolution, such as ADP ribosylation, interaction of
myosin VI with cargo proteins, mediation of apoptosis, hyphal heteroincompatibility, hedgehog signaling, arthropod
toxins, cell-cell interaction molecules like teneurins and different signaling messengers.
Reviewers: This article was reviewed by AM, FE and IZ.
Background
Production and deployment of “chemical armaments” is
one of the most common strategies in inter-organismal
conflict. Such molecules, namely toxins or antibiotics,
are observed at practically every level of biological
organization ranging from multicellular organisms like
animals and plants, through bacteria, all the way down to
intra-genomic selfish elements [1-4]. These molecules
span an entire biochemical spectrum from diffusible
small molecules (e.g. antibiotics) to some of the largest
proteins in the biological world (secreted bacterial toxins)
[5,6]. Beyond their natural roles, these molecules have
considerable significance as biotechnological reagents,
biodefense agents, therapeutic targets, and therapeutics
against numerous disease-causing agents [1,2,4,6,7].
Traditional toxicology has now been joined by genomics
and sequence analysis in uncovering the enormous bio-
chemical diversity across life forms of such molecules
and of the systems that synthesize and traffic them. This
diversity is seen both in the structure and action of sys-
tems involved in synthesis of diffusible antibiotics and
proteinaceous toxins [5,6]. It is becoming increasingly
clear that proteinaceous toxins are a common feature of
biological conflicts at every organizational level [7]: 1) In
antagonistic interactions between different multicellular
eukaryotes, such as the castor bean ricin, Aspergillus sar-
cin and various snake venom proteins [2,3,8,9]. 2) Action
by multicellular organisms against their pathogens (e.g.
anti-microbial peptide toxins and defensive RNases such
as RNaseA and RNase L [10-13]). 3) Action of pathogenic
and symbiotic bacteria directed against their hosts (e.g.
the cholera toxin and the shiga toxin [4,14]). 4) Inter-
specific conflict in bacteria [15]. 5) Conflict between bac-
terial sibling strains of the same species, namely contact
dependent inhibition systems and related secreted toxins
[16-19]. 6) Inter-genomic conflicts between cellular gen-
omes and selfish replicons residing in the same cell (e.g.
classical bacteriocins and plasmid addiction toxins [20]).
7) Intra-genomic conflicts between selfish elements and
the host genome (restriction-modification systems [21]
and genomic toxin-antitoxin systems [22-24]).
Studies in the past decade are pointing to certain uni-
fying themes across the proteinaceous toxins deployed
in each of these distinct types of biological conflict. The
most prominent theme is the use of enzymatic toxins
that disrupt the flow of biological information by target-
ing nucleic acids and proteins [7]. Thus, several toxin
domains are nucleases targeting genomic DNA, tRNAs
and rRNAs, nucleic acid base glycosylases, nucleic acid-
modifying enzymes, peptidases that cleave key protein
targets, and protein-modifying enzymes that alter the
properties of proteins, such as components of the trans-
lation apparatus [4,6,7,17,18,25]. A secondary theme
seen across toxins from phylogenetically diverse sources
is the presence of domains that disrupt cellular integrity
by forming pores in cellular membranes [26,27]. Gen-
omic analysis has also revealed that the richest source of
proteinaceous toxins is the bacterial superkingdom,
wherein several systems involved in most of the levels of
biological conflict enumerated above are encountered
[4,6,17,18,21,22,25].
It is also becoming apparent that inter- and intra- spe-
cific and inter- and intra- genomic conflicts in prokar-
yotes have resulted in an intense arms race with respect
to proteinaceous toxins. There is evidence for multiple
episodes of escalation of the conflict in terms of the evo-
lution of immunity proteins, followed by alterations in
the toxins to evade the action of the immunity proteins
[15,17,18,24,28]. Another major evolutionary theme seen
in secreted proteinaceous toxins is the exploration of
several alternative secretory mechanisms for their effect-
ive trafficking and delivery to potential targets. In par-
ticular, bacteria display at least eight distinct secretory
mechanisms over and beyond the ancestral Sec (or Type
II) system that is shared with the other branches of life
(Table 1). Both the T2SS and alternative secretory
mechanisms have been repeatedly coopted for trafficking
toxins [15,17,18,29,30]. In addition to the T2SS, exam-
ples of other widely utilized secretory pathways that have
been frequently coopted for trafficking of toxins include
three distinct systems dependent on ATPase pumps: 1)
ABC ATPase-dependent Type I system, which has been
adapted for the delivery of the large RTX toxins [31]; 2)
the FtsK-like ATPase-dependent type VII (ESX) system
of Gram-positive bacteria, which has been recruited for
delivering several toxins, including those frequently
deployed in intraspecific conflict [17,32,33]; 3) the plas-
mid conjugation apparatus-derived type IV system [34],
which is also dependent on FtsK-related ATPases [33].
On the other hand some of the other alternative
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Table 1 Features of secretion pathways by which polymorphic toxins are exported
Secretion pathway Signature N-terminal
leader domains or
pre-toxin-domains
Signature genes
in neighborhood
Processing proteases/repeats
in toxin proteins
Phyletic patterns Additional Notes
T2SS/Sec-dependent
system
Signal peptide - Proteases: Caspase, HINT,
MCF1-SHE, subtilisin3, ZU54
In all bacteria Default pathway for protein
export. Might contain
MAFB-N (DUF1020),
MicroscillaN, APD1, APD2,
Inactive transglutaminase
Repeats: ALF, ankyrins,
β-propeller, RHS,
Sel11, TPR1, Tail-fiber2
T5SS N-terminal TpsA-like
secretion
domain (TPSASD)
FhaB/CdiB coding for
porin-like protein
Proteases: HINT Repeats: FilH α,β,γ,δ,E-proteobacteria,
acidobacteria,
bacteroidetes/chlorobi,
firmicutes5, fusobacteria
The TPSASD domain binds
the outer-membrane
FhaB/CdiB during the
export of the toxin domain
Pre-toxin domains:
DUF637(PT637),DUF637-N,
PT-VENN
T6SS VgrG domain, PAAR
domain, Hcp1
ClpV-like AAA+Atpase,
MOG1/PspB-like, VgrG,
Hcp1, Phage tail/base-plate
related proteins
Repeats: RHS All proteobacteria,
acidobacteria,
bacteroidetes/chlorobi,
firmicutes
Complete T6SS delivered
toxins are often typified
by a N-terminal PAAR
domain
Photorhabdus virulence
cassette pathway (PVC)
PVC-Metallopeptidase CDC48-like AAA+ATPase,
VgrG, Phage tail/base-plate
related proteins
Proteases: Metallopeptidase,
Subtilisin, Caspase, MCF1-SHE
Euryarchaeota,
α,β,γ,δ,E-proteobacteria,
acidobacteria, actinobacteria,
bacteroidetes, chlorobi,
chloroflexi, cyanobacteria,
deinococci, firmicutes,
nitrospirae, spirochaetes
Repeats: RHS, tail fiber
T7SS/ESX/ESAT-6
secretion system
WxG, LxG, LDxD
domains
YueA-like FtsK/HerA
ATPase, EsaC
Proteases: HINT, Caspase,
MCF1-SHE Repeats: RHS,
Tail-fiber
Firmicutes, actinobacteria,
chloroflexi, other bacterial
lineages6
Toxins exported by these
systems may or may not
possess repeat domains
TcdB/TcaC A signal peptide followed
by a SpvB domain
coupled to a C-terminal
integrin-like β-propeller
domain
TcdB Repeats: Integrin-like beta
propeller, RHS, tail-fiber
Euryarchaeota,
α,β,γ,δ-proteobacteria,
actinobacteria, bacteroidetes
Chloroflexi, fibrobacteres,
firmicutes, lentisphaerae,
spirochaetes
Proteases: HINT, Caspase, ZU5
Zhang
et
al.Biology
D
irect
2012,7:18
Page
3
of
76
http://w
w
w
.biology-direct.com
/content/7/1/18
Table 1 Features of secretion pathways by which polymorphic toxins are exported (Continued)
PrsW PrsW-peptidase domain Repeats: RHS Euryarchaeota,
α,β,γ,δ-proteobacteria,
actinobacteria Bacteroidetes,
chloroflexi, cyanobacteria,
deinococci, dictyoglomi,
firmicutes, fusobacteria,
gemmatimonadetes,
spirochaetes, verrucomicrobia
PrsW is a transmembrane
peptidase with several
transmembrane helicesProteases: PrsW
Phage DNA
packaging system
MuF MuF, large and small
subunits of terminase
Proteases: Papain-like Euryarchaeota, acidobacteria,
α,γ,δ-proteobacteria,
actinobacteria, bacteroidetes,
chlorobi, firmicutes, fusobacteria,
spirochaetes, caudovirales
The toxin is predicted to
be packaged into the
phage head as in phage
transduction systems
1: Note only fused to toxins exported by the SEC-dependent pathway in Amoebophilus asiaticus; 2. Note only fused to toxins exported by the SEC-dependent pathway in Microscilla marina; 3: Note only fused to toxins
exported by the SEC-dependent pathway in Acetivibrio cellulolyticus; 4: Note only fused to toxins exported by the SEC-dependent pathway in Caldicellulosiruptor species; 5: Note in firmicutes, the export pathway is only
present in Veillonella and Selenomonas species, also referred to as the Negativicutes species; 6: Certain bacterial lineages within the β,E,γ-proteobacteria, planctomycetes, verrucomicrobia, cyanobacteria and
bacteroidetes have solo WXG domains that have a distinct YueA-like ATPase with 3 HerA/FtsK domains of which only the middle one is active. These appear to be mobile versions of T7SS.
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secretory mechanisms appear to be primarily utilized in
trafficking toxins rather than any other function: 1) The
type III system based on the flagellar basal body-like ap-
paratus [35]; 2) the two-partner or Type V system which
resembles the porins [36,37]; 2) the type VI [38,39]; 3)
Photorhabdus virulence cassette (PVC)-type secretory
system [40,41]. Both T6SS and the PVC-SS utilize caud-
ate bacteriophage tail-derived proteins as an “injection
syringe” and distinct AAA+ATPases to recycle the in-
jection apparatus in an ATP-dependent manner after a
single use [39]; 4) TcdB/TcaC-like export pathway [42];
4) the PrsW-like peptidase-dependent system export sys-
tem [43]. Depending on the secretory pathway, toxins
might either be directly injected into target cells (e.g.
T6SS delivered toxins) or diffuse into the surrounding
medium (e.g. certain T2SS or T7SS toxins) or be
anchored on the surface of producing cells to be deliv-
ered upon contact with the target cell (e.g. T5SS and
certain T2SS, T6SS and T7SS delivered toxins). Add-
itionally, these prokaryotic toxins might also display fur-
ther adaptations that allow their processing subsequent
to their secretion – these include the presence of “pre-
toxin domains” that might be sites for proteolytic pro-
cessing or in-built peptidase domains that cleave off the
toxin domain to facilitate its delivery into the target cell
[17,20] (Table 1).
The selective pressures related to the above-described
adaptations for trafficking, processing and delivery ap-
pear to have been instrumental in shaping the domain
architectures of plasmid-encoded bacteriocins and pro-
karyotic toxins deployed in inter- and intra-specific con-
flicts [17,20]. Consequently, most toxin proteins have N-
Figure 1 (A) Workflow for identification and analysis of toxin and immunity domains in bacterial polymorphic toxin systems. (B)
General domain architecture template for polymorphic toxins along with representative architectures seen in different secretory systems.
Trafficking domains are colored grey, repeats light green, pre-toxin domains (PT-domain) yellow, releasing peptidases blue, and toxin domains
pink. Newly identified domains are encircled in dashed lines in all figures in this paper. Proteins are not drawn to scale. Note, only repeats
automatically detected by profiles are shown in all figures; the proteins usually have much longer repeat units than shown due to repeats being
below the detection threshold. Toxins are grouped based on their secretion pathways that are defined by their canonical trafficking domains
(Table 1). Proteins are denoted by their gene name, species abbreviations and GI (Genbank Index) numbers separated by underscores. (C) General
gene-neighborhoods template for polymorphic toxin operons. Individual genes are represented as arrows pointing from the 5′ to the 3′-end of
the coding frame. Genes are labeled by their domain architectures. The gene neighborhood is labeled by the gene name, species abbreviation
and GI number of the SUKH gene marked with an asterisk. Toxins are colored pink, immunity proteins orange, and other trafficking related
proteins grey. For species abbreviations refer to supplementary material.
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terminal domains involved in secretion and/or cell sur-
face anchorage, central domains involved in adhesion or
presentation to target cells and C-terminal domains that
bear the actual toxin activity (Figure 1, Table 1). These
might be occasionally combined with further
processing-peptidase or pre-toxin domains [17,18,20].
These stereotypic architectural features strongly distin-
guish such toxins from those involved in intra-genomic
conflicts, such as those from classical toxin-antitoxin sys-
tems and restriction-modification systems, even though
certain domains with toxin activity might be common
across these different systems [17,22,28]. Hence, domain
architectural analysis considerably aids in the detection
of new toxins involved in inter-organismal conflicts and
the delineation of specific domains associated with each
of the above-listed trafficking related roles. This has led
Figure 2 Domain architectures of selected examples of polymorphic toxins containing distinct releasing peptidases: (A) HINT, (B) ZU5,
(C) PrsW peptidase, (D) Caspase peptidase, (E) MCF1-SHE-like predicted peptidase. The alignment of MCF1-SHE domain is shown with
predicted catalytic residues marked with blue asterisks. For all alignments in this study, proteins are denoted by their gene name, species
abbreviations and GI (Genbank Index) numbers separated by underscores. Secondary structure assignments are shown above the alignment,
where the blue arrow represents the β-strand and the red cylinder the α-helix. Poorly conserved inserts are excluded in the alignment and
replaced by the length of the inserts. Columns in the alignment are colored based on their amino acid conservation at consensus shown below
the alignment. The coloring scheme and consensus abbreviations are as follows: h, hydrophobic (ACFILMVWY), l, aliphatic (LIV) and a, aromatic
(FWY) residues shaded yellow; b, big residues (LIYERFQKMW), shaded gray; s, small residues (AGSVCDN) and u, tiny residues (GAS), shaded green;
p, polar residues (STEDKRNQHC) shaded blue; and c, charged residues (DEHKR) shaded magenta. Absolutely conserved residues are shaded red.
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to an exciting discovery in the past two years, namely the
identification and characterization of an extremely wide-
spread system of secreted toxins, primarily involved in
intra-specific conflict between related strains of prokar-
yotes [16-19]. These toxin systems are found in practic-
ally all major bacterial lineages and also a small number
of archaea. Toxin proteins of these systems are as a rule
multi-domain and display a bewildering diversity in terms
of domains possessing toxin activity [17,18]. An import-
ant feature of these proteins is the tendency to vary their
toxin domains through a process of recombination that
might replace an existing toxin domain by a distinct one
encoded by standalone cassettes, while retaining the rest
of the protein’s architecture (i.e. parts related to traffick-
ing and delivery) intact. As a consequence these toxins
might be termed polymorphic toxins and encompass the
so called contact dependent inhibition (CDI) systems that
were recently described in proteobacteria [17,44,45]. Fur-
ther, these systems typically possess a chromosomally
linked immunity protein that helps in protecting cells
against their own toxin. These systems might also display
several more chromosomally linked or distantly located
immunity proteins that could serve as a potential line of
defense against toxins delivered by “non-self” strains. The
presence of immunity proteins is a key feature that distin-
guishes the polymorphic toxins from conventional toxins
whose primary targets are in distantly related organisms
(hence, no “self” immunity is required). Thus, these poly-
morphic secreted toxins could play a central role in “self
versus non-self” or kin recognition in bacteria and
thereby have an important role in regulating intra-
specific altruistic and cooperative behavior [17,18].
Our studies on the toxin domains of these polymorphic
toxin systems have uncovered a remarkable array of
nucleases and deaminases that are likely to target different
cellular nucleic acids [17,18]. Our preliminary investiga-
tions also uncovered some other toxin domains in these
systems with alternative modes of action, such as protein
AMP/UMPylating enzymes, ADP-ribosyltransferases and
peptidases. Interestingly, we observed that several of the
toxin and processing peptidase domains from poly-
morphic secreted toxins are also present as toxin domains
of conventional toxins deployed in inter-specific conflict,
such as against eukaryotic hosts by pathogenic or symbi-
otic bacteria [46-54]. In a similar vein, we observed that
both the polymorphic toxins deployed in intra-specific
conflicts and toxins used in inter-specific conflict often
rely on similar secretory mechanisms, such as the T5SS,
T6SS and T7SS [17,18]. These observations suggested that
both types of secreted toxins have been “constructed” in
course of evolution from a common pool of domains and
consequently possess similarities in their domain architec-
tures. We also observed that several domains seen in
secreted prokaryotic toxins and their immunity proteins
have been transferred to eukaryotes and their viruses, and
have contributed to the provenance of major regulatory
molecules in the development of multicellular animals,
RNA-editing, DNA-mutagenesis and virus-host interac-
tions [17,18]. Thus, the evolutionary and functional sig-
nificance of domains found in prokaryotic toxin systems
extends beyond the mechanisms and dynamics of intra-
organismal conflict.
Our previous studies on the polymorphic toxins fo-
cused on identifying and characterizing the diversity of
toxin domains that operate on nucleic acids, in particular
nucleases and deaminases, and characterizing some of
the most prevalent immunity proteins, such as those with
the SUKH and SuFu domains. We also reported a pre-
liminary characterization of the major secretory systems
involved in toxin trafficking and processing peptidases.
Here, we build on our previous studies to systematically
characterize novel domains in polymorphic toxin sys-
tems, with a particular focus on those involved in toxin
activity, immunity and maturation of toxins. Conse-
quently, we report herein a greatly expanded repertoire
of toxin domains and immunity proteins directed against
them. Thus, we also considerably extend their structural
and mechanistic diversity to include a diverse array of
peptidases, ADP ribosyltransferases, glycosyltransferases,
kinases, membrane perforators and domains with several
other activities. Even in terms of toxin acting on nucleic
acids we report numerous previously unrecognized
nucleases and deaminases. This expanded repertoire of
toxin domains also helps to better understand the com-
monalities between the polymorphic toxin systems and
the classical secreted toxins deployed against distantly
related organisms. This comprehensive characterization
also provides a handle to investigate the ecological sig-
nificance of such secreted toxin systems in prokaryotes.
Our analysis also uncovered novel features regarding the
secretory systems that traffic these toxins. The detailed
analysis of these toxin systems and their immunity pro-
teins further pointed to several additional examples of
domains from them being acquired by eukaryotes and
their viruses. Thereby we greatly widen the contributions
of components of these systems to the evolution of sev-
eral eukaryotic regulatory systems. We present a compre-
hensive inventory of intra-specific polymorphic toxin
systems and related components from toxin systems
deployed in inter-specific conflicts. This database is likely
to serve as an useful reference for future studies on this
enormously significant group of proteins.
Results and discussion
Search strategy to identify new toxins and immunity
proteins
In order to identify novel polymorphic toxins we adopted
a strategy of matching diagnostic domain-architecture
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and gene-neighborhood templates, similar to what we
had done earlier to identify novel type II toxin-antitoxin
systems [22]. In the case of polymorphic toxins the do-
main architecture template is defined by the presence of
multi-domain proteins, wherein the C-terminal-most do-
main has toxin activity, while the N-terminal-most
domains are associated with trafficking (Table 1, Figure 1).
The central domains might be involved in adhesion, pres-
entation or processing. One of the most common features
of this central region is the presence of RHS (Recombin-
ation hot spot)/YD or filamentous hemagglutinin (FilH)
repeats which form extended fibrous or filamentous
structures that help in displaying the C-terminal toxin
domain on the cell-surface [17,18,37,45,55,56]. With the
above domain-architecture template (Figure 1), we iden-
tified an initial set of exemplars, which were used in se-
quence similarity searches to identify homologs that were
similar over most of their length but differing in their
C-terminal-most domains – a hallmark of polymorphic
toxins (Figure 1B). This enabled us to precisely define the
boundaries of the C-terminal toxin domains and use
them as seeds in iterative sequence profile searches with
the PSI-BLAST and JACKHMMER programs. These
searches allowed us to recover both standalone toxin do-
main cassettes and examples where they are combined
with other types of N-terminal trafficking, presentation
and processing domains, distinct from those found in the
starting queries. This process was used transitively to de-
tect further toxin domains and full length toxins. As a re-
sult, we were able to not only capture other polymorphic
toxins but also identify cases where these toxin domains
might be used as the active domains of other secreted
toxins that are deployed against more distantly related
organisms (e.g. T3SS or T4SS delivered host-directed
toxins). To further understand the sequence and struc-
ture affinities of toxin domains, we also used their mul-
tiple alignments in profile-profile comparisons with the
HHpred program to recover distant homologs and deter-
mine their protein fold. Additionally, detailed domain-
architecture analysis of the associated domains in the
case of the full length toxins allowed us to delineate the
domains involved in the other processes mentioned
above.
In terms of gene-neighborhood templates (Figure 1),
we exploited the fact that the polymorphic toxin genes
are accompanied by several solo toxin cassettes and
genes for immunity proteins and in some cases genes en-
coding trafficking components (e.g. T6SS or PVC-SS).
Hence, we systematically extracted the genomic neigh-
borhoods for all detected toxin-encoding genes from
complete genome sequences or assembled CONTIGs
and subjected them to gene-neighborhood analysis.
Matches to the above template allowed us to distinguish
the classical polymorphic toxins from related toxin
systems that are deployed against more distantly related
organisms. A combination of the gene-neighborhood
analysis with the domain architecture analysis also
allowed us to determine the trafficking mechanisms of
full-length toxins in the majority of cases. Further, this
genomic analysis also led to the recovery of potential im-
munity proteins associated with the polymorphic toxins.
The identification of novel immunity proteins utilized
the fact that the immunity protein gene/s are invariably
adjacent to the toxin gene in an operon and typically en-
code a small single domain protein (Figure 1). We con-
firmed novel immunity proteins by initiating sequence
searches with them and using the newly detected homo-
logs in gene-neighborhood analysis to check if they
showed any co-occurrence with toxin genes. The gene-
neighborhood analysis of the newly identified immunity
proteins also helped recover any loci that might have
been missed in the initial toxin-centric analysis and also
pointed to certain novel types of loci comprised primarily
of multiple immunity genes (See below).
As a result of the above searches, we were able to
assemble a comprehensive inventory of toxins and im-
munity proteins, which we provide as a resource accom-
panying this article (Table 2, 3 and Additional File 1).
For the sake of systematic nomenclature we adopted the
following convention: 1) The toxin domains are labeled
‘Tox’ followed by the name of the superfamily they
belong to. Thus, a toxin domain of the restriction endo-
nuclease (REase) superfamily would be labeled Tox-
REase. 2) The domain might be further distinguished by
a numeral if there are multiple distinct toxin families
within a given superfamily, e.g. Tox-REase-1, Tox-
REase-2 and so on. 3) In the case of certain highly diver-
gent families, each with their own structurally distinct
features, such as those belonging to the HNH/EndoVII
nuclease fold, each family of toxin domains might re-
ceive a separate label, e.g., Tox-HNH, Tox-AHH, Tox-
LHH or Tox-NucA that identifies the specific family of
nucleases. 4) Novel toxins that could not be unified with
any previously known superfamily are labeled as ‘Ntox’
followed by a number, e.g. Ntox1, Ntox2 etc. (we identi-
fied a total of 50 such novel, monophyletic toxin groups
in this study). 5) The immunity proteins were similarly
named according to their superfamily. Thus, immunity
proteins of the SUKH, SuFu and LRR superfamilies are
respectively labeled as Imm-SUKH, Imm-SUFU or Imm-
LRR. 6) Novel immunity proteins that could not be
unified with any known superfamily were labeled as
Imm followed by a number, e.g. Imm1, Imm2 etc. (we
detected 73 such immunity proteins in this work).
In the initial section we present the results of the
above analysis from a domain-centric viewpoint by
laying out the main conserved domains we identified
in toxins (Table 2), immunity proteins (Table 3) and
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains
Toxin1 Fold; conserved residues
or motifs2 and additional
notes
Phyletic spread3 Export pathway4 Immunity proteins Repeats/processing
Proteases
DNase toxins
Tox-NucA HNH/EndoVII fold; GH,
N, N, E
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chloroflexi, firmicutes,
spirochaetes, verrucomicrobia
T2SS, T5SS, T6SS, T7SS
(WXG,LXG,LDXD), PVC
Imm36, Imm-SUKH,
Imm-NTF2
Proteases:
PVC-Metallopeptidase,
Caspase; Repeats: FilH,
RHS, Tail-fiber
Tox-ColE7 HNH/EndoVII fold (PDB:
1zns);HH, H, H
Bacteroidetes, α,γ,δ,E-proteobacteria,
firmicutes
T2SS, T5SS, T6SS, T7SS
(WXG,LXG), PyocinS
Imm-ColE7, Imm-SUKH Repeats: FilH, RHS
Tox-HNH (including
Tox-HNH-CIDE)
HNH/EndoVII fold;
A DHxxE characterizes
the Tox-HNH-CIDE clade.
Acidobacteria, actinobacteria,
bacteroidetes, chlorobi, firmicutes,
proteobacteria, Eukaryotes:metazoa
T2SS, T5SS, T7SS
(WXG,LXG, LDXD),
PVC, TcdB/TcaC
Imm-SUKH, Imm-SuFu,
Imm14, Imm18, Imm24,
Imm33,
Proteases:
PVC-Metallopeptidase,
HINT, Tox-PLOTU,
ZU5; Repeats: FilH, RHS
Tox-AHH HNH/EndoVII fold; [AG]HH,
N, H, H, Y motif and
residues
Actinobacteria, α,β,γ,δ,E-proteobacteria,
bacteroidetes, cyanobacteria, firmicutes,
fusobacteria, lentisphaerae, planctomycetes,
spirochaetes, verrucomicrobia,
eukaryotes: hexapoda, Viruses:
Ostreococcus lucimarinus virus,
Bathycoccus sp. RCC1105 virus
T2SS, T5SS, T6SS, T7SS
(LXG, WXG, LDxD),
TcdB/TcaC
Imm-PA2201, Imm-ank,
Imm11, Imm20, Imm23,
Imm24, Imm43
Proteases: HINT;
Repeats: RHS, FilH
Tox-DHNNK HNH/EndoVII fold; DH, N,
N, N, K motif and residues
Acidobacteria, actinobacteria
α,β,γ,δ,E-proteobacteria, firmicutes,
fusobacteria, planctomycetes, spirochaetes,
archaea: euryarchaeota, eukaryotes:
fungi(ascomycota, basidiomycota)
T2SS, T6SS, T7SS
(LXG, LDXD,WXG), PVC
Imm-SUKH, Imm-SuFu,
Imm33
Proteases:
PVC-Metallopeptidase,
HINT
Tox-EHHH HNH/EndoVII fold; [ED]H, H, H Actinobacteria, bacteroidetes,
β,γ,δ-proteobacteria, firmicutes
T2SS, T5SS T6SS, T7SS
(WXG, LxG), TcdB/TcaC
Imm8, Imm50 Repeats: FilH, RHS
Tox-GH-E HNH/EndoVII fold; GH, E, N,
E motif and residues
Actinobacteria, bacteroidetes,
β,γ,δ,E-proteobacteria, chloroflexi,
firmicutes, planctomycete, spirochaetes,
archaea: euryarchaeota
T2SS (MafBN), T5SS,
T6SS, T7SS (WXG, LxG,
LDXD), PVC
Imm-SuFu, Imm-ank Proteases: HINT,
PVC-Metallopeptidase;
Repeats: RHS, FilH,
Tail Fiber
Tox-GHH HNH/EndoVII fold; WxxE,
W, G[HQ]H, NIxF, [DE]H;
Eukaryotic versions lack the
conserved histidines and a
C-terminal helix
Acidobacteria, bacteroidetes, firmicutes,
γ-proteobacteria, planctomycete,
eukaryotes: metazoa
T2SS, T6SS, T7SS
(LXG), TcdB/TcaC
Imm-SUKH Repeats: RHS
Tox-GHH2 HNH/EndoVII fold; s[AGP]HH,
HxxxH
β,γ-proteobacteria, bacteroidetes, firmicutes T2SS, T6SS - Repeats: RHS
Tox-HHH HNH/EndoVII fold; N, s[GD]xxR,
HHH, H
Actinobacteria, bacteroidetes,
γ-proteobacteria, firmicutes
T2SS, T5SS,T6SS, T7SS
(LXG,LDXD), PVC
Imm-SUKH Proteases:
PVC-Metallopeptidase;
Repeats: FilH, RHS
Tox-LHH HNH/EndoVII fold; N, LHH, E,
H, H, W
Actinobacteria, α,β,γ,δ,E-proteobacteria,
bacteroidetes, firmicutes, fusobacteria,
planctomycetes
T2SS, T5SS, T6SS, T7SS
(WXG,LXG), PVC
Imm-SUKH Proteases:
PVC-Metallopeptidase,
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
HINT; Repeats: FilH,
RHS, Tail-fiber
Tox-SHH HNH/EndoVII fold; [SG]HH, H
motif and residue
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, cyanobacteria, firmicutes,
planctomycetes, eukaryotes: crustacea,
viruses: caudovirales
T2SS, T5SS, T6SS, T7SS
(LDXD, LXG, WXG)
Imm-SUKH, Imm11,
Imm24, Imm30,
Imm55
Proteases: HINT
Repeats: FilH, RHS, ALF
NGO1392-like
(Also known as
Tox-SuFu-Nuc)
HNH/EndoVII fold; CxxC,
DH, CXXC, Q
Actinobacteria, α,β,γ,δ-proteobacteria,
chlorobi, chloroflexi, cyanobacteria,
firmicutes, spirochaetes, eukaryotes:
alveolata(apicomplexa), choanoflagellida,
metazoa, stramenopiles, viridiplantae,
Viruses: several Mycobacteriophages,
caudovirales
T2SS (MafBN), T5SS,
TcdB/TcaC, PVC
Imm-SuFu, Imm13,
Imm21, Imm33,
Imm38
Proteases: HINT,
PVC-Metallopeptidase,
ZU5; Repeats: FilH,
RHS, Tail fiber
Tox-WHH HNH/EndoVII fold; WHH,
L, H, HxG
Actinobacteria, α,β,γ,δ,E-proteobacteria,
bacteroidetes, chloroflexi, firmicutes,
fusobacteria, planctomycete, synergistetes
T2SS, T5SS, T6SS, T7SS
(WXG, LXG, LDXD),
PVC, TcdB/TcaC
Imm-SUKH, Imm28,
Imm37
Proteases: HINT,
PVC-Metallopeptidase;
Repeats: RHS, ALF, FilH
Tox-REase-1 Restriction endonuclease
fold; E, D, ExK, Q
Actinobacteria, bacteroidetes,
β,γ,E-proteobacteria, cyanobacteria,
fusobacteria, firmicutes, gemmatimonadetes,
planctomycetes, eukaryotes: alveolata,
heterolobosea
T2SS,T5SS, T6SS, T7S
(WXG,LXG), TcdB/TcaC
Imm-PA2201, Imm49 Proteases: HINT,
Caspase, ZU5; Repeats:
FilH, RHS, Tail-fiber
Tox-REase-2 Restriction endonuclease
fold; E, DG, [DE]xK, T, W
Actinobacteria T2SS, T7SS (WXG),
PrsW
- Proteases: PrsW-peptidase
Tox-REase-3 Restriction endonuclease
fold; [KR]ExD, K, ExQxK
β,γ-proteobacteria, firmicutes T2SS (MafBN), T6SS,
T7SS (WXG), PrsW
Imm-SUKH, Imm7 Proteases: PrsW-peptidase;
Repeats: RHS
Tox-REase-4 Restriction endonuclease
fold; D, ExK
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, cyanobacteria, firmicutes,
planctomycetes, spirochaetes, eukaryotes:
stramenopiles
T2SS, T5SS, T6SS, T7SS
(WXG,LDXD), PrsW
Imm-SUKH, Imm22,
Imm54
Proteases: PrsW-peptidase;
HINT; Repeats: FilH, RHS,
Tail fiber
Tox-REase-5 Restriction endonuclease
fold; Y, FDG, EAK, Y, Q,W
Actinobacteria, α,β,γ,δ-proteobacteria,
firmicutes, fusobacteria,
Viruses: caudovirales
T2SS, T5SS, T6SS, PrsW Imm52 Proteases: PrsW-peptidase;
Repeats: FilH, RHS
Tox-REase-6 Restriction endonuclease
fold; E, D, ExK, Q, Y
Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, cyanobacteria, firmicutes,
eukaryotes: heterolobosea
T2SS, T5SS, T6SS, T7SS
(WXG), PrsW
Imm49 Proteases: PrsW-peptidase;
Repeats: RHS, Tail fiber
Tox-REase-7 Restriction endonuclease
fold; GxxxE, IxD, ExK, Q
Actinobacteria, α,γ,E-proteobacteria,
bacteroidetes, cyanobacteria, firmicutes,
planctomycetes, verrucomicrobia
T2SS, T5SS, T6SS, T7SS
(WXG)
ImmHEAT, Imm23,
Imm54
Proteases: HINT; Repeats:
FilH, RHS, Tail-fiber
Tox-REase-8 Restriction endonuclease
fold; GxxxQ, DD, QxK
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chlorobi, chloroflexi, firmicutes,
spirochaetes, verrucomicrobia, eukaryotes:
metazoa(crustacea, hexapoda,placozoa)
T2SS (APD1) - Repeats: Ankyrin repeats,
TPR repeats, RHS
Tox-Rease-9 Restriction endonuclease
fold; GxxxH, E, D, ELKP, YxxE
Actinobacteria, γ-proteobacteria,
bacteroidetes, chlamydiae, firmicutes
T2SS, T7SS (LxG) Imm54 Proteases: HINT; Repeats:
RHS
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Tox-Rease-10 Restriction endonuclease fold;
E, Q, [DE], ExKNY, R, DxRG
β,γ,E-proteobacteria, firmicutes,
fusobacteria, spirochaetes
T2SS, T5SS, T7SS
(WXG, LXG),
Imm54, Imm70 Repeats: FilH
Tox-URI1 URI nuclease fold; Y, YxG,
R, [RK]xxE, N
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chlamydiae, chloroflexi,
firmicutes, lentisphaerae, nitrospirae,
verrucomicrobia, archaea: euryarchaeota,
viruses: Ostreococcus lucimarinus virus,
eukaryotes: fungi
T2SS, T5SS, T6SS,
TcdB/TcaC
Imm14, Imm26,
Imm44, Imm51
Proteases: HINT; Repeats:
RHS, FilH, Tail fiber
Tox-URI2 URI nuclease fold; Y, KxG, [EQ] Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, firmicutes
T2SS, T6SS Imm9, Imm39, Imm12,
Imm44
Proteases: HINT;
Repeats: RHS, Tail fiber
RNase toxins of known fold
Tox-Barnase Barnase-EndoU-ColicinE5/D-RelE
like nuclease (BECR) fold
(α+ β); H, H, [ST], FP, [STD]
Actinobacteria, bacteroidetes,
β,γ,δ,E-proteobacteria, chlamydiae, chloroflexi,
cyanobacteria, deinococci, fibrobacteres,
firmicutes, fusobacteria, nitrospirae,
planctomycetes archaea: euryarchaeota
T2SS, T6SS, T7SS
(WXG), TcdB/TcaC,
MuF, PVC
Imm-Barstar Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Tox-Colicin D BECR fold (α+ β); (PDB: 1v74);
[KH]K, Hxx[ED], [ST], [TS]xxK;
Of the conserved residues in
ColicinD (PDB: 1v74), K607, K608,
H611, D614, and S677 are
essential for activity
β,γ,δ-proteobacteria, chloroflexi,
firmicutes, spirochaetes, archaea: euryarchaeota,
eukaryotes: fungi (ascomycota)
T2SS, T5SS, Cloacin,
TcdB/TcaC, PVC, MuF
ImmD, Imm64; ImmD
is the major immunity
protein share with
plasmid borne colicin
systems
Proteases:
PVC-Metallopeptidase;
Repeats: RHS, FilH
Tox-ColicinC/E5
tRNase
BECR fold (α+ β, PDB: 2dfx); K,
W, Y, Y, Q, [RK], W; Of the
conserved residues in Colicin
E5 (PDB: 2dfx), Y81 and S95 are
predicted to be involved
in catalysis
β,γ-proteobacteria, firmicutes, Plasmid ColE5-099 T2SS, T5SS, T7SS (LXG),
Cloacin/PyocinS,
TcdB/TcaC
ImmE5 Repeats: RHS, FilH
Tox-EndoU
(including XendoU)
BECR fold (α+ β, PDB: 2c1w); H,
H, [SNT],[SNT]; This structural
core contains two BECR fold
units, where the N-terminal unit
has lost strand-4, while the
helix in the C-terminal unit
has flipped to the opposite
end. In 2c1w, H162 and T278
form one pair of catalytic
residues and H178 and S229
form the other.
Some members use a Mn2+
probably as a transition state
stabilizer
Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, chlamydiae, cyanobacteria,
fibrobacteres, firmicutes, fusobacteria, tenericutes,
eukaryotes: hemichordata, viridiplantae,
stramenopiles, metazoa
T2SS (MafBN), T5SS,
T6SS, T7SS (WXG,LXG)
Imm-SUKH, Imm-SuFu,
Imm28
Proteases: HINT;
Repeats: FilH, RHS
Tox-RelE BECR fold (α+ β); [KR], R; The
active site residues in the
classical RelE (PDB: 3kha)
correspond to residues R61
and R81
Actinobacteria, α, γ, -proteobacteria,
bacteroidetes, cyanobacteria,
firmicutes, fusobacteria
T2SS Imm54 Proteases: HINT;
Repeats: RHS
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Ntox7 Predicted BECR fold (α+ β);
DGx + xhR, N motif
Actinobacteria, bacteroidetes, β,γ,
δ- proteobacteria, chlamydiae, chloroflexi,
firmicutes
T2SS (MafBN), T2SS
(APD1), T5SS, T7SS,
TcdB/TcaC
Imm8, Imm31, Imm32,
Imm-NMB0513, Imm-SuFu;
Imm8 is the predominant
immunity protein across
a wide phyletic range
Proteases: HINT, ZU5;
Repeats: FilH, RHS
Ntox19 Predicted BECR fold (α+ β);
D,H,DxxxR,E,HxxF; Also found
in mimivirus, where it is fused
to ankyrin repeats,
β,γ,δ- proteobacteria, firmicutes,
fusobacteria, bacteroidetes, Viruses:
Acanthamoeba polyphaga mimivirus
T2SS (MafBN), T5SS,
T7SS (LxG and WxG),
TcdB/TcaC
Imm38, Imm40. These
associations are seen
across many different
bacterial lineages
Repeats: FilH, RHS
Ntox21; Also referred
to as the E. clocae
CdiAC; Shown to
be a tRNAse
Predicted BECR fold (α+ β); K,
[DS]xDxxxH, K, RxG[ST], RxxD
Actinobacteria, α,β,γ-proteobacteria
bacteroidetes, firmicutes
T2SS (MafBN), T5SS,
T4SS, T7SS
Imm-Barstar, Imm41 Proteases: HINT;
Repeats: RHS, FilH
Ntox35 Predicted BECR fold (α+ β);
H, KH
Actinobacteria, bacteroidetes,
β-proteobacteria, chlamydiae,
chloroflexi, firmicutes, planctomycetes
T2SS (MafBN) - Repeats: RHS
Ntox36 Predicted BECR fold (α+ β); N,
[RY], [DE]
Acidobacteria, actinobacteria,
β,γ-proteobacteria, cyanobacteria,
elusimicrobia, firmicutes
T2SS, T5SS - Proteases: HINT;
Repeats: RHS, FilH
Ntox41 Predicted BECR fold (α+ β);
[RK]H, [KR], [ST]xxP
Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, firmicutes, planctomycetes
T2SS, T5SS, T7SS
(WXG,LXG)
- Proteases: HINT;
Repeats: RHS, FilH, ALF
Ntox47 Predicted BECR fold (α+ β); D,
[HRK], RT, E, D, PH, H, [DE], R
β,γ-proteobacteria, firmicutes T2SS, T6SS, T7SS
(LXG,WXG)
- Proteases: HINT;
Repeats: RHS
Ntox48 Predicted BECR fold (α+ β);
R, [RK], Q, Q
Acidobacteria, actinobacteria,
α,β,γ,δ-proteobacteria,
bacteroidetes,
cyanobacteria, firmicutes,
fusobacteria, planctomycetes
T2SS, T5SS, T6SS
T7SS (WXG,LXG),
Imm60, Imm62, Imm66,
Imm71
Proteases: HINT;
Repeats: RHS, FilH
Ntox49 Predicted BECR fold (α+ β);
H, [KR]
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chlamydiae, chloroflexi,
cyanobacteria, firmicutes, thermotogae,
archaea: euryarchaeota, eukaryotes:
stramenopiles, viridiplantae,
viruses: caudovirales
T2SS (MafBN), T5SS,
T7SS (WXG,LXG), MuF,
PVC
Imm22 Proteases:
PVC-Metallopeptidase,
HINT, ZU5; Repeats: RHS
Ntox50 Predicted BECR fold (α+ β);
H, S, K, T, H, K, HxVP
Actinobacteria, β,γ,δ-proteobacteria,
chlamydiae, firmicutes, fusobacteria,
viruses: caudovirales
T2SS (MafBN), T6SS,
T7SS (WXG,LXG), MuF
- Proteases: HINT
Predicted metal-independent RNase toxins
Tox-CdiAC All-β; N, [DSN],E β,γ,δ-proteobacteria T2SS, T5SS, T6SS,
TcdB/TcaC
Imm-CdiI, Imm5+ Imm36.
Imm-CdiI is the most
prominent immunity
protein to this toxin
Repeats: RHS, FilH
Tox-ColE3 All-β; ColE3 cytotoxic
ribonuclease fold, R,
Dxx + [HK], E, H
Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, cyanobacteria,
firmicutes, fusobacteria
T2SS (MafBN), T5SS,
T7SS (WXG,LXG)
Imm-Cloacin, Imm45 Proteases: HINT;
Repeats: RHS, FilH
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Tox-RES; PF08808 in
Pfam. Also found
in toxin-antitoxin
systems (see text);
α+ β; R, R, E, S Acidobacteria, actinobacteria,
α,β,γ,δ,E-proteobacteria, bacteroidetes,
chlorobi, chloroflexi, cyanobacteria,
deinococci, firmicutes, nitrospirae,
spirochaetes, synergistetes,
verrucomicrobia, Viruses: caudovirales
T2SS, T5SS, T6SS Imm51, Antitoxin-
DUF2384(in AT system)
Repeats: RHS, FilH
Ntox2 α+ β+ α-helical C-terminus;
GEsH motif and conserved
E, RE, H and K; Multiple copies
in the same gene neighborhood
in Microscilla
Microscilla marina (Bacteroidetes) PVC - Proteases:
PVC-Metallopeptidase
Ntox4 α+ β; Several charged residues Nitrosococcus, Frankia PVC - Proteases:
PVC-Metallopeptidase
Ntox5 α+ β; Several charged residues Streptomyces, Nitrobacter PVC - Proteases:
PVC-Metallopeptidase
Ntox9 Mostly β; RxY, E, WxE and
H; Catalytic mechanism likely
to be similar to that of
Colicin-E3
Actinobacteria, α,β,γ-proteobacteria
bacteroidetes, chlamydiae, fusobacteria
T2SS (MafBN), T5SS,
T6SS
- Proteases:
PrsW peptidase; Repeats: RHS
Ntox12 All-β; D, D, H Actinobacteria, chlamydiae,
firmicutes, α,β,γ- proteobacteria
T2SS, T5SS T6SS, T7SS
(WxG and LxG),
TcdB/TcaC
Imm32; Note immunity
protein also present in
intracellular parasite
Odyssella
Proteases: OUT;
Repeats: RHS, FilH
Ntox13 β/α, KxxxxxxE motif Firmicutes, β-proteobacteria T2SS Imm59 Repeats: RHS
Proteases:
Transglutaminase
Ntox15 Mostly α, HxxD motif Actinobacteria, firmicutes,
α,β,γ- proteobacteria
T2SS, T6SS, T7SS
(LDxD and LxG), PVC
Imm-SUKH Proteases:
PVC-Metallopeptidase,
HINT
Ntox16 α-helical domain; R,
[DNE]xxH; part of polytoxin
in Xanthomonas fuscans
Cyanobacteria, β,γ, δ proteobacteria,
verrucomicrobia
T2SS, T6SS, PVC - Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Ntox17 Mostly β; ExD, H, several
charged residues
α,β,γ proteobacteria, firmicutes T2SS (MafB),
TcdB/TcaC, T7SS
Imm31; association
widespread several
lineages
Repeats: RHS
Ntox20 Mostly β; conserved R Acidobacteria, α,β,γ,E-proteobacteria T2SS (MafBN), T5SS Imm-NMB0513,
Imm-SUKH Imm28
Repeats: FilH
Ntox23 All-β; Bacteroidetes T2SS, TcdB/TcaC - Repeats: RHS
ND, DxxR, H
Ntox24 All-β; Y, H, H; Also found
in Toxin-Antitoxin systems
(see text)
Actinobacteria, α,β,γ-proteobacteria,
chlamydiae, chloroflexi, firmicutes,
fusobacteria
T2SS, T5SS T7SS
(WXG,LXG), MuF
Imm50, Imm53 Proteases: HINT;
Repeats: RHS, FilH
Ntox25 Mostly β; FGPY motif α,γ-proteobacteria, bacteroidetes T2SS, T5SS - Repeats: FilH
Zhang
et
al.Biology
D
irect
2012,7:18
Page
13
of
76
http://w
w
w
.biology-direct.com
/content/7/1/18
Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Ntox27 α+ β; D, E, RxW Actinobacteria, bacteroidetes,
fusobacteria
T2SS, T7SS (WXG) - Proteases: HINT;
Repeats: ALF, RHS
Ntox28 All-α; D,K[DE], [DN]HxxE, E Actinobacteria, α,γ-proteobacteria,
firmicutes
T2SS, T5SS T7SS (WXG) - Repeats: FilH
Ntox31 α+ β; K, E, E Actinobacteria, α,γ-proteobacteria,
bacteroidetes, firmicutes,
eukaryotes: ciliophora
T2SS, T5SS, T6SS,
T7SS (WXG, LXG)
Imm62 Repeats: RHS, FilH
Ntox32 All-α; H, [KR], [ED], [DE] Bacteroidetes, α,γ-proteobacteria,
firmicutes, eukaryotes: insects
T2SS - Proteases: Peptidase S8
(Subtilisin family);
Repeats: RHS
Ntox34 All-α; GNxxD, K, C, C, K, WxCxH
and other charged residues
γ,δ,E-proteobacteria, firmicutes T2SS, T6SS Imm-HEAT Repeats: RHS
Ntox37 All-β; E, [KR] Hx[DH] Actinobacteria, γ-proteobacteria,
chlamydiae, chloroflexi, firmicutes
T2SS, T7SS(WXG) Imm32 Proteases: Tox-PLOTU;
Repeats: RHS
Ntox39 All-β; Several basic residues Firmicutes T2SS - Repeats: RHS
Ntox40 All-β; DRxxG, R, Y Acidobacteria, actinobacteria,
α,β,γ,E-proteobacteria, bacteroidetes,
firmicutes, planctomycetes,
synergistetes, eukaryotes: fungi
T2SS, T5SS, T6SS, T7SS
(WXG,LXG,LDXD),
TcdB/TcaC
Imm35, Imm36, Imm59,
Imm60, Imm61, Imm63
Repeats: RHS, FilH
Ntox42 α+ β; GK, ExxxH, DxYxF[ED] Firmicutes (negativicutes) T5SS - Repeats: FilH
Ntox44 All-α; DxK, GNxxxG, and DxxxD. Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chloroflexi, firmicutes,
proteobacteria, spirochaetes,
eukaryotes: fungi (microsporidia)
T2SS, T6SS,
T7SS(WXG,LXG)
- Proteases: Papain-like
protease; Repeats:
RHS, ALF
Predicted RNase toxins with two conserved histidine residues
Tox-EDA39C α+ β; H, Sx[HS]Y; Present in
a wide range of eukaryotes
where it might be a defensive
RNAse
Acidobacteria, actinobacteria,
α,β,γ,δ-proteobacteria, bacteroidetes,
chlamydiae, chloroflexi, firmicutes,
gemmatimonadetes, planctomycetes,
verrucomicrobia, eukaryotes: plants,
chlorophytes, fungi, dictyosteliida,
stramenopiles
T2SS, T5SS, T6SS,
T7SS (LXG)
Imm-SuFu Proteases: HINT;
Repeats: RHS
Ntox18 α/β; H, S, H α,β,γ- proteobacteria, bacteroidetes,
chloroflexi, cyanobacteria, firmicutes,
eukaryotes: metazoan: Lateral
transfer to Branchiostoma
T2SS (MafBN), T2SS Imm29, Imm42; Imm29
association is widespread
across bacteria
Proteases: HINT;
Repeats: RHS, FilH
Ntox22 Mostly β, D, D, H, E, H Ralstonia, Burkholderia phymatum T5SS - Repeats: FilH
Ntox26 α+ β; KHxx[DE], Q, W, H Actinobacteria, α,β,γ-proteobacteria,
firmicutes, fusobacteria
T2SS, T5SS T7SS (LXG) - Proteases: HINT;
Repeats: RHS, FilH,
Tail fiber
Ntox30 All-β; RxH, R THIP Actinobacteria, bacteroidetes,
α,γ-proteobacteria, firmicutes, spirochaetes
T2SS, T6SS, T7SS (WXG,
LXG), TcdB/TcaC
- Repeats: RHS
α+ β; with two conserved H T2SS, TcdB/TcaC - Repeats: RHS
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Ntox43; Pseudomonas
RhsT-C belongs to
this clade
Actinobacteria, γ,δ-proteobacteria,
firmicutes, verrucomicrobia
Tox-JAB-1 Deaminase fold (α+ β);
NxxxE, HxH, S, D
Bacteroidetes T2SS Imm65 Repeats: RHS
Tox-JAB-2 (DUF4329
in Pfam)
Deaminase fold (α+ β);
E, H[ST]H, S, D
α,γ,δ-proteobacteria bacteroidetes,
cyanobacteria, firmicutes, eukaryotes:
fungi (ascomycota), viruses: caudovirales
T2SS, T6SS, T7SS
(WXG), TcdB/TcaC
Imm-NTF2 family 2 Repeats: RHS
Tox-ComI α+ β fold; DE motif Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, firmicutes, verrucomicrobia,
eukaryotes: dictyosteliida, fungi
(ascomycota, basidiomycota), viruses:
Bacillus phage SP10
T2SS, T6SS Imm-ComJ, Imm-SUKH Proteases: HINT;
Repeats: RHS
Tox-HET-C All-α; H, [DE], HxD, HxxxDxxxH,
Nxx[DE], [ST]G; We predict that
the Het-C domain is related to
phospholipase C and the S1-P1
nuclease and shares a common
active site and fold (see text)
Actinobacteria, cyanobacteria,
γ,δ-proteobacteria, dictyoglomi,
eukaryotes: fungi (ascomycota,
basidiomycota), metazoa
T2SS, T6SS, PVC - Proteases:
PVC-Metallopeptidase
Ntox29 All-β; D,D, HxE, D, K, R residues β,γ-proteobacteria, firmicutes T2SS, T5SS,T7SS (LXG) Imm41 Proteases: HINT;
Repeats: RHS, FilH
Predicted RNase toxins with uncertain metal dependence
Ntox1 α+ β fold; C, C, H, E Acidobacteria, α-proteobacteria PVC Proteases:
PVC-Metallopeptidase
Ntox3 All-β; several charged residues
including as D, R, H, C;
associated with Annexin
domain in Haliangium
Haliangium (δ-proteobacteria),
Microscilla (Bacteroidetes)
PVC - Proteases:
PVC- Metallopeptidase;
Repeats: Annexin
Ntox6 α+ β; several charged residues; Microcoleus(Cyanobacteria),
Haliangium(δ-proteobacteria)
PVC - Proteases:
PVC- Metallopeptidase
Ntox8 α+ β fold; HxR and
HxxxH motifs
β-proteobacteria, bacteroidetes,
firmicutes, eukaryotes: dictyosteliida
T2SS, T6SS Imm16 Repeats: RHS
Ntox10 α+ β; Several charged residues Bacteroidetes, verrucomicrobia T2SS Imm27, Imm53; Imm27
primary immunity
protein across most
lineages
Repeats: RHS
Proteases:
Transglutaminase
Ntox11 α/β followed by β rich
C-terminus; N-terminal GxR,
RxxxoH motif, C-terminal
domain has H, GxE, GxxH and
an acidic residues; Naegleria
possibly secreted
Actinobacteria, cyanobacteria, firmicutes
α, δ,γ-proteobacteria, eukaryotes:
Trichoplax, Naegleria
PVC - Proteases:
PVC- Metallopeptidase
Ntox14 α+ β; Several charged residues Desulfobacca, Pelobacter
(δ-proteobacteria)
PVC Imm22 Proteases:
PVC-Metallopeptidase
Zhang
et
al.Biology
D
irect
2012,7:18
Page
15
of
76
http://w
w
w
.biology-direct.com
/content/7/1/18
Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Ntox33 α+ β; [DN]xHxxK, DxxxD Actinobacteria, cyanobacteria,
firmicutes, γ-proteobacteria,
verrucomicrobia
T2SS - -
Ntox45 α+ β; DxD motif Actinobacteria, α-proteobacteria,
bacteroidetes
T2SS - Proteases: HINT;
Repeats: RHS
Other toxins that act on nucleic acids
Tox-Deaminase Deaminase fold (α+ β);
[HCD]xE, CxxC; As
previously reported, nine
distinct families of deaminase
belonging to two distinct clades
are present in polymorphic toxin
systems as toxins. We report
two additional families below
Acidobacteria, actinobacteria,
bacteroidetes, chlorobi, cyanobacteria,
firmicutes, α,β,γ,δ,-proteobacteria
Eukaryotes: See text and previous
publication
T2SS (MafBN), T5SS,
T6SS, T7SS (WXG,
LDXD, LXG), PVC,
TcdB/TcaC
Imm1, Imm2, Imm3,
Imm4, Imm5,
Proteases:
PVC-Metallopeptidase,
HINT, CPD, PrsW
peptidase, Caspase;
Repeats: RHS, FilH, ALF,
PPR
Imm6, Imm10, Imm18,
Imm-SUKH, Imm-ank
Tox-Deaminase
(sce3516-like)
Deaminase fold (α+ β);
H[occasionally D]xE,
CxxC; Toxins of this family
belong to the strand-hairpin
clade of deaminases
Actinobacteria, β,γ,δ,-proteobacteria T2SS, T5SS, T6SS
T7SS, TcdB/TcaC
Imm-SUKH Proteases: HINT
Repeats: RHS, FilH
Tox-Deaminase
(WD0512-like)
Deaminase fold (α+ β); CxE,
CxxC; Toxins of this family
belong to the Helix-4 clade of
deaminases. These proteins
additionally contain a C-terminal
toxin, the Tox-Latrotoxin-CTD
α- proteobacteria (Wolbachia) T2SS - Repeats: RHS
Tox-ParB ParB fold (α+ β); R Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, firmicutes
T2SS (MafBN), T5SS,
T6SS, T7SS (WXG), PVC
Imm20, Imm27,
Imm-SuFu
Proteases:
PVC-Metallopeptidase,
HINT; Repeats: RHS, FilH
Tox-ParBL1 Predicted ParB fold (α+ β);
[ST], [NT][RT][RT]; note the
latter two residues of this
motif are mostly R
Actinobacteria,α,β,γ-proteobacteria,
firmicutes, euryarchaea, eukaryotes:
stramenopiles, viridiplantae,
ascomycota, chlorophyta,
choanoflagellida,metazoa,ciliophora,
kinetoplastida
T2SS (MafBN), T5SS,
T6SS, T7SS (WXG, LXG)
Imm-SUKH, Imm44 Proteases: HINT;
Repeats: FilH, RHS
Tox-HTH HTH fold; RxxY, R, [ST] Acidobacteria, actinobacteria,
α,β,γ,δ,E-proteobacteria, bacteroidetes,
cyanobacteria, firmicutes, proteobacteria,
archaea, eukaryotes: ascomycota,
viridiplantae,
T2SS, T5SS, T6SS, T7SS
(LXG, WXG, LDXD),
PVC, MuF
- Proteases:
PVC-Metallopeptidase;
Repeats: FilH
Peptidase toxins
Tox-
ALFMetallopeptidase(Anthrax
lethal factor)
metallopeptidase fold
(α+ β); HExxH
Actinobacteria, bacteroidetes,
δ-proteobacteria, firmicutes, fibrobacteres
PVC, T2SS Imm-SuFu Proteases:
PVC-Metallopeptidase
Repeats: FilH
Tox-HopH1 metallopeptidase fold
(α+ β); HExxH, [DE]N
Actinobacteria, α,β,γ-proteobacteria
bacteroidetes, planctomycetes
T2SS,T3SS,T5SS,
T6SS,T7SS (WXG), PVC, TcdB/TcaC
- Proteases:
PVC-Metallopeptidase,
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
ZU5, caspase; Repeats:
RHS
Tox-MPTase1 metallopeptidase fold
(α+ β); HExxH
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chlorobi, cyanobacteria,
deinococci, planctomycetes, spirochaetes,
thermotogae
T2SS,T7SS (WXG),
TcdB/TcaC
- Repeats: RHS
Tox-MPTase2 metallopeptidase fold
(α+ β); Y, HExxH,
Bacteroidetes TcdB/TcaC - Proteases: ZU5;
Repeats: RHS
Tox-MPTase3 metallopeptidase fold (α+ β);
K, HExxH, F[DE]
α-proteobacteria, bacteroidetes T2SS, PVC - Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Tox-MPTase4 metallopeptidase fold (α+ β);
F[DN], [RK], HExxH
γ-proteobacteria, fusobacteria,
firmicutes, planctomycetes
T2SS, T6SS, T7SS
(WXG,LDXD,LXG)
- Repeats: RHS
Tox-MPTase5 metallopeptidase fold
(α+ β); HEELH
Actinobacteria, γ-proteobacteria T2SS - Repeats: RHS
PVC-Metallopeptidase metallopeptidase fold (α+ β);
HExxH; Most versions of this
domain are releasing peptidases
in polymorphic toxins. However,
some versions, often present
at the C-terminal end of
polymorphic toxins, are likely to
additionally function as toxins
Acidobacteria, actinobacteria,
α,β,γ,δ-proteobacteria, bacteroidetes,
chlorobi, chloroflexi, cyanobacteria,
deinococci, firmicutes, nitrospirae,
verrucomicrobia, archaea: euryarchaeota,
eukaryotes: fungi(ascomycota)
PVC - Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Tox-MCF1-SHE All-α; S, T, HSxxE Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chlamydiae, viruses:
Acanthamoeba polyphaga mimivirus
T2SS, T7SS(WXG), PVC - Proteases:
PVC-Metallopeptidase,
Caspase, Tox-PLOTU
Tox-SerPeptidase α+ β; H, R, R Actinobacteria, α,β,γ,δ,E-proteobacteria T2SS, T7SS (WXG) - Proteases: Tox-PLOTU
Tox-YabG α+ β; HxD, Y, E, [DE], GHD, Y, R Bacteroidetes, firmicutes PVC DUF1021(antitoxin in
toxin-antitoxin
systems), Imm-SUKH
Proteases:
PVC-Metallopeptidase
Tox-LD-peptidase LD-peptidase (PDB: 1ZAT);
H, S, C
Actinobacteria, bacteroidetes,
β,γ,δ-proteobacteria, chloroflexi, firmicutes
T2SS,T6SS, TcdB/TcaC Imm16, Imm57 Proteases: ZU5;
Repeats: RHS
Tox-Caspase Caspase-like fold (α/β); H, C;
Most versions of this domain
are releasing peptidases in
polymorphic toxins. However,
some versions, often present
at the C-terminal end of
polymorphic toxins, are likely
to additionally function as toxins
Actinobacteria, α,β,γ,δ,E-proteobacteria,
bacteroidetes, chloroflexi, cyanobacteria,
firmicutes, viruses: caudovirales
T2SS,T6SS, T7SS
(WXG,PPE), PVC
Imm36 Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Tox-HDC α+ β; H, D, C β,γ-proteobacteria, viruses: caudovirales T2SS - Proteases: Caspase;
Repeats: RHS
Tox-NLPC/P60 Papain-like peptidase fold
(α+ β); C, H, D
Bacteroidetes, δ-proteobacteria T6SS, PVC, TcdB/TcaC -
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Proteases:
PVC-Metallopeptidase,
ZU5; Repeats: RHS
Tox-PL1 Papain-like peptidase fold
(α+ β); NC, H, D; Most
versions of this domain are
toxins in polymorphic toxins.
However, some versions are,
additionally, likely to be releasing
peptidases
Actinobacteria, bacteroidetes,
γ,δ-proteobacteria, firmicutes, fusobacteria,
gemmatimonadetes
T2SS, T3SS, T6SS, T7SS
(WXG), MuF
- Proteases: Tox-Caspase,
HINT; Repeats: RHS
Tox-PL-2 Papain-like peptidase fold
(α+ β); C, NxxH, DN
β,δ-proteobacteria, cyanobacteria, firmicutes T2SS, TcdB/TcaC Imm73 Proteases: HINT, PLOTU,
ZU5; Repeats: RHS
Tox-PL3 Papain-like peptidase fold
(α+ β); C, [DE]H, [DE], R
Bacteroidetes, fibrobacteres, δ,E-proteobacteria T2SS, TcdB/TcaC - Proteases: ZU5;
Repeats: RHS
Tox-PLOTU Papain-like peptidase fold
(α+ β); C, H, D; Most versions
of this domain are releasing
peptidases in polymorphic toxins.
However, some versions, often
present at the C-terminal
end of polymorphic toxins, are
likely to additionally function
as toxins
Actinobacteria, α,γ-proteobacteria, bacteroidetes,
chlamydiae, eukaryotes: fungi (ascomycota),
metazoa, viridiplantae, viruses: Invertebrate
iridescent virus 3, Wiseana iridescent virus
T2SS (APD1),
T7SS (WXG)
- Repeats: Ankyrin,
Sel1, FilH
Tox-PLC39 Papain-like peptidase fold
(α+ β); C, H, D
Bacteroidetes, chloroflexi, firmicutes T2SS, T6SS, PVC - Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Tox-PLDMTX Papain-like peptidase fold
(α+ β); C, W, H, D, Q
α,β,γ-proteobacteria T2SS - -
Tox-TGase Papain-like fold (α+ β); C, H, D β,γ,δ-proteobacteria, bacteroidetes,
cyanobacteria
T2SS, T3SS, PVC - Proteases:
PVC-Metallopeptidase
Tox-UCH Papain-like fold (α+ β) C, H, D β-proteobacteria PVC - Proteases:
PVC-Metallopeptidase
Tox-OmpA α+ β; α,β,γ-proteobacteria, cyanobacteria PVC - Proteases:
PVC-Metallopeptidase
Protein-modifying toxins
Tox-ART-RSE; ADP-ribosyltransferase fold
(α+ β); RxDxR, S, [DN]xN, E
Actinobacteria, α,β,γ,δ-proteobacteria,
bacteroidetes, chloroflexi, firmicutes,
planctomycetes, spirochaetes, tenericutes,
eukaryotes: fungi (ascomycota,
basidiomycota), metazoan (hexapoda,
mollusca), viridiplantae, viruses: Vibrio
phage CTX
T2SS, T6SS, T7SS
(WXG, LXG, LDXD)
Imm41, Imm-ADP-
RGHD (ADP-ribosyl
glycohydrolase)
Proteases: HINT,
Caspase, MCF1-SHE
Repeats: RHS, Tail-fiber
Tox-ART-PARP ADP-ribosyltransferase fold
(α+ β); HG[ST], Y, K, E
Actinobacteria PVC - Proteases:
PVC-Metallopeptidase
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
Tox-ART-HYE1 ADP-ribosyltransferase fold
(α+ β); H, Y, E
γ-proteobacteria TcdB/TcaC? - Repeats: RHS
Tox-ART-HYD1 ADP-ribosyltransferase fold
(α+ β); H,[RK], [FY], [DE]
Actinobacteria, β,γ-proteobacteria,
bacteroidetes, firmicutes
T2SS, T6SS, T7SS Imm-My6CBD; Proteases: HINT;
Repeats: RHS
Tox-ART-HYD2 ADP-ribosyltransferase fold
(α+ β); H, D, GFY, W, R
Actinobacteria, bacteroidetes, deinococci,
fibrobacteres, firmicutes, fusobacteria,
γ-proteobacteria, lentisphaerae, spirochaetes,
synergistetes, eukaryotes: choanoflagellida,
Capsaspora, fungi, cnidaria
T2SS, PVC - Proteases: HINT,
PVC-Metallopeptidase;
Repeats: RHS, Tail-Fiber
Tox-ARC
(ADP-Ribosyl cyclase)
Flavodoxin fold (α/β); [ST]
[DE], S, E
Actinobacteria, bacteroidetes, cyanobacteria,
firmicutes, β, γ- proteobacteria, spirochaetes
eukaryotes: fungi (ascomycota, basidiomycota),
Capsaspora, choanoflagellida, metazoa;
This domain appears to have independently
been acquired by the fungi and the animals
from the bacteria.
T2SS, T5SS, T6SS,
T7SS (LXG, WXG)
Imm74, Imm63; Imm74
is the primary immunity
protein across wide
phyletic range
Repeats: RHS, FilH
Tox-Doc Doc/Fic fold (PDB: 2f6s, All-α);
HxFx[DE]GNxR; (See Pfam
PF02661)
Actinobacteria, γ-proteobacteria T5SS, T7SS (WXG) Imm23, Imm-SUKH,
Imm13
Proteases: Caspase;
Repeats: FilH
Tox-CNF (Cytotoxic
necrotizing factor)
CNF1/YfiH fold (α+ β, PDB:
1hzg); D, C, H; See Pfam
PF05785
γ-proteobacteria T6SS - Repeats: RHS
Tox-Glycosyltransferase Nucleotide diphospho-sugar
transferase fold (α/β); [DNE]xxR,
YxDxD; See Pfam PF04488
Actinobacteria T7SS (WXG), PVC - Proteases:
PVC-Metallopeptidase
Tox-Peptide Kinase α+ β; DxH, YKP[KR], DxHxEN,
DxE, S, R; Related to the kinase
domain found in lantibiotic
synthetases
Firmicutes PVC - Proteases:
PVC-Metallopeptidase
Pore-forming toxins
Tox-WTIP Two membrane spanning
α-helices; RxxR, Wx[ST]IP
α,β,γ-proteobacteria T2SS, PVC - Proteases:
PVC-Metallopeptidase;
Repeats: RHS
Toxins that act on carbohydrates
Tox-Aldo-ketoreductase Rossmann (α/β); Bacteroidetes, cyanobacteria PVC - Proteases:
PVC-Metallopeptidases;
Tox-Glucosaminidase Lysozyme-like fold (α+ β); E, N,
Y (See Pfam PF01832)
Firmicutes T6SS, PVC - Proteases:
PVC-Metallopeptidase
Toxins that act on lipids
Tox-AB hydrolase1
(Pfam DUF2235)
α/β hydrolase (α/β); DG, [ST]N,
[KR], D, ExE, GxHxD
Acidobacteria, actinobacteria,
α,β,γ,δ,E-proteobacteria, bacteroidetes,
cyanobacteria, nitrospirae planctomycetes,
verrucomicrobia, eukaryotes:
T2SS, T6SS - Repeats: RHS
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Table 2 Phyletic distribution, export pathways, and contextually-associated domains and proteins of polymorphic toxin domains (Continued)
fungi(ascomycota, basidiomycota),
rhodophyta, viridiplantae
Tox- AB hydrolase3 α/β hydrolase (α/β); G[ST],
GHSxG
Actinobacteria, α,β,γ-proteobacteria,
bacteroidetes, firmicutes
T2SS, T6SS,T7SS (WXG),
TcdB/TcaC
Imm66, Imm69 Repeats: RHS, FilH
Tox-PLA2 Phospholipase A2 fold
(All-α, PDB: 1kp4);
DxC[ST], CxxHxxxYxN, C
Actinobacteria, α,β,γ,δ-proteobacteria,
aquificae, bacteroidetes, chlorobi, chloroflexi,
cyanobacteria, deinococci, firmicutes,
fusobacteria, nitrospirae, planctomycetes,
spirochaetes, eukaryotes: fungi(ascomycota),
heterolobosea, metazoa, stramenopiles,
viridiplantae, Viruses: Campylobacter
phage
T2SS - Repeats: RHS, ALF
Tox-CDP-alcohol
phosphatidyltransferase
All-α; DxxDGxxxR, DxxxD;
See Pfam PF01066
β-proteobacteria (mainly Neisseria species) PVC - Proteases:
PVC-Metallopeptidase
Tox-Glycerophosphoryl
diester phosphodiesterase
(GDPD)
TIM Barrel (PDB: 1VD6; α/β);
HRG, E, ExD, D, H; See Pfam
PF03009
Cyanothece sp. (Cyanobacteria) PVC - Proteases:
PVC-Metallopeptidase
Miscellaneous toxins
Tox-AB hydrolase2 α/β hydrolase superfamily (α/β);
NG, [DE], [KR], HSxG, D, H
acidobacteria, α,β,γ,δ,E-proteobacteria,
chlamydiae, fusobacteria, verrucomicrobia,
eukaryotes: fungi(ascomycota,
basidiomycota), stramenopiles
T2SS, T5SS, T6SS Imm-SUKH Repeats: FilH, RHS
Tox-ODYAM1 All-α; Several charged residues α-proteobacteria, bacteroidetes T2SS (APD1) - Proteases: Tox-PLOTU;
Repeats: Sel1
Tox-LatrotoxinCTD Two conserved α-helices;
D, [ST], Y, E
α,γ-proteobacteria, eukaryotes: metazoa
(Latrodectus hasseltii, Latrodectus
tredecimguttatus)
T2SS - Proteases: Tox-PLOTU;
Repeats: ankyrin
Tox-SGS (salivary gland
secreted protein)
α+ β; C, C, C, C, [DE}xx[ND] Eukaryotes: metazoan
(crustacea, hexapoda)
T2SS - Repeats: RHS
Ntox38 All-β; PXhhG and several
hydrophobic residues
Actinobacteria T2SS, T7SS (WXG) Imm56 Proteases: Mycosin
(Subtilisin)-like protease
in the neighborhood
Ntox46 α+ β; [KR]STxxPxxDxx[ST], Q α,γ,δ-proteobacteria, bacteroidetes T2SS, T6SS - Repeats: RHS, FilH
1. Toxins are grouped and arranged based on the similarity of their known or predicted biochemical functions.
2. Where possible, known or predicted folds are described. The folds are further classified as All-α (composed entirely of α-helices), All-β (composed entirely of β-strands), α+ β (Containing α-helices and β-strands) or
α/β (comprising repeated α-helix-β-strand units) depending on the arrangement of their structural elements. Individual conserved residues and motifs are separated by commas. Alternative residues are enclosed in
square brackets; ‘x’ denotes any residue, ‘h’ indicates a hydrophobic residue (LIYVFMCW).
3. By default most lineages are bacterial unless stated otherwise. Eukaryotes and viruses are shown in bold.
4. T2SS: Type 2 secretion system; T5SS: Type 5 secretion system, T6SS: Type 6 secretion system, T7SS: Type 7 secretion system. The secretory domains for T7SS are shown next to it in parentheses.
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems
Immunity protein Fold; Conservation1 Associated toxins2 Phyletic distribution Additional Notes
Imm-SUKH α+ β (PDB: 3D5P); Several
hydrophobic residues and
family-specific differences.
Refer to previous paper
for details
HNH fold families: Tox-SHH,Tox-
HNH,Tox-HNH-CIDE, Tox-WHH,
Tox-DHNNK, Tox-LHH,
Tox-GHH, Tox-HHH, Tox-NucA,
Tox-ColE7;
Acidobacteria, actinobacteria,
αβγδE-proteobacteria, bacteroidetes,,
chloroflexi, cyanobacteria, deinococci,
firmicutes, fusobacteria, planctomycetes,
spirochaetes, synergistetes,
verrucomicrobia Eukaryotes: Giardia,
ciliophora, choanoflagellida, fungi,
Naegleria, metazoa, stramenopiles,
viridiplantae, chlorophyta, eukaryotic
viruses
This superfamily comprises 5 major families
(SUKH1-5), which have been combined
in this study; Shows fusions on occasions
to toxins and immunity domains;
For e.g. fusions to Tox-GHH, Imm-SuFu,
Imm33, Imm37, Imm66, Imm67, Imm68,
Imm69. Found in homogeneous and
heterogenous polyimmunity loci
Restriction endonuclease fold
families: Tox-REase-4, Tox-REase-3;
Deaminase families: YwqJ,
XOO2897, BURPS668_1122
Proteases: YabG, Tox-PL1;
Other toxins: Tox-EndoU,
Tox-DOC, Caspase, Tox-ParBL1,
Tox-ComI, Ntox15, Ntox20,
Tox-ABhydrolase2, Tox-
ABhydrolase3
Imm-SuFu α+ β (PDB: 1M1L);
GxS, E, E, DxxR
NGO1392-like Tox-HNH fold
domaina (SuFu-associated
nuclease), Tox-GHEb, Tox-ParBc,
Tox-DHNNK d, Tox-AHHe,
Tox-HNHf, Tox-EndoUg, Tox-EDA39Ch,
Tox-PL-C39-like peptidasei,Tox-
ALF-MPTasej, Ntox7k
Acidobacteria, actinobacteriaab,d,
α,βa,b,c, f,γa,c, d,δe, h,E-proteobacteria,
bacteroidetesb,I,k, chloroflexi, firmicutesb,e,g,
fusobacteria, planctomycetes, spirochaetesj,
tenericutes verrucomicrobia.
Fused to members of the SUKH family,
ankyrin repeats, Imm5, Imm11, Imm33,
Imm36, Imm66, Imm67, Imm68, Imm69,
PsbP/MOG1. Found in homo- and
heterogeneous polyimmunity loci.
See Pfam PF05076
Eukaryotes: chlorophyta, ascomycota,
choanoflagellida, metazoa
Imm-SuFu- family 2 α+ β; [ST]xxG, [DE] Tox-ColE7a, Tox-DHNNK, Tox-HNH
foldb, Tox-ALFMPTasec,Tox-GDPDd
actinobacteria αd,β,γ,δ,E-proteobacteria,
bacteroidetes, cyanobacteria, fibrobacteres,
firmicutes a,b, fusobacteria, gammaproteobacteria,
planctomycetes, proteobacteria, spirochaetesc,
verrucomicrobia
Fused to Imm34, Imm33, Imm66, Imm67,
Imm68, Imm69; Found in heterogeneous
polyimmunity loci
Imm-Cloacin FKBP-like α+ β;
EYSxD, NxG
Tox-ColE3a Plasmid a,ColE6-CT14 a, γ-proteobacteria a
HEAT repeats All α; Tox-REase-7a Actinobacteriaa,bacteroidetes,cyanobacteria,γ-
proteobacteria,planctomycetesa,verrucomicrobiaa
Ankyrin repeats
(Imm-ank)
All α; Tox-AHHa Firmicutesa, planctomycetesa, γ-proteobacteriaa Fused to SuFu-like immunity domains in
firmicutes and found in heterogeneous
polyimmunity loci
LRR-repeats α/β; Next to T5SSa toxins actinobacteria,bacteria,β,γa,E-proteobacteria,
firmicutes, tenericutes
Found in heterogeneous polyimmunity loci
Imm-CdiI Two transmembrane helices;
several hydrophobic residues
CdiAC γ-proteobacteria
Imm-NTF2 NTF2 fold (α+ β); W, W, W Tox-NucA a Bacteroidetes, β,γ a,E-proteobacteria, firmicutes,
fusobacteria, verrucomicrobia
Fused to ankyrin repeats and Imm13
in some proteins
Imm-NTF2-2 NTF2 fold (α+ β); Y,W Tox-JAB-2 γ –proteobacteria (E. coli only) Although related in structure to
Imm-NTF2, the sequences are quite
divergent from each other
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
Imm-PA2201 Two all-α domains(PDB:
2FEF); D, W,GxWxxE, D, YPxD
Tox-REase-1a, Tox-AHHb Bacteroidetesa, β a,γ a, b,E a -proteobacteria,
firmicutes a
See Pfam DUF1910 +DUF1911
Imm-Barstar α/β (PDB: 1BRS); DxxxD and
several hydrophobic residues
Tox-Barnase-like ribonucleasea Acidobacteria, actinobacteriaa,
α, βa,γa,δa,Ea-proteobacteria
bacteroidetesa, chlamydiaea, chloroflexia,
cyanobacteriaa, deinococcia, elusimicrobia,
firmicutesa,fusobacteriaa, nitrospiraea,
planctomycetesa, verrucomicrobia, Archaea:
euryarchaeaa, Eukaryotes:dictyosteliida,
Naegleria,
chlorophyta
See Pfam PF01337
Imm-ADP-RGHD; ADP
ribosyl glycohydrolase
All-α; (PDB: 1t5j); D, D[DE],
[RK], H
Tox-ART-RSEa acidobacteria, β,γa-proteobacteria, firmicutesa See Pfam Pf03747; an example of an
enzymatic immunity protein
Imm-NMB0513 wHTH fold (α+ β, PDB:
2O5H); W, W
Ntox20a, Ntox7b betaproteobacteriaa,b gammaproteobacteriaa Corresponds to Pfam DUF596
Imm-ComJ Mostly β; W, F[DE], PF, Y, Y Tox-ComI-like competence
nucleasea
αaβaγa-proteobacteria, bacteroidetesa,
cyanobacteria, firmicutesa,
Eukaryotes: viridiplantae
Imm-VC0424 α+ β; α+ β RRM fold, W
at C-terminus
- Firmicutes, fusobacteria, α,β,γ-proteobacteria Also known as DUF1260 in the Pfam
database. Only a subset of members
is found in polymorphic toxin systems
as potential immunity proteins. These
species are listed in column 3
Imm-My6CBD α+ β; E, R, F, W Tox-ART-HYD1a actinobacteria a, bacteroidetes a, firmicutes a,
fusobacteria, β a,γ a –proteobacteria,
Eukaryotes: Metazoa
The type VI myosin cargo-binding
domain of metazoa appears to have
been acquired by lateral transfer
from a bacterial version
Imm1 α+ β; aromatic and W
at C-terminus
SCP1.201 deaminasesa Actinobacteriaa, bacteroidetes, cyanobacteria,
firmicutes, planctomycetes α,β,γ-proteobacteria,
verrucomicrobia
Imm2 All α; acidic and
hydrophobic residues
BURPS668_1122 deaminases β, γ- proteobacteria
Imm3 All α; charged, V BURPS668_1122 deaminases Firmicutes found in heterogeneous
polyimmunity loci
Imm4 α+ β SCP1.201 deaminases Burkholderia pseudomallei
Imm5 Mostly α; R, D DYW deaminasesa, CdiACb Actinobacteriaa, bacteroidetesa, firmicutesa,
α,β,γa, b,proteobacteria
Fused to Imm36 on occasions
Imm6 Mostly α; P, [DE] YwqJ deaminasesa Actinobacteriaa, α-proteobacteria, firmicutesa Found in homo and heterogeneous
polyimmunity loci
Imm7 α+ β; GxaG Tox-REase-3a actinobacteria, firmicutes a, planctomycetes
Imm8 α+ β; WEa (a:aromatic)
at C-terminus
Ntox7a Acidobacteria, actinobacteria, bacteroidetes a,
firmicutes a, α, β a, γ a, δ-proteobacteria
Imm9 Tox-URI2 Bacteroidetes, γ-proteobacteria
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
α+ β; K and several
conserved acidic
residues
Found in heterogeneous
polyimmunity loci
Imm10 Mostly β; R and several
hydrophobic residues
Pput_2613 deaminasea actinobacteria bacteroidetes chloroflexi
firmicutes β, γa,δ,E-proteobacteria;
Eukaryotes: ascomycetes
Lateral transfer to fungi, found in
heterogeneous polyimmunity loci
Imm11 α+ β; several conserved
hydrophobic residues
Tox-AHHa, Tox-HNHb, Tox-SHHc Bacteroidetesa, chloroflexi, cyanobacteria,
firmicutesa, planctomycetesa,
α,βa,γa,δa,b,c,Ea-proteobacteria
spirochaetesa verrucomicrobiaa
Listed in the Pfam database as DUF1629.
Fused to SuFu on occasions. Found
in heterogeneous and homogeneous
polyimmunity loci.
Imm12 α+ β; several conserved
charged and hydrophobic
residues
Tox-URI2a Bacteroidetesa, spirochaetes Found in heterogeneous
polyimmunity loci
Imm13 α+ β; D, D, D, D Tox-DOCa Actinobacteria, bacteroidetes cyanobacteria,
firmicutes, fusobacteriaa, spirochaetes,
verrucomicrobia, α,β,γ,δ-proteobacteria,
Note lateral transfer to eukaryotes.
Found in heterogeneous polyimmunity
loci. Fused to Imm33 in some instances
Eukaryotes: Naegleria
Imm14 Mostly β; several hydrophobic
residues
Tox-URI1a, Tox-HNHb Actinobacteriaa, α,βa,γa,,δb-proteobacteria,
bacteroidetesa, chlamydiaea, chloroflexia,
cyanobacteria, firmicutesa, fusobacteria,
spirochaetes, verrucomicrobia
Found in heterogeneous polyimmunity
loci; Fused to Imm51 in one instance
Imm15 α+ β; several polar and
hydrophobic residues
Bacteroidetes, firmicutes, synergistetes Found in heterogeneous
polyimmunity loci
Imm16 α+ β; several hydrophobic
residues including a highly
conserved W
Ntox8a Actinobacteria, bacteroidetes a,
β a,γ,δ-proteobacteria, firmicutes a,
planctomycetes, spirochaetes,
verrucomicrobia
Also known as DUF2750
Imm17 Two TM helices; WxW and
a R in the region between
them
Bacteroidetes, firmicutes, fusobacteria,
spirochaetes
Found in heterogeneous
polyimmunity loci
Imm18 Mostly β; highly conserved D Tox-HNH a Actinobacteria a, αβ a γ a δ a -proteobacteria,
bacteroidetes a, firmicutes
Found in heterogeneous
polyimmunity loci
Imm19 α+ β; HxxRN motif and
several conserved hydrophobic
residues
- Bacteroidetes Found in heterogeneous
polyimmunity loci
Imm20 α+ β; several conserved
hydrophobic residues
Tox-AHH a, Tox-ParB b Acidobacteria, actinobacteria, bacteroidetes,
β a, b,γ a,δ-proteobacteria, cyanobacterium
firmicutes a, fusobacteria, planctomycetes,
spirochaetes, verrucomicrobia,
Eukaryotes: ascomycota
Found in heterogeneous
polyimmunity loci. Note presence
in ascomycetes
Imm21 α+ β; absolutely conserved
WxG, YxxxC and several
hydrophobic residues
NGO1392-like HNH folda Actinobacteria, α,δ-proteobacteria, bacteroidetes,
firmicutesa, verrucomicrobia
Found in heterogeneous
polyimmunity loci
Imm22
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
α+ β; W, Y, and an acidic
residue (mostly D)
ColD/E5 folda, Tox-REase-4b, Ntox49c,
Ntox14d
Actinobacteria, bacteroidetesa,c,
β,γ-proteobacteria, firmicutes b,d,
fusobacteria, planctomycetes,
verrucomicrobia, Eukaryotes: ascomycota
Previously known as SNCF1. Found
in heterogeneous polyimmunity
loci across a wide range of bacteria
Imm23 α+ β; several hydrophobic
residues including a
WxW motif
Tox-AHHa, Tox-REase-7b bacteroidetesa cyanobacteria b, firmicutes
γ-proteobacteria verrucomicrobia
Some versions fused to Imm11;
found in heterogeneous polyimmunity
loci
Imm24 Mostly α-helical with
C-terminal β-hairpin; several
hydrophobics including a
PxG motif (where x is
mostly C)
Tox-AHHa, Tox-SHHb Bacteroidetesc, βa,γa,E-proteobacteria,
firmicutesa,b, verrucomicrobia
found in heterogeneous
polyimmunity loci
Imm25 α+ β; highly conserved in
limited sequences
- Bacteroidetes Potential immunity protein found in
heterogeneous polyimmunity loci,
and a limited phyletic presence
Imm26 Mostly α; R and D and
several hydrophobic residues
Tox-URI1a Actinobacteria, bacteroidetesa,
β,γa,δ-proteobacteria, firmicutes,
fusobacteria, planctomycetes,
spirochaetes, Eukaryotes: Ascomycota
Note presence in ascomycetes, present
in heterogeneous polyimmunity loci
Imm27 α+ β; D, GGxP Ntox10a, Tox-ParBb Actinobacteria, bacteroidetes a,
β,δb-proteobacteria, verrucomicrobia a
Wide distribution but sporadic numbers
Imm28 Mostly α; acidic, P,G, R Tox-WHHa, Tox-EndoUb, Ntox20c Actinobacteria, αa,βb,c,γa-proteobacteria Note presence in Odyssella, present in
heterogeneous polyimmunity loci
Imm29 Mostly α; R and acidic
and several hydrophobic
residues
Ntox18 a Actinobacteria, α a,β a,γ a -proteobacteria,
bacteroidetes, firmicutes, fusobacteria
Note presence in Odyssella, present in
heterogeneous polyimmunity loci
Imm30 Mostly α; Several conserved
hydrophobics and DxG motif
Tox-SHHa α a,β,γ a –proteobacteria Note presence in Odyssella. Limited
number of hits, present in heterogeneous
polyimmunity loci
Imm31 All-β; GxS, [R] Ntox17a, Ntox7b α a,βb,γ a,δ-proteobacteria, cyanobacteria Note presence in Odyssella.
Limited distribution
Imm32 α+ β; H, and several
conserved residues
Ntox12a, Ntox37 b, Ntox7 c α a,β,γ a,c,δ-proteobacteria, chlamydiae,
bacteroidetes b, firmicutes a, verrucomicrobia
Note presence in Odyssella, chlamydiae.
Limited distribution
Imm33 Mostly β; W Tox-HNH a, Tox-DHNNK b,,
NGO1392-like- HNHc
Acidobacteria, actinobacteria,
αβ a,c γδc-proteobacteria, bacteroidetes,
chloroflexi, firmicutes, b, fusobacteria,
planctomycetes, Eukaryotes: dictyosteliida
Also known as DUF2185 in the Pfam
database, fused to Imm- SUKH, Imm13,
Imm34 and Imm-SuFu, Note presence in
dictyosteliida where it is fused to Imm34,
present in homo and heterogeneous
polyimmunity loci
Imm34 Mostly β; ExxW, C-terminal D - Actinobacteria, α,β,γ,δ,E-proteobacteria,
bacteroidetes, firmicutes, fusobacteria,
planctomycetes, spirochaetes,
verrucomicrobia, Eukaryotes:
dictyosteliida, heterolobosea, cnidaria
Also known as DUF2314. Fused to
Imm-SuFu family 2, Imm33, ankyrin
repeats, TM helices, fusion to Imm33
appears to have occurred on multiple
occasions independently, present in
heterogeneous polyimmunity loci.
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
Note presence in Naegleria, dictyosteliida
and cnidarians. In dictyostellids, it is
fused to Imm33
Imm35 α+ β; W, [ST] Tox-PL1a, Ntox40b Actinobacteriaa, b, bacteroidetesa,
β,γa-proteobacteria, planctomycetes
Fused to Papain-like toxin and
ADP-ribosyl glycohydrolase and Peptidase
S8, in some instances. Possible protease
inhibitor
Imm36 BH3703-like fold (α+ β); W, W Tox-NucAa, DYW-Deaminaseb, Ntox40c,
Tox-CdiACd, Tox-Caspasee
Actinobacteriaa, c, e, αa,βa,γa,d,δ-proteobacteria,
bacteroidetesa,b, firmicutesa, fusobacteria,
spirochaetesa
Also known as DUF600, fused to
Tox-NucA, Imm-SuFu, Imm5, on occasions.
Tox-NucA appears to be the primary toxin
association. One of the large families.
Found in homo and heterogeneous
poly-immunity loci. Profile-profile analysis
predicts a BH3703-like fold
Imm37 α+ β; ExG Tox-WHHa Acidobacteria, actinobacteria,
αβγaE-proteobacteria, bacteroidetes,
chloroflexi, cyanobacteria, deinococci,
firmicutesa, fusobacteriaa, planctomycetes,
verrucomicrobia
Previously known as SNCF2, fused to
SUKH in some instances. Found in
heterogeneous polyimmunity loci
Imm38 Mostly α; W at N and aromatic
residue at C
Ntox19a, NGO1392-like- HNHb Actinobacteria, bacteroidetes a,
β a,b,γ a,δ a -proteobacteria,
firmicutes a, fusobacteria a, nitrospirae
Also known as DUF2247. Found in
heterogeneous polyimmunity loci
Imm39 α+ β; GR, GxK and several
polar and hydrophobic residues
Tox-URI2 a α a γ a-proteobacteria Limited distribution
Imm40 α+ β; GGD, F, W Ntox19a bacteroidetesa, chloroflexi firmicutes,
βa,E,γa- proteobacteria
Imm41 α+ β; SF, W and several
hydrophobic residues
Ntox21a, Ntox29 b, Tox-ART-RSE c Actinobacteria, β a,b,γc,E-proteobacteria,
firmicutes, planctomycetes
Found in homo- and heterogeneous
polyimmunity loci
Imm42 α+ β; Several conserved
hydrophobic residues
Ntox18a α,β a,γ a -proteobacteria, firmicutes a
Imm43 α/β; W, P, D, S, R Tox-AHHa Bacteroidetesa, β-proteobacteriaa, firmicutes Found in heterogeneous
polyimmunity loci
Imm44 α+ β; Multiple polar and
hydrophobic residiues
Tox-URI1a, Tox-URI2b, Tox-ParBL1c Bacteroidetes, β-proteobacteriaa,b, firmicutesc Limited phyletic distribution; Found
in heterogeneous polyimmunity loci
that show variations in structure
even between closely related strains
Imm45 α+ β; C-terminal W Tox-ColE3a bacteroidetes,β a,γ a,E-proteobacteria,
firmicutes
Imm46 α+ β; E, W, E - Bacteroidetes, β-proteobacteria Limited phyletic distribution. Found
next to a predicted toxin
Imm47 α+ β; KxGDxxK - β-proteobacteria, firmicutes Found in heterogeneous
polyimmunity loci
Imm48 All-α; HRG - Firmicutes,verrucomicrobia Found in heterogeneous
polyimmunity loci
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Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
Imm49 All α; Hydrophobic residues, P Tox-REase-1a, Tox-REase-6b Actinobacteria b, Bacteroidetes a,b,
cyanobacteria b, firmicutes a,
fusobacteria a, planctomycetes,
β a,b,δ,γ a,b -proteobacteria
Also known as DUF556
Imm50 Mostly β; Several hydrophobic
residues
Tox-HHHa, Ntox24b actinobacteria, bacteroidetesa, firmicutesa,
planctomycetes, α,βa,b,γa-proteobacteria,
verrucomicrobia
Imm51 α+ β; W, Dx[DE] and several
hydrophobic residues
Tox-RESa, Tox-URI1b Actinobacteria, bacteroidetesa,
β,γ-proteobacteria, cyanobacteria,firmicutes b,
fusobacteria, spirochaetes
Fused to Imm14 on one occasion,
Found in polyimmunity loci
Imm52 α+ β; W,GT,F Tox-REase-5a Caudoviruses a, α,β a,γ a,δ a –proteobacteria
Imm53 α+ β (Central β-sheet with
flanking α-helices); W,
WE, PGW, W
Ntox24a, Ntox10b Acidobacteria, actinobacteria,
α,β,γ,δ,E-proteobacteria, bacteroidetes,
chlamydiae b, cyanobacteria, firmicutes a,
spirochaetes, verrucomicrobia
Imm54 α+ β; GF, Q Tox-REase-9a, Tox-RelEb, Tox-URIc,
Tox-REase-4d, Tox-REase-7e, Tox-REase-10f
actinobacteria, bacteroidetes a, c, d,
chlamydiae a, firmicutes a, c, d,e,
fusobacteriab,f, planctomycetes,
α,β c,γ a,δ,E-proteobacteria, spirochaetes,
verrucomicrobia
Found in heterogeneous
polyimmunity loci
Imm55 α+ β; G and several
hydrophobic residues
Tox-SHHa actinobacteria, bacteroidetesa, cyanobacteriaa,
firmicutesa, lentisphaerae, planctomycetes,
α,β,γa-proteobacteria, synergistetes,
verrucomicrobia
Imm56 α+ β; D, GR Ntox38a, Tox-HNHb Actinobacteria a,b,
chloroflexi a
Imm57 Mostly α; D, SE, C Tox-LD-peptidasea, Tox-Caspaseb βa,γa, b-proteobacteria
Imm58 α+ β; YxxxD, WxG, KxxxE Unknown toxins with RHS repeats β,δ -proteobacteria Limited distribution
Imm59 α+ β (Central β-sheet with
flanking α-helices); [DE]R motif
Ntox13a, Ntox40b firmicutes a,b Fused to Imm63 on some instances
Imm60 Mostly β; N, W Ntox40 a, Ntox48b bacteroidetes Found in heterogeneous
polyimmunity loci
firmicutes a, fusobacteria,
α b,γb –proteobacteria,
euryarchaea
Imm61 α+ β; R Ntox40a actinobacteria a
Imm62 α+ β; -(mostly E), W Ntox31a, Ntox48b Firmicutesa, b, Found in heterogeneous
polyimmunity loci
γ-proteobacteria
Imm63 α+ β; E + G, -(mostly E)xxY Ntox40a, Tox-CdiACb, Tox-ARC actinobacteria a,c Found in polyimmunity loci
bacteroidetes
firmicutesa, β,γa,b -proteobaceria
Zhang
et
al.Biology
D
irect
2012,7:18
Page
26
of
76
http://w
w
w
.biology-direct.com
/content/7/1/18
Table 3 Phyletic distribution and associated toxins of Immunity proteins associated with polymorphic toxin systems (Continued)
Imm64 α+ β; DxEA, R motifs Tox-ColDa Euryarchaeaa, firmicutesa, E-proteobacteria
Imm65 α+ β; YxC, and several
charged residues
Tox-JAB-1 Bacteroidetes Contains a signal peptide and a lipbox
Imm66 Mostly α; D, W, F, Y,W Tox-ABhydrolase3a, Ntox48b Actinobacteria, bacteroidetes,
cyanobacteria, firmicutes
Fused to one or more immunity
domains such as Imm68, SUKH,
Imm-SuFu- family 2, Imm33, Imm69,
Imm67, Imm-SuFu, Imm66, and TPR
repeats. Some proteins in firmicutes
have up to 10 immunity domains
Fusobacteria, α,β a,γb,E-proteobacteria,
spirochaetes, verrucomicrobia,
Eukaryotes: Ascomycota, viridiplantae
Imm67 α+ β; W, E, W - actinobacteria, bacteroidetes, chloroflexi,
cyanobacteria, firmicutes, fusobacteria,
planctomycetes, α,β,γ,δ, E-proteobacteria,
spirochaetes, verrucomicrobia
Fused to one or more immunity
domains such as Imm68, Imm33,
Imm-SUKH, Imm-SuFu-family 2,
Imm69, Imm-SuFu, Imm66, Imm67,
TPR and ankyrin repeats. Some proteins
in firmicutes have up to 10 immunity
domains
Imm68 α+ β; E - actinobacteria, bacteroidetes, firmicutes,
spirochaetes
Fused to one or more immunity
domains such as Imm-SUKH, Imm-SuFu,
Imm67, Imm66, Imm-SuFu-family 2, Imm69,
Imm33, Imm68 andTPR repeats. Some
proteins in firmicutes have up to
10 immunity domains
Imm69 α+ β; W,hGE(h: hydrophobic) Tox-ABhydrolase3a Actinobacteria, bacteroidetes, firmicutes a,
fusobacteria, planctomycetes,
α,β.γ,E-proteobacteria,, spirochaetes,
verrucomicrobia
Fused to one or more immunity
domains such as Imm68, Imm-SUKH,
Imm33, Imm-SuFu-family 2, Imm-SuFu,
Imm67, Imm66, SP, Imm69 and TPR
repeats. Some proteins in firmicutes
have up to 10 immunity domains
Imm70 α+ β; Y,W Tox-REase-10a Acidobacteria, actinobacteria, bacteroidetes,
firmicutesa, βa,γa,Ea-proteobacteria,
spirochaetesa, verrucomicrobia
Imm71 Mostly α; R,F, R Ntox48a acidobacteria a, β a,γ a -proteobacteria Often fused to Imm72
Eukaryotes: viridiplantae
Imm72 All-β; GxxE, WxDxRY, E Ntox48a acidobacteria a, β a,γ a -proteobacteria Often fused to Imm71
Imm73 All-α; Several hydrophobic
residues
Tox-PL-2a, Tox-HNHb acidobacteria, actinobacteriab, bacteroidetes,
cyanobacteria a, firmicutes a, fusobacteria,
β,γ,δ a -proteobacteria, verrucomicrobia
Sometimes found in 2–3 tandem copies
in a polypeptide
Imm74 α+ β; G[DE], [DE] Tox-Arca bacteroidetesa, firmicutesa, planctomycetes,
α,β,γa,δ -proteobacteria,
Found in heterogeneous
polyimmunity loci
1. Where possible, known or predicted folds are described. The folds are further classified as All-α (composed entirely of α-helices), All-β (composed entirely of β-strands), α+ β (Containing α-helices and β-strands) or
α/β (comprising repeated α-helix-β-strand units) depending on the arrangement of their structural elements. Individual conserved residues and motifs are separated by commas. Alternative residues are enclosed in
square brackets; ‘x’ denotes any residue.
2. Each toxin in column3 that is present in a gene neighborhood along with the corresponding immunity protein in column 1 in the toxin-immunity gene order is marked by a superscript letter, so as to identify the
phyletic pattern of this association in column 4.
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some novel features associated with trafficking
(Table 1). In course of discussing the conserved do-
main families, we describe key features relating to
their domain architectures and gene-neighborhoods,
and present the relevant functional inferences
derived from them. In the following sections we ex-
plore the general features of the domain architecture
and gene-neighborhood networks, phyletic distribu-
tion, relationships between various proteinaceous
toxin systems, ecological implications and the evolu-
tionary connections between components of these
toxin systems and eukaryotic and viral functional
systems.
Peptidase domains in polymorphic toxins and
related proteins
Peptidase domains from these systems can be function-
ally categorized into 1) those that are involved primarily
in processing toxin proteins; 2) those that function both
in processing and as toxins; 3) those that function
mainly as toxins. Autoproteolytic processing by diverse
peptidases has been long recognized in classical secreted
toxins deployed by pathogenic bacteria against their
hosts [49,51,54]. For example, the Vibrio cholera RTXA
peptide ligase toxin, clostridial glucosyltransferase toxins
and certain Yersinia toxins are autoproteolytically pro-
cessed by intrinsic caspase-like thiol peptidase domains,
Figure 3 (A) Multiple sequence alignment, (B) predicted topology diagram, (C) domain architectures, and (D) gene neighborhoods for
papain-like peptidase 1 (Tox-PL1) toxins. (E) Domain architectures of OTU papain-like peptidase toxins. The labeling scheme for domain
architectures and alignments, and the coloring scheme and consensus abbreviations are as in Figure 3.
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which are induced by small molecules such as GTP and
inositol hexakisphosphate in the host cytoplasm
[49,52,57]. Similarly, we presented evidence that the
HINT autopeptidase domains are likely to be an import-
ant player in the autoproteolytic release of several poly-
morphic toxins (Figure 2A) [17]. In toxins of several
pathogens, peptidase domains have also been character-
ized as bearing the actual toxin activity. Examples in-
clude the Yersinia pestis YopT papain-like peptidase
domain that triggers actin depolymerization in host cells
by cleaving the C-termini of Rho GTPases [50] and the
Bacillus anthracis lethal factor that disrupts signaling
cascades by cleaving the N-termini of several MAPK
kinase [48]. However, to date peptidase domains have
not been systematically characterized in classical poly-
morphic toxin systems. In polymorphic toxins, pepti-
dases acting in either of the above three functional
categories can be distinguished mainly based on their lo-
cation within the polypeptide. Those involved in autop-
roteolytic processing are mostly located either at the N-
terminus or prior to the C-terminal toxin domain in the
multi-domain toxin proteins (Figure 1). The toxin ver-
sions invariably occur at the C-termini. Those which
might occur at both of these locations can be inferred as
functioning as either toxins or processing proteins de-
pending on their position in the polypeptide. In addition
to these categories, there are inactive peptidase domains
that might serve as peptide-binding modules involved in
anchorage and interactions of toxins. We discuss below
the previously unrecognized peptidase domains that we
identified in polymorphic toxin systems and also discuss
their connections to related peptidase domains in other
toxin systems (Table 2).
Domains identified as being primarily auto-processing
peptidases
ZU5 superfamily domains functions as processing
autopeptidase in toxins
The ZU5 (Zona pellucida 5) domain was first identified
as an autoproteolytic domain in the PIDD protein which
forms the core of the PIDDosome, a protein complex in
animals providing a platform for recognizing molecular
patterns that are associated with loss of genomic integ-
rity and genotoxic stress [58]. It is a major player in
p53-induced apoptosis and activation of NF-κB pathway
in response to DNA damage and its assembly involves
multiple autoproteolytic cleavages mediated by its two
ZU5 domains [59]. Our structural comparisons with the
DALIlite program and sequence profile searches
revealed that the ZU5 domain is homologous to the GPS
domain involved in autoproteolytic cleavage of the
polycystin-1 and certain G-protein-couple receptors
[60], and the autoproteolytic domain of the nuclear pore
Nup96/98 proteins [61]. All these domains are
characterized by the presence of a C-terminal CxH motif
which forms their thiol autopeptidase active site (Add-
itional File 1). Accordingly, we include all these domains
in the ZU5 superfamily. Our iterative sequence searches
identified ZU5 domains in several potential polymorphic
toxins: They are typically located at the N-terminus of
large proteins with central RHS repeats (Figure 2B). In
polymorphic toxins, the ZU5 domain is most frequently
associated with the SpvB and β-propeller domains sug-
gesting that it might be functionally coupled to the
TcdB/TcaC-like export pathway [42,62]. Its N-terminal
location is notably different from the previously
observed HINT autopeptidase domains of polymorphic
toxins which are instead found at the C-terminus close
to the toxin domain [17] (Figure 2B). This suggests that
the autoproteolytic activity of the two peptidases have
distinct functions – the ZU5 autopeptidase most likely
cleaves the toxin at the base of the filamentous structure
in order to release it at the cell surface during its extru-
sion by the TcdB/TcaC system. In contrast, the C-
terminally located HINT autopeptidase is likely to be
critical for the release of just the toxin domain, probably
upon contact with the target cell. In the classical poly-
morphic toxins ZU5 autopeptidases are found in associ-
ation with a diverse array of nuclease and peptidase
toxin domains (Figure 2B). Related ZU5 domains are
also found in several other large bacterial cell surface
proteins, which additionally contain diverse adhesion
modules and other enzymatic domains, such as glycohy-
drolases, lipases and phosphodiesterases (Additional File
1). Thus, ZU5 autoproteolytic processing might be a
more general feature among bacterial surface proteins
that are deployed for the degradation or remodeling of
extracellular biopolymers and matrices.
PrsW peptidase family defines a novel secretion pathway to
release C-terminal toxin domains
The PrsW family of membrane-embedded peptidases is
prototyped by the enzyme catalyzing site-1 cleavage of
anti-σW factor RsiW in Bacillus subtilis [43]. Most
representatives bear eight transmembrane helices and
four conserved motifs (Figure 2C), which show distant
relationship to several other peptidase families like CPBP
and APH-1 [63]. Given that the active site of the PrsW
is located within the membrane-spanning helices
(Figure 2C), it is likely that they also form a transmem-
brane conduit for the simultaneous extrusion and pro-
cessing of the toxin. We first recognized the PrsW
domain as being a potential processing peptidase in
polymorphic toxins on account of its N-terminal fusion
with a novel deaminase toxin domain of the DYW clade
(gi: 320532150) [18]. Further analysis revealed that N-
terminal PrsW domains are associated with a diverse
array of toxin domains, including several distinct
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versions of the restriction endonuclease superfamily
(Figure 2C), mainly in Gram-positive bacteria. These
toxin domains are typically connected by a short linker
to the core membrane-spanning PrsW domain. How-
ever, in certain cases the toxin domain might be con-
nected via a long filamentous structure formed by RHS
repeats to the N-terminal PrsW domain (e.g. in a Strep-
tomyces violaceus protein with a novel toxin domain
(Ntox9; gi: 307326465). Thus, the PrsW domain might
be used to autoproteolytically process polymorphic tox-
ins both of the soluble secreted type (one with short lin-
kers) and of the filamentous contact dependent type
(with RHS repeats). In archaea (e.g. Pyrococcus horikoshi
PH0065) and fungi (e.g. Aspergillus fumigatus; gi:
146324562), the PrsW peptidase domains are respect-
ively fused at their N-termini to another PrsW-like pep-
tidase (DUF2324 in PFAM), or a ceratoplatanin domain
that is found in secreted phytotoxic virulence factors of
fungal pathogens [64]. It is conceivable that in these
examples the PrsW domain has been recruited for the
processing of potential N-terminal toxins that are used
against more distantly related organisms or plant hosts.
In several bacteria the PrsW domain is fused to intracel-
lular signaling domains such as the PilZ domain which
recognizes cyclic diguanylate, cyclic nucleotide binding
domains, phosphopeptide-binding FHA domains and
Zn-ribbon domains [65] (Additional file 1). These ver-
sions can be clearly distinguished both in terms of their
sequence relationships and domain architectures from
those associated with toxin domains. These are more
likely to function as signaling peptidases that cleave pro-
teins in conjunction with signals sensed by the asso-
ciated domains.
Peptidase domains that function both in auto-processing
and as toxins
Caspase-like peptidases
As noted above, peptidases of the caspase-like superfam-
ily [66] (also known as “clan CD” [67]) were originally
identified as processing peptidases of diverse host-
directed toxins (e.g. RTX toxins) of pathogenic bacteria
[49,57]. Likewise, some of these domains were identified
in certain large bacterial surface proteins where they
might function as autoproteolytic processing domains
[52]. Other secreted bacterial members of this fold, such
as the clostripains have been implicated in proteolytic
processing of surface proteins, whereas the gingipains
act as virulence factors that cleave host proteins [47]. In
this study we obtained evidence based on domain archi-
tectures and gene neighborhoods that the caspase-like
peptidase domains occur both as potential processing
peptidases (typically internal domains) and as toxin
domains (the C-terminal-most domain) in polymorphic
toxins from bacterial lineages such as bacteroidetes,
gammaproteobacteria and actinobacteria (Figure 2D).
Architectural analysis clearly shows that the caspase do-
main toxins might be delivered via the T7SS, PVC-SS,
TcdB/TcaC-like export pathway, in addition to the T2SS
(Figure 2D). Versions of the caspase-like domain that
are likely to function as processing peptidases of poly-
morphic toxins usually occur just upstream of a distinct
C-terminal toxin domain, in a position similar to the
HINT autopeptidase domains in other polymorphic tox-
ins (Figure 2A), suggesting that they might similarly aid
in the autoproteolytic release of the toxin domain.
Architectural analysis suggests that the caspase-like
peptidase might be nearly as prevalent as the HINT
peptidase in proteolytic processing of polymorphic tox-
ins (Additional File 1). Certain other toxin proteins have
an array of repeats of the caspase-like domain upstream
of the C-terminal toxin domain (e.g. a protein from
Streptomyces flavogriseus with ADP-ribosyltransferase
and MCF peptidase toxin domains; gi: 357410654; see
below) (Figure 2D), suggesting that their processing
might involve multiple autoproteolytic events to release
multiple cleavage products. Some of the caspase domain
repeats in these proteins lack the catalytic residues and
might merely play a structural or peptide-binding role.
Papain-like peptidases
Papain-like peptidase domains, which constitute the
most diverse and widespread superfamily of thiol pepti-
dases, have been previously recorded as the toxin
domains of both exotoxins and those delivered into the
host cells by various pathogenic bacteria. Examples of
the former include the Streptococcus pyogenes exotoxin
SpeB, while those of the latter include the Pseudomonas
syringae AvrPphB toxin, which cleaves the plant serine/
threonine kinase PBS1, and the Pasturella multocida
toxin PMT [68-70]. We found evidence for domains
belonging to multiple distinct clades of the papain-like
superfamily in polymorphic toxin polypeptides.
The first of these, the Tox-PL1 (Tox-papain-like-1)
family was recovered as a previously unknown conserved
domain in several predicted polymorphic toxins, usually
secreted by way of the T7SS (i.e. with N-terminal WxG
domains) and TcdB/TcaC-like system (N-terminal SpvB
domain) in actinobacteria, and bacteroidetes. Examin-
ation of its multiple alignment revealed a conserved NC-
H-DxQ signature (Figure 3A), which is reminiscent of
the conservation pattern seen in papain-like peptidases
[53,71,72]. This relationship was confirmed via profile-
profile comparisons with the HHpred program that sig-
nificantly recovered papain-like peptidases (p = 10-5; 95%
probability). In a subset of the predicted polymorphic
toxins Tox-PL1 is the only catalytic domain, and occurs
at the extreme C-terminus of the toxin polypeptide, sug-
gesting that it is the toxin domain (Figure 3C). In other
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cases it occurs in internal positions in polypeptides bear-
ing a diverse set of toxin domains [18], or in the middle
of an array of filament-forming RHS repeats (Figure 3C).
In these cases it is likely to function as an auto-
processing peptidase that releases associated toxin
domains comparable to the HINT and caspase-like pep-
tidases [17]. In Shewanella we observed a protein com-
bining a SopD domain [73] with a C-terminal Tox-PL1
domain, which is encoded by a gene embedded within a
T3SS operon. Given that Shewanella is known to sup-
press the growth of competing distantly related bacteria
and infect eukaryotic hosts [74], it is possible that this
protein might be used as a toxin delivered by the T3SS
in such conflicts. In diverse bacteria we observed a dis-
tinctive architecture of Tox-PL1, wherein it is fused to
the MuF domain (Figure 3C), which we had previously
characterized as a DNA-packaging protein of bacterio-
phages utilizing the portal-terminal system [75]. Gene-
neighborhood analysis indicated that these are encoded
by prophage remnants that also include the terminase,
portal protein and capsid protein genes (Figure 3D).
Additionally, several of these neighborhoods might en-
code proteins with previously noted bona fide toxin
domains that operate on nucleic acids (e.g. the HNH nu-
clease; Figure 3)[17,18]. Hence, we propose that these
gene neighborhoods represent a novel phage-derived
secretory mechanism, distinct from the previously iden-
tified T6SS and PVC-SS that utilizes a capsid packaging-
like mechanism. It is conceivable that in these systems
the toxins encoded by associated genes are loaded into a
capsid-like structure that is then delivered to target cells.
Here, the Tox-PL1 domain might be involved in proces-
sing proteins either during the assembly of the secretory
structure or the release of toxins into target cells.
The second major family of papain-like peptidases
with potential processing as well as toxin functions are
those belonging to the OTU family [53,76] (Figure 3E).
These enzymes have been studied mainly in eukaryotes,
where they function as deubiquitinating enzymes (DUBs)
[77]. We found evidence for a diverse set of OTU
Figure 4 Features of PVC metallopeptidase toxins: (A) multiple sequence alignment, (B) predicted topology diagram, (C) representative
domain architectures, and (D) conserved gene neighborhoods for PVC containing genes across different bacterial lineages and
archaea. In (D), PVC toxins are shown in blue, the AAA + ATPase associated with the PVC system (PVC-AAA) in orange and phage-derived
proteins in yellow. Gene neighborhoods are labeled with the corresponding information for the PVC-metallopeptidase containing genes marked
with an asterisk. The labeling scheme for domain architectures and alignments, and the coloring scheme and consensus abbreviations are as in
Figure 3.
Zhang et al. Biology Direct 2012, 7:18 Page 31 of 76
http://www.biology-direct.com/content/7/1/18
peptidase domains in potential polymorphic toxins deliv-
ered by the T7SS (with N-terminal WXG domains) in
actinobacteria and via T2SS in the Acanthamoeba endo-
symbiont Odyssella thessalonicensis [78]. In these bacter-
ial lineages they occupy positions suggestive of both
processing and toxin functions (Figure 3E). Additionally,
we found related OTU-like peptidases in large proteins
resembling polymorphic toxins in several endo- symbi-
otic/parasitic bacteria of animals and amoebozoans, such
as Amoebophilus, Waddlia and Wolbachia. However, in
these organisms their gene-neighborhoods suggest that
they are unlikely to be polymorphic toxins used in intra-
specific conflicts; rather, they are likely to be used against
their host. In several cases, the OTU-like domains of
these intracellular bacteria occur at the extreme C-
terminus of large proteins with several domains, includ-
ing repeats forming extended structures such as the Sel1,
ankyrin and TPR repeats (Figure 3E). This suggests that
they might be deployed similar to the classical poly-
morphic toxin, but within the host cell. In other proteins
from the same group of bacteria they might occur as in-
ternal domains accompanied by several other potential
toxin domains (Figure 3E), such as GIMAP GTPase, lip-
ase, latroxin-C and Tox-MCF1-SHE (see below). The
preponderance of these OTU-like peptidase domains in
intracellular bacteria suggests that they might function as
toxins that suppress the Ub-dependent anti-pathogen
mechanisms of their eukaryotic hosts due to DUB activ-
ity [79,80]. Indeed, a comparable role was originally pro-
posed for the OTU-like peptidases in chlamydiae [53,76].
However, their presence in free-living bacteria (e.g. di-
verse actinobacteria) indicates that a subset of these
OTU-like peptidase proteins might function as either as
processing-peptidases that autoproteolytically process
polypeptides or as conventional toxin domains that
cleave proteins in rival cells.
PVC secretory system-type metallopeptidase domains
The “Photorhabdus virulence cassette” or PVC-SS was
originally identified as a prophage-derived secretory sys-
tem in Serratia entomophila, where it delivers toxins that
confer a strong anti-feeding activity against the infected
grass grub beetle larvae [41] and in Photorhabdus, where
it extrudes toxins that destroy insect hemocytes by indu-
cing actin condensation [40]. This system is typified by
several caudate phage-derived gene products, such as the
tail sheath protein and gp19 (these two form the tail tu-
bule), gp25 (forms the baseplate), and a distinct clade of
AAA+ATPases that are related to CDC48 [81]. Thus,
the PVC-SS parallels the T6SS in being derived from the
Figure 5 Representative domain architectures for toxin proteins containing: (A) several distinct metallopeptidase toxin domains such as
HopH1 peptidase and Tox-MPTases 1 – 5, (B) LD-peptidase, (C) Tox-HDC domain. (D) Sequence alignment and domain architectures of
inactive transglutaminase-containing toxins. The labeling scheme for domain architectures and alignments, and the coloring scheme and
consensus abbreviations are as in Figure 3.
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tails of prophages, but differs from it in terms of the
associated AAA+ATPase, which in the case of T6SS is a
member of the ClpB clade of AAA+ATPases (ClpV)
[39,81,82]. Hence, these two systems represent independ-
ent prophage-based innovations that have recruited dis-
tinct sets of AAA+ATPases to facilitate recycling of the
injection apparatus after it has been deployed. We
observed in our recent studies that several toxin
domains closely related to those found in polymorphic
toxins are secreted via the PVC-SS across most major
bacterial lineages and certain euryarchaea (Figure 4).
Our preliminary analysis of these toxin proteins secreted
via the PVC-SS revealed that they contained a conserved
metallopeptidase domain that occurred N-terminal to
the toxin domain [17,18]. A more detailed analysis in
course of this study indicated that this metallopeptidase
domain is a pervasive feature of the PVC-SS and pro-
vides an excellent marker to identify novel toxins
secreted via this system. Accordingly, we term it the
PVC-metallopeptidase (Figure 4). This domain is charac-
terized by a highly conserved HExxHxxQ-E signature
and profile-profile comparisons using HHpred recovered
several zincin-like metallopeptidases as the best hits (e.g.
PDB: 2vqx, 1u4g, 3cqb; p< 10-5; >90% probability). A
multiple alignment based on these hits suggests that the
PVC-metallopeptidase adopts a similar structure with
three beta-strands and three alpha helices, with the con-
served histidines on the second helix and glutamate on
the third helix forming the Zn-dependent active site [83]
(Figure 4A, B).
Our analysis of the domain architectures of PVC-
metallopeptidase proteins affirmed their general resem-
blance to the classical polymorphic toxins: the strongly
conserved metallopeptidase domain occupied the N-
terminal region, followed in each protein by highly vari-
able C-termini, each of which usually corresponded to a
different family of toxin domains. Thus, they appear to
have evolved through a recombination process compar-
able to that of the polymorphic toxins, which combined a
“constant” N-terminal peptidase with variable C-terminal
toxin domains (Figure 4C). This positional polarity of
the PVC-metallopeptidase domains with respect to the
associated toxin domains resembles that of the HINT,
PrsW, caspase-like and papain-like peptidases, indicating
that they are likely to act as autoproteolytic domains
that release the toxin after or during its export by the
PVC-SS [17,18]. The C-terminal toxin domains asso-
ciated with the PVC metallopeptidases span an extraor-
dinary diversity and include numerous, structurally
unrelated nucleases, nucleic acid deaminases, peptidases,
pore-forming domains and several other enzymatic
domains (Figure 4C). There are multiple toxins with the
PVC architecture in several bacteria and archaea (e.g.
Halogeometricum borinquense; Additional File 1), with a
high diversity of C-terminal toxin domains similar to
those found in conventional polymorphic toxins. Our
analysis also showed that the PVC toxins are not limited
to pathogenic or symbiotic bacteria but are abundant in
several free-living bacteria (e.g. the cyanobacterium
Microcoleus chthonoplastes and Nitrosococcus oceani)
and archaea (e.g. Halogeometricum borinquense). This
suggests that the PVC-SS toxins are not exclusively used
against host but might also be used in inter-bacterial
conflicts, just like the T6SS [15,30,39]. However, a not-
able proportion of the PVC-SS dependent systems, un-
like conventional polymorphic toxin systems, lack
adjacent genes encoding immunity proteins (Figure 4D).
This might imply the activity of PVC toxins is primarily
directed against distantly related organisms.
In addition to the above cases, we observed instances
where a second PVC-metallopeptidase domain occurred
at the extreme C-termini of proteins in a position com-
parable to the toxin domain (Figure 4C). Consistent with
this, domain architecture and gene-neighborhood analysis
showed that the PVC-metallopeptidase indeed also occurs
as a toxin domain of certain polymorphic toxins, pre-
ceded by an array of RHS repeats (e.g. a protein from the
verrucomicrobium Pedosphaera parvula; gi 223934413;
Figure 4C). Similarly, the PVC-metallopeptidase domain
might occur as a C-terminal domain fused to a T6SS
phage base-plate/tail polypeptide (e.g. Burkholderia sp.;
gi: 78060725) (Figure 4C). These examples suggest that in
addition to its predominant role in autoproteolytically
processing PVC toxins, this metallopeptidase might take
on the role of a peptidase toxin in several cases.
The MCF1-SHE domain: A possible novel serine peptidase
shared by polymorphic toxins and secreted effectors?
We initially identified this domain as a conserved region
shared by certain predicted polymorphic toxins (e.g.
Caci_8529 from the actinobacterium Catenulispora acid-
iphila) and PVC-SS toxins (e.g. Hoch_1384 Haliangium
ochraceum). Iterative sequence profile searches with the
PSI-BLAST program recovered homologous regions in
proteins from a diverse group of bacteria and the mimi-
virus (L389, gi: 311977774) prior to convergence. These
proteins include the MCF1 (makes caterpillars floppy)
[84] and FitD entomotoxins, respectively from Photo-
rhabdus luminescens and Pseudomonas fluorescens [85-
87], and the phytotoxin of Pseudomonas syringae
HopT1-1 which is secreted via the T3SS [88,89]. A mul-
tiple alignment of this domain revealed that its core com-
prises of two kinked helices, predicted to form a hairpin
(Figure 2E). The predicted kinks in the two helices are re-
spectively associated with a conserved serine and a
HxxxE motif and are likely to face each other. Accord-
ingly, we named this domain the MCF1-SHE domain for
the first characterized protein that bears it and the
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conserved triad of residues. While this domain does not
resemble any previously known domain, the above cata-
lytic triad suggests that it could potentially function as a
novel serine peptidase. In several cases its occurrence at
the extreme C-termini of polymorphic toxin proteins
points to a potential toxin function for the MCF1-SHE
domain (Figure 2E). Consistent with this, it is also found
in several secreted proteins of both extracellular patho-
gens such as Edwardsiella and Xenorhabdus, and intra-
cellular bacterial and viral pathogens such as Legionella,
Coxiella burnetii and Yersinia pseudotuberculosis and the
mimivirus (Figure 2E). In particular it appears to have
expanded in legionellae, where up to four distinct MCF1-
SHE toxin paralogs might be present per organism. This
phyletic pattern suggests that MCF1-SHE proteins might
be both toxins in intra-specific conflict and also import-
ant effectors that have dispersed through lateral transfer
across phylogenetically diverse pathogens. Certain do-
main architectures of the MCF1-SHE domain are con-
sistent with the predicted peptidase role, although in a
different capacity. It often occurs just upstream of several
toxin domains, such as the ADP ribosyltransferase
domains related to those found in the Pseudomonas syr-
ingae HopU1 phytotoxin (Figure 2E). In these cases, it
could function as a potential processing peptidase that
releases the C-terminal toxin. Similarly, in actinobacteria,
it is embedded in gigantic proteins (>10,000 amino acids
in length) with other peptidase domains such as the
anthrax-lethal factor metallopeptidase, caspase-like and
OTU domains (e.g. gis: 345002682, 326780819).
Other peptidases that function predominantly as toxin
domains of polymorphic toxin proteins
Besides the above discussed domains, we uncovered sev-
eral other peptidase domains that are clearly predicted
to function as toxin domains rather than as processing
peptidases on the basis of their domain architectures
(Table 2). In addition to classical polymorphic toxin sys-
tems and PVC-SS delivered toxins, these peptidase toxin
domains are also found in several host-directed effectors
of pathogenic bacteria. However, it should be noted that
outside of these toxin systems, related peptidase
domains might perform other unrelated functions.
Papain-like peptidases
Several of the peptidases predicted to function as the
toxin domains of classical polymorphic and PVC-SS
delivered toxins belong to a number of distinct clades
from the papain-like superfamily (Figure 2, 4): 1) The
NlpC/P60 clade – peptidases of this clade were first
recognized as enzymes that cleaved peptide bonds in
peptidoglycan and are nearly universally distributed
across bacteria and also found in several bacteriophages
[71]. We recovered such peptidase toxins in proteins
such as Hoch_2166 from the myxobacterium Halian-
gium (gi: 262195395, Figure 4C); by analogy to other
members of the NlpC/P60 clade they are predicted to
function by degrading cell-walls of target cells. 2) The
Tox-transglutaminase domain (Tox-TGase) – In
addition to toxins from free-living bacteria, this transglu-
taminase domain is also found in toxins delivered by dif-
ferent secretory systems of parasitic bacteria, where they
appear to be directed against the host cells. In particular,
it is the toxin domain of T3SS effectors directed against
plants, such as AvrPphE Pseudomonas syringae (gi:
30231092) and related effectors of Ralstonia, Xanthomo-
nas and Acidovorax, in RTX toxins directed against ani-
mal hosts (e.g. Vibrio caribbenthicus RtxA; gi:
312885249) and in a novel secreted effector of Legionella
pneumophila (lpg2408; gi: 52842617). These enzymes
might either catalyze a conventional thiol peptidase reac-
tion or act as transglutaminases that mediate crosslink-
ing of proteins via a transglutaminase reaction [53].
Alternatively, they could catalyze polyamination of target
glutamine, as has been observed in the case of the Bor-
datella pertussis transglutaminase that modifies the
mammalian RhoA GTPase [90]. 3) The Tox-PL-C39 do-
main – these peptidase domains are related to the C39/
ComA-like peptidase domains that cleave the leader-
peptides of certain proteins secreted by ABC transpor-
ters such as the bacteriocins (Figure 4C) [91,92]. 4)
Papain-like peptidases Tox-PL2 and Tox-PL3 – these
are novel peptidase domains that we identified in this
study and the former is prototyped by the toxin domain
of a polymorphic toxin from Sorangium cellulosum (gi:
162456110, Figure 2A) and the latter by a polymorphic
toxin from Prevotella sp. (gi: 260911294, Figure 2B).
Thus far, such peptidase domains are not found outside
of polymorphic toxin systems and are typified by a C-H-
D catalytic triad. 5) We also detected a toxin domain
with a papain-like peptidase belonging to the classical
ubiquitin C-terminal hydrolase (UBCH/UBHYD) clade
associated with the PVC-SS in the plant pathogenic bac-
terium Burkholderia gladioli (gi: 330820326, Figure 4C).
Similar UBCH domains are also found in potential tox-
ins secreted by a variety of other bacterial endosym-
bionts of amoebae such as Simkania negevensis,
Waddlia chondrophila, Amoebophilus asiaticus and Pro-
tochlamydia amoebophila and giant nucleocytoplasmic
DNA viruses that infect them (Additional File 1). These
predicted toxins display no associated immunity proteins
suggesting that like the OTU domains of pathogens and
endosymbionts, they are likely to function as DUBs that
deubiquitinate eukaryotic target proteins [79].
Metallopeptidases
Beyond the toxin versions (as opposed to autoproteolytic
processing versions) of the PVC-metallopeptidase
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domain described above, we recovered several other dis-
tinct clades of the Zincin-like metallopeptidase super-
family that are predicted to function solely as toxin
domains in classical polymorphic and PVC-SS toxin pro-
teins. These include: 1) The anthrax lethal factor-like
metallopeptidase (ALF-MPTase) domains [48] that are
found primarily among PVC-SS delivered toxins (e.g.
Hoch_1736 from Haliangium; gi: 262194969, Figure4C).
2) The HopH1-like metallopeptidase domain
(Figure 5A)—this domain is also found in several plant-
Figure 6 Sequence alignment and representative domain architectures of novel HNH nuclease families: (A) Tox-HHH, (B) Tox-EHHH, (C)
Tox-SHH, (D) Tox-GHH2, and (E) Tox-GHH. ‘#’ indicates residues involved in metal ion-binding, ‘%’ indicates the conserved histidine which is
required for activation of the water molecule for hydrolysis, and ‘*’ indicates polar residues (often asparagine) that are conserved in the HNH fold.
The labeling scheme for domain architectures and alignments, and the coloring scheme and consensus abbreviations are as in 3.
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directed T3SS-delivered effectors, such as Pseudomonas
syringae HopH1 (gi: 28867816), and the animal-directed
T3SS effectors such as Citrobacter rodentium and enter-
opathogenic and enterohemorrhagic Escherichia coli
NleD that blocks apoptosis of mammalian cells [93,94].
3) We also identified five smaller families of previously
unknown zincin-like metallopeptidases (Tox-MPTase1-
5) that are exclusively found in polymorphic toxins from
phylogenetically diverse of bacteria (Figure 5A). In gen-
eral terms they are similar in size and distantly related
to the Wss1-like desumoylating metallopeptidase of
eukaryotes [95]. All of these are typically associated with
N-terminal RHS repeats and at least in the case of a
polymorphic toxin with a Tox-MPTase4 domain from E.
coli, it might be delivered via the T6SS.
Other miscellaneous peptidases
Beyond these, we also recovered domains in PVC-SS and
polymorphic toxins belonging to the L,D-peptidase,
pyroglutamyl-peptidase [96] and YabG peptidase families
[97]. Of these, the L,D peptidase domain is a distinct thiol
peptidase domain with a β-barrel catalytic domain that is
unrelated to the papain-like peptidases (Figure 5B)[98,99].
It has been shown that the classical cell-wall associated
LD-peptidase domain catalyzes a transpeptidase reaction
that cleaves the peptide bond between L-Lys3-D-Ala4 in
peptidoglycan while concomitantly forming a crosslinking
peptide bond between the COOH group of L-Lys3 and
the NH2 group of the D-isoasparagine linked to the E-
NH2 group of Lys3 from an adjacent chain [98]. Cell-wall
associated L,D-peptidases are found in most major
lineages of bacteria and are likely to play a role in the re-
modeling of peptidoglycan especially in face of antibiotics
that inhibit cross-linking. Polymorphic toxins with L,D-
peptidase domain are distinguished from the typical
cell-wall associated L,D peptidases by their distinct archi-
tecture with RHS repeats and genomic organization with
linked immunity proteins. It is likely that the toxin L,D-
peptidases act by hydrolyzing L-Lys3 crosslinks with D-
amino acids, thereby compromising the integrity of the
cell-wall.
The bacteriophage APSE of the endosymbiont Hamil-
tonella defensa, which protects aphids and other sap-
feeding insects against parasitoid wasps, encodes several
distinct toxins [100,101]. We noted that one of these
(APSE305; gi: 211731800) displays an architecture simi-
lar to the conventional polymorphic toxins with a poten-
tial novel C-terminal toxin domain (Figure 5C). Analysis
of this domain revealed that it is widely distributed in
several other proteobacteria and is characterized by
three motifs respectively bearing a [SGxH] signature, a
conserved D or N and an absolutely conserved C (Add-
itional File 1). Secondary structure prediction revealed
that this domain is characterized by an α/β fold that is
likely to be similar to the Rossmannoid three-layered
sandwich adopted by the caspases and the flavodoxin-
like fold. The absolutely conserved H, D/N and C are
predicted to lie at the ends of the three successive
strands of this structure and are likely to comprise the
catalytic triad of the peptidase active site. Accordingly
we named this domain Tox-HDC and predict that it
might function as a thiol peptidase or a transglutami-
nase. Proteins bearing this predicted toxin domain are
particularly common in both intracellular (e.g. Coxiella
burnetii) and extracellular (e.g. Xenorhabdus nemato-
phila and Photorhabdus luminescens) pathogens and
typically lack associated genes coding for immunity pro-
teins. Thus, these toxins appear to be primarily directed
against distantly related targets such as eukaryotes.
In conclusion, at least 23 distinct clades of peptidases
belonging to several structurally unrelated superfamilies
have been recruited as toxins, and are often shared be-
tween polymorphic toxins and host-directed effectors
from diverse plant and animal pathogens. This suggests
that several of these peptidase domains have evolved
considerable substrate flexibility in targeting both
eukaryotic and bacterial proteins.
Inactive transglutaminase domains in polymorphic toxins
In course of the current study we observed that several
polymorphic toxin proteins with several distinct types of
C-terminal toxin domains displayed a N-terminal trans-
glutaminase domain (Figure 5D). However, closer examin-
ation of the multiple alignment of these transglutaminase
domains revealed that one or more of the conserved resi-
dues (a C, H, and D), which constitute the catalytic triad
of their papain-like peptidase active site, were lost [53]
(Figure 5D). This suggests that they lack peptidase activ-
ity. Domain architectural analysis showed that these in-
active transglutaminase domains are always located
immediately after a N-terminal signal peptide or TM
helix and are followed by an array of RHS repeats that
constitute the filamentous part of the toxin. Occasionally,
they might be adjacent to domains of the immunoglobu-
lin superfamily (the so called “bacterial Ig” type domains;
Figure 5D). This position suggests that, unlike the above-
described active peptidase domains, these inactive trans-
glutaminases have no role in toxin or processing activity.
Instead, they might simply serve in anchoring the toxin
on the cell surface by binding peptides.
Identification of further toxin domains in polymorphic
toxins and related proteins that operate on nucleic acids
In our earlier study we had shown that majority of toxin
domains in polymorphic toxin systems operate on nu-
cleic acids – nucleases and base deaminases [17,18]. In
this study we were able to further extend the diversity of
toxin domains that act on nucleic acids via the discovery
Zhang et al. Biology Direct 2012, 7:18 Page 36 of 76
http://www.biology-direct.com/content/7/1/18
Figure 7 Sequence alignment and representative domain architectures of novel restriction endonuclease families described in this
study: (A) Tox-REase-2, (B) Tox-REase-3, (C) Tox-REase-4, (D) Tox-REase-5, (E) Tox-REase-6, (F) Tox-REase-7, (G) Tox-REase-8, (H) Tox-
REase-9, (I) Tox-REase-10. The labeling scheme for domain architectures and alignments, and the coloring scheme and consensus abbreviations
are as in Figure 3.
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of additional nucleases and deaminases that were not
previously recognized (Figures 6, 7, 8, 9). We observed
that the divalent cation-dependent nucleases among
polymorphic toxins are frequently drawn from ancient
nuclease folds, namely the HNH/EndoVII, REase and
URI endonuclease folds [102-107]. Additionally, we
present evidence below that representatives of few other
potential cation-dependent enzymatic domains might
function as nuclease domains in polymorphic toxins.
Interestingly, the PIN domains, which are major divalent
cation-dependent nucleases in the toxin-antitoxin sys-
tems [22,108], do not appear to be utilized in the poly-
morphic toxins and related systems. Toxin nucleases that
utilize divalent cations can catalyze the direct hydrolysis
of the phosphodiester bond and as a result attack both
DNA and RNA. However, the metal-independent
nucleases can only act as RNases as their endonucleolytic
action involves the formation of a cyclic 2’-3’ phosphate
that does not require metal-dependent direction of a
hydrolytic attack [107]. Such RNases belong to many dis-
tinct folds, several of which appear to have emerged only
in course of the diversification of toxin domains of poly-
morphic toxins, bacteriocins and classical toxin-antitoxin
systems [17,22,28,107,109,110]. While we were able to
unify several of the metal-independent RNases, which
were previously considered to be unrelated, into a single
monophyletic assemblage, there are still several distinct
toxin domains that likely to represent novel metal-
independent RNases (see below; novel toxins). This
structural diversity of metal-independent RNases and the
repeated emergence of several such nuclease domains
among different toxin systems suggest that there are
some fundamental constraints in the evolutionary
innovation of nuclease domains. It appears that the inde-
pendent emergence of multiple residues for metal-
chelation and acid–base catalysis to constitute an active
site that can support hydrolytic cleavage of nucleic acids
is a far less likely event than the emergence of a metal-
independent active site that utilizes the innate reactivity
of RNA to facilitate an internal attack with the formation
of 2’-3’ cyclic phosphates. We briefly describe below the
newly recovered toxin domains that act on nucleic acids.
Novel toxins with the HNH/EndoVII nuclease domain
In our earlier studies we found nuclease toxin domains
belonging to eight distinct clades of the HNH/EndoVII
fold among the polymorphic toxin systems [17,18]. Of
these, nucleases belonging to the classical HNH and
NucA clades widely occur beyond the polymorphic toxins
across diverse sub-cellular systems, such as, DNA repair/
recombination, restriction-modification (R-M) and envir-
onmental nucleic acid degradation systems [103,106,111].
Figure 8 Representative domain architectures of several nucleic acid-targeting toxin domains: (A) two distinct families of URI
nucleases (Tox-URI1 and Tox-URI2), (B) Tox-ComI nuclease, (C) two distinct ParB fold families (Tox-ParB, Tox-ParBL1), (D) two novel JAB
families (Tox-JAB-1, Tox-JAB-2). (E) Multiple sequence alignment of the Het-C domain with Zinc-dependent phospholipase C and S1-P1
nuclease, showing their homologous relationship. Conserved catalytic residues are labeled with blue ‘#’. The labeling scheme for domain
architectures and alignments, and the coloring scheme and consensus abbreviations are as in Figure 3.
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In contrast, the GH-E, DHNNK, WHH, LHH and AHH
domains appear to have arisen in and remained largely
restricted to polymorphic toxin systems. The NGO1392
clade appears to have arisen in the bacterial polymorphic
toxin systems, but was transferred to eukaryotes where it
might have assumed a role in DNA repair [17]. In this
study we recovered six more clades of HNH domain
nucleases that appear to have primarily diversified among
bacterial polymorphic and related PVC-SS-associated
toxins. Keeping with the earlier nomenclatural system,
we named five of these novel clades on the basis of the
conserved motifs that characterized them as the SHH,
HHH, GHH, GHH-2 and EHHH clades of HNH domains
(Figure 6). The sixth of these is related to the version of
the HNH domains found in the restriction enzyme SphI
[112] and the animal CIDE (CAD/DFF40) protein involved
in nucleolytic DNA fragmentation during apoptosis [113],
and is termed HNH-CIDE (Table 2). Architectural analysis
indicated that the novel HNH clades occur both as poten-
tial diffusible toxins (mainly in Gram-positive bacteria)
and as contact-dependent toxins borne at the tip of
long filamentous structures (proteobacteria, bacteroi-
detes, planctomycetes and certain Gram-positive bacteria;
Figure 6). Representatives of the SHH clade have been
transferred to crustacean (e.g. Daphnia; gi: 321474287)
and tailed bacteriophages (e.g. Bacillus phage SPbeta; gi:
9630134). The former transfer is consistent with occur-
rence of an effector with a SHH nuclease domain in the
eukaryotic endosymbiont, Simkania (gi: 338732338).
The CIDE protein was previously known only from
metazoans with no known representatives from other
eukaryotes; hence, its origin remained mysterious [114].
Figure 9 (A) Shared common core of the BECR fold illustrated with representative structures from Barnase, RelE, ColE5, ColD, and
EndoU families. PDB ids are shown in brackets. All structural cartoons are shown in an approximately similar orientation. The α-helices are
colored red, β-sheets yellow and loops gray. The predicted and known active site residues are labeled. Representative domain architectures of
polymorphic toxins containing (B) Tox-Barnase, (C) Tox-RelE, (D)Colicin E5 (Tox-ColE5), (E) Tox-EndoU, (F) Colicin D (Tox-ColD), and (G) several
other novel toxin domains predicted to contain the BECR fold. The labeling scheme for domain architectures and alignments, and the coloring
scheme and consensus abbreviations are as in Figure 3.
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The identification of the HNH-CIDE toxin domains sug-
gests that this nuclease domain first arose in context of
bacterial conflicts and was laterally transferred to animals
early in their evolution. In animals, its innate cytotoxic
action appears to have been channelized as an effector of
apoptosis. Our searches also showed that the C-terminal
domain of teneurin and Odd Oz proteins from the animal
lineage (metazoans + choanoflagellates) contain an in-
active version of a HNH domain belonging to the GHH
clade (Figure 6E). While presence of RHS repeats in these
proteins related to those in bacterial RHS proteins has
been previously recognized [115], the relationship of their
C-terminal domain to a specific bacterial toxin domain
has not been hitherto reported. Teneurin/Odd Oz pro-
teins function as developmental regulators with a poten-
tial role in cell-surface adhesion in diverse processes such
as cell migration, neuronal path finding and fasciculation,
gonad development, and basement membrane integrity
[115-117]. The region of these proteins spanning the in-
active GHH nuclease domain has been described as being
cleaved off and amidated at the C-terminus in vertebrates
to give rise to a peptide with possible neuromodulatory
activity [118]. This region in tenurin-2 is also the ligand
for latrophilin-1, which is also the receptor for another
molecule, latrotoxin, whose origins also lie among the
bacterial toxins (see below) [116]. Hence, it is conceivable
that the RHS portion of these proteins participates in cel-
lular adhesion, while the cleaved off inactive GHH do-
main act as a diffusible signal. It would be of interest to
investigate if this inactive GHH domain might bind nu-
cleic acids upon being taken up by target cells. Our detec-
tion of the GHH domain in the Teneurin/Odd Oz
proteins establishes that they have emerged from the sin-
gle transfer of a specific type of a complete bacterial poly-
morphic toxin gene followed by its fusion to EGF repeats
of animal provenance (Figure 6E).
Novel restriction endonuclease fold domains in
polymorphic toxins
In our earlier study we had identified toxin domains
in polymorphic toxins belonging to a previously
uncharacterized clade of the REase fold (REase-1) [17].
Further analysis revealed that there are nine additional,
previously unknown clades of the REase fold that are
present exclusively as toxin domains of a diverse group
of polymorphic toxins (Figure 7; numbered serially
REase-2-REase-10). Their domain architectures and
gene-neighborhoods indicate that they are secreted by
means of the T2SS, T5SS, T7SS, TcdB/TcaC and the
PrsW-type peptidase-dependent system in different bac-
terial lineages. Of these, at least four distinct versions,
namely REase-2, REase-3, REase-5 and REase-6 are
coupled with a PrsW peptidase, suggesting that a not-
able diversification of these nucleases appears to have
happened in the context of these systems (Figure 7).
Many of the REase toxins secreted via the other systems
have central RHS repeats (e.g. REase-9; Figure 7). These
architectures suggest that REases might function both as
diffusible and contact-dependent toxins. Tox-REase-8 is
primarily found in the arthropod endosymbiont Wolba-
chia and the Acanthamoeba endosymbiont Amoebophi-
lus and is usually associated with arrays of ankyrin
repeats (Figure 7G). These lack associated genes for im-
munity proteins and are likely to be deployed against tar-
gets in the host cells – this represents the first instance
of a REase domain effector being used by endosymbionts
of eukaryotes. Representatives of Tox-REase-8 are found
in the genomes of arthropods, such as the crustacean
Daphnia, several mosquitoes, ants and beetles, and the
placozoan Trichoplax. This suggests that Tox-REase-8
has been repeatedly transferred to diverse animals from
their Wolbachia-like endosymbionts. Beyond conven-
tional polymorphic toxin systems, REase-9 is also found
in a Parachlamydia effector (PUV_01770, gi: 338174171)
that might target nucleic acids in its host Acanthamoeba.
All ten clades of REase toxins have an active site that
closely conforms to the classical REase active site with a
D-[EQ]XK signature in the core strands that constitute
the metal-chelating site [103]. The majority of character-
ized members of this fold act on DNA targets; hence, it is
conceivable that these toxins also attack the genome of
the target cells through endonucleolytic cleavage.
URI domain nuclease toxins
The URI domain was first identified as a conserved
metal-dependent endonuclease domain catalyzing the
cleavage of the 3′ side of a damaged DNA base during
nucleotide excision repair by UvrC, and mediating site-
specific insertion of certain introns [102,119]. Similar
nuclease domains have also been found in certain
REases, such as R. Eco29kI, and the transposase module
of Penelope-like non-LTR retroelements [104]. In this
work we identified, for the first time, URI domain
nucleases in polymorphic toxins that are present in bac-
teria from most major bacterial lineages (Figure 8A,
Table 2) that are usually secreted via T2SS, T5SS, TcdB/
TcaC and T6SS. The Tox-URI domains can be divided
into two major clades, with the second clade being par-
ticularly divergent (Additional File 1). A version of the
Tox-URI domain belonging to the first clade has also
been transferred to fungi, where it occurs as an intracel-
lular domain fused to an ABC ATPase transporter (e.g.
Neurospora crassa NCU06946; gi: 164424641; Additional
File 1). Given this architecture, it is conceivable that they
function in degradation of nucleic acids taken up by these
fungi. Interestingly, certain URI domain toxins belonging
to the second clade are present in distantly related intra-
cellular symbionts/pathogens of Acanthamoeba, such as
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the Simkania negevensis (gi: 338731950), Odyssella (gi:
344925485) and Rickettsia belli (gi: 91206213). Analysis of
the gene-neighborhoods of these toxins suggests that they
have adjacent genes encoding immunity proteins (Add-
itional File 1), suggesting that these toxins are likely to be
used in intra-conflict rather than being directed against
the host. Along with the above-described Otu peptidase
toxins from Odyssella, these URI domain toxins represent
relatively rare examples of polymorphic toxins deployed in
intraspecific conflict by endo-symbiotic/parasitic bacteria.
Other than the versions from intracellular bacteria, the
URI domain toxins are typically associated with filament-
ous RHS repeats.
All the above metal-dependent nuclease domains are
shared by polymorphic toxin systems with R-M systems,
but are apparently absent among classical toxin-
antitoxin systems [22,28]. However, the versions found
in the polymorphic toxins differ from those in classical
R-M systems in lacking a complex array of associated
DNA-binding domains [120]. Hence, we suspect that the
versions of these nuclease domains deployed by the
polymorphic toxin systems might have lower target se-
quence specificity than those deployed in R-M systems.
Further, those from the former systems are under selec-
tion imposed by the physical interactions with cognate
immunity proteins. It appears that these factors might
eminently disallow exchange of nuclease domains be-
tween polymorphic toxin and R-M systems.
The competence nuclease (ComI) domain
This nuclease domain is prototyped by the secreted 17
kDa competence nuclease ComI of Bacillus subtilis,
which is a major determinant of DNA uptake when the
bacterium becomes capable of transformation prior to
stationary phase [121]. We recovered related nucleases
as toxin domains of polymorphic toxins from actinobac-
teria (e.g. gi: 296130766 from Cellulomonas flavigena)
and proteobacteria (e.g. gi: 326318161 from Acidovorax
avenae; Figure 8B). This domain could not be unified
with any previously known fold observed among
nucleases. A multiple alignment of this domain showed
that it contained a central dyad of two acidic residues
(usually a DE motif ) followed by a third conserved acidic
residue a few positions downstream (Additional File 1).
These residues could potentially form a divalent cation-
chelating site, suggesting that the ComI nuclease is likely
to be the fourth metal-dependent nuclease superfamily
among the toxin domains. Interestingly, the B.subtilis
competence nuclease is physically associated with the 18
kDa product of the adjacent ComJ gene, which acts as
its inhibitor – the interplay between the ComI nuclease
and its inhibitor ComJ has been suggested to be import-
ant for optimal digestion of incoming DNA, so as to fa-
cilitate transformation [121]. The structure of this
operon with a nuclease followed by its inhibitor is rem-
iniscent of the polymorphic toxin systems with the toxin
gene followed by the immunity protein. Consistent with
this, ComJ homologs occurs as an immunity protein for
polymorphic toxins with the ComI nuclease domain in
several proteobacteria. Hence, it is possible that these
key components of the Bacillus DNA uptake system
have evolved from a toxin-immunity gene pair.
ParB domain toxins
We recovered several polymorphic toxins with N-
terminal filamentous regions formed by RHS or fila-
mentous haemagglutinin repeats and C-terminal ParB
toxin domains (Figure 8C). The ParB domain is the sub-
ject of much confusion: based on a study, which claimed
to demonstrate both endo- and exo- DNase activity in
the ParB protein [122], required for maintenance of the
plasmid RK2, the domain was labeled as a nuclease do-
main. However, it should be noted that this study was
based on entirely erroneous assumptions that the RK2
ParB domain was related to nucleases such as the
staphylococcal nuclease and RuvC [122]. In contrast,
other members of the ParB superfamily, such as sulfire-
doxin, have been convincingly demonstrated to possess
metal-dependent phosphotransferase activity that utilizes
ATP to form a phosphoryl ester of sulfinate generated
from the active site cysteine of the peroxiredoxins [123].
Through sequence profile searches we were able to dem-
onstrate that DndB is a member of the ParB superfamily.
DndB negatively regulates the formation of the unusual
DNA phosphorothioate modification, in which the non-
bridging oxygen in the phosphodiester linkage of DNA
is replaced by a sulfur atom in a sequence-specific man-
ner [124]. Hence, it appears that even this member of
the ParB superfamily, comparable to sulfiredoxin might
hydrolyze a phoshoryl ester linked to a sulfur center.
The convincingly inferred metal-dependent phospho-
transfer activity of the ParB superfamily implies that in
principle certain representatives might also be able to
catalyze nuclease activity through a comparable hydroly-
sis of a phosphodiester bond. Hence, it is conceivable
that, even though the ParB domain was considered a nu-
clease for the wrong reasons, this activity might be still
valid for some representatives of the superfamily. This is
also consonant with the earlier recovery of ParB
domains in nucleases encoded by certain R-M like sys-
tems [103,125]. The predominance of nuclease domains
among the toxin domains of polymorphic toxin systems
also supports a potential nuclease function for the ParB
toxin domains. Examination of the multiple alignment of
the ParB domains from polymorphic toxins suggests that
they possess a strongly conserved DGHHR motif that is
predicted to form part of their highly conserved metal-
binding active site (Additional File 1). In addition to the
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classical ParB toxin domains, we recovered a second
large group of toxin domains typified by that found in
Neisseria gonorrhoeae NGK_2271 (gi: 194099761), which
could be united using profile-profile comparisons with
the ParB domain (HHpred probability 93%; p = 2x10-6
match to 1vz0 Thermus ParB). While being rather diver-
gent from the classical ParB domains, they display a
motif with a conserved arginine that is equivalent to the
DGHHR motif in the former. Additionally, they display
a conserved N-terminal serine that is absent in the clas-
sical ParB domains. Hence, we termed this distinct fam-
ily of ParB-related domains as Tox-ParBL1 (Figure 8C).
In addition to the bacterial polymorphic toxins, Tox-
ParBL1 domains are also found in several eukaryotes
such as kinetoplastids, and several metazoans, fungi,
plants, stramenopiles and ciliates (Table 2 and Add-
itional File 1). Thus, this example represents an inde-
pendent acquisition by eukaryotes of a ParB-related
domain from the polymorphic toxin systems, distinct
from the sulfiredoxins.
The JAB domain
We detected two distinct clades of the JAB domain
superfamily as the potential toxin domain of several
classical polymorphic toxins (Figure 8D). The JAB do-
main has been previously shown to be a peptidase that
specifically targets the C-termini of ubiquitin-like pro-
teins (UBLs) either as a DUB or as a processing enzyme
[126-128]. All previously identified prokaryotic JAB
domains are intracellular proteins. Most representatives
of them are components of systems utilizing UBLs in
biosynthetic pathways or protein modification. As these
toxin genes are accompanied by immunity proteins they
are likely to be used in intraspecific conflict rather than
against eukaryotic targets. Hence, the presence of the
JAB domain among the toxin modules of classical poly-
morphic toxins was unexpected, because most of the
bacteria in which they are present lack systems with
conjugated or processed ubiquitin-like proteins [126].
However, based on contextual information from domain
architectural analysis it was recently proposed that a
subset of the JAB domains (i.e. those belonging to the
RadC clade) are more likely to function as nucleases that
cleave DNA, rather than as peptidases [18]. The two
clades of JAB domains found among the polymorphic
toxins, like RadC, are rather divergent with respect to
those that act on UBLs, and do not conserve the resi-
dues lining the tunnel that accommodates the UBL tail
in the peptidase versions (Additional File 1). This sug-
gests that, as previously proposed for RadC, the toxin
JAB domains might function as nucleases rather than as
peptidases. Of the two clades Tox-JAB-1 is found in only
in the bacteroidetes lineage associated with N-terminal
RHS repeats (Figure 8D). Tox-JAB-2 is more widely
distributed across proteobacteria, bacteroidetes and few
firmicutes which partly overlaps with the “domain of un-
known function”, DUF4329 from the PFAM database
(Figure 8D). Versions of Tox-JAB-2 are also present in
several NCLDVs, such as iridoviruses, mimiviruses and
algal viruses, and Xanthomonas phages (e.g. phage
OP1). These latter versions are secreted proteins and
could potentially function as phage-encoded virulence
factors.
The Het-C hydrolase domain
The Het-C domain was first identified as a major player
in the phenomenon of fungal vegetative incompatibility
[129], wherein it mediates programmed cell death upon
interaction with incompatible hyphae. Subsequently, a
version of the Het-C domain encoded by Pseudomonas
syringae was shown to be required for the infection of
fungal hyphae by this bacterium, by exploiting the mech-
anism of hetero-incompatibility [130]. In our analysis we
recovered Het-C domains in systems related to the poly-
morphic toxins that utilize PVC-SS (e.g. gi: 148657895
from Roseiflexus; Figure 4C). Profile-profile comparisons
using an alignment of the Het-C domain (Figure 8E)
revealed hits with borderline significance (p = .001; 50%
probability) to a group of α-helical hydrolases sharing a
common a fold, including zinc-dependent phospholipase
C [131] and the S1-P1 nucleases [132]. The predicted
secondary structure for the Het-C domain was also com-
patible with the α-helical fold seen in those hydrolases
and examination of the multiple alignments revealed
that the two possessed a comparable set of conserved ac-
tive site residues (Figure 8E). This includes four con-
served histidines and 3 acidic residues (D/E) suggesting
that the Het-C domain possess a metal-dependent active
site similar to that seen in the phospholipases and S1-
P1-like nucleases. Indeed, secreted versions of this do-
main with both phospholipase and nuclease activity are
known from different bacteria [132]. This suggests that
the Het-C domain might also possess either metal-
dependent nuclease or phospholipase activity, and that
this activity is likely to be critical for the apoptotic and
toxin action of this domain in fungi and bacteria.
Barnase-EndoU-colicin E5/colicin D-RelE like nuclease fold:
A large assemblage of metal-independent RNases
In our earlier study we had recovered the EndoU do-
main as a metal-independent RNase frequently found in
polymorphic toxin systems. We had further shown that
the EndoU fold is marked by a potential duplication of a
core helix-β-sheet element that constitutes its active site
[17]. In another earlier study we had unified the colicin
E5 and colicin D RNase domains with the RNase do-
main of the RelE toxin that is found in classical toxin-
antitoxin systems [133]. A comparison showed that the
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core structural element in EndoU, Colicin E5, colicin D
and RelE is a similar strand-β-sheet unit (Figure 9A).
Transitive structure-comparison searches using the
DALIlite program confirmed that these RNase domains
are indeed related as they preferentially recovered each
other (with Z> 3.5). Further, these DALIlite searches
showed that they could be united with several other
metal-independent RNase domains, namely the RNase
toxins and other secreted RNases from fungi, such as
sarcin, RNaseT and RNase U2, and the bacterial RNases
prototyped by barnase (Z> 3.5; Figure 9A; this latter
group is described as the microbial RNase fold in the
SCOP database [134]). We term the common structural
unit shared by all the representatives of the above-
unified assemblage the BECR (Barnase-EndoU-Colicin
E5/D-RelE) fold. The common structural unit, which
constitutes the catalytic domain of the BECR fold
RNases contains a N-terminal helical segment that is fol-
lowed by a sheet formed by 4-stranded meander
(Figure 9A). In several cases the 4th strand is followed by
an additional short 5th strand that is differentially posi-
tioned in various versions of this fold. Furthermore, the
location of the active site residues is often comparable
across these enzymes and our sequence analysis revealed
that many of these RNases (including EndoU, colicin
E5/D and some clades of RelE) share a conserved alco-
holic residue (S/T) in the 4th strand that contributes
to the active site (Figure 9A).
In addition to the EndoU clade, our sequence compari-
sons indicated that several of the newly recovered BECR
fold toxin domains from polymorphic toxin systems belong
to other previously defined clades in this fold, such as bar-
nase, colicin E5, and colicin D clades (Figure 9B-F). While
the classical RelE endoRNase domain is common in type-II
toxin-antitoxin systems, we observed only a single instance
of it being used as a toxin domain in the polymorphic tox-
ins (gi: 357015358 from Paenibacillus elgii). However, using
secondary structure prediction combined with profile-
profile comparisons we also discovered distinct, previously
unrecognized clades of RNases displaying the BECR fold
(Figure 9G): these include the clades 1) Ntox7 (e.g. y1701,
gi: 22125595 from Yersinia pestis); 2) Ntox19 (NMW_1482,
gi: 254673263 in Neisseria meningitidis); 3) Ntox35 (typified
by NGMG_00731; gi: 291044920 from Neisseria gonor-
rhoeae); 4) Ntox36 (typified by the toxin domain of gll0213;
gi: 37519782 from Gloeobacter violaceus); 5) Ntox47 (typi-
fied by the toxin of rhs2; gi 366079994 from Salmonella
enterica); 5) Ntox48 (e.g. gi:251789613 from Dickeya zeae);
6) Ntox49 (gi:59801914 in Neisseria gonorrhoeae; 7) Ntox50
(gi: 254804532 in Neisseria meningitidis). Together with
previously characterized clades, these seven novel clades
are extensively represented among the toxin domains of
classical polymorphic toxins and in some cases related
toxins delivered by the PVC-SS (Figures 4 and 9). This
observation suggests that the BECR fold has supplied one of
the most extensive radiations of RNase toxins, which cuts
across mechanistically distinct systems – the polymorphic
and related secreted toxins and the classical toxin-
antitoxin systems. Examination of the predicted active site
residues among the newly characterized clades pointed to
each clade acquiring their own unique features. For ex-
ample, Ntox35 has acquired two conserved N-terminal his-
tidines in addition to the conserved S/T from the C-
terminal strand. Ntox50 and Ntox19 instead have a single
N-terminal histidine, similar to one observed in several
members of the colicin E5/D clade [110], accompanied by
a second C-terminal histidine found at the position usually
occupied by the conserved S/T of the BECR fold (Add-
itional File 1). The presence of two histidines in the above
three clades is reminiscent, though not equivalent in terms
of secondary structure context, to those seen in the EndoU
clade, suggesting a comparable reaction mechanism in all
these versions of the fold. In contrast, Ntox36 lacks any
conserved histidine; instead it displays other clade-specific
conserved residues; e.g. an asparagine in the N-terminal re-
gion. Most of these enzymes, especially those with two
conserved histidines are likely to utilize a metal-
independent mechanism similar to that observed in RNa-
seA (see below) [107]. This is supported by the generation
of cleavage products with 2’-3’ cyclic phosphate termini in
several biochemically characterized members of these
RNases (e.g. XendoU). Some members of the EndoU clade
have been shown to require Mn2+ for effective catalysis of
RNA cleavage [135]; however, given that they still produce
2’-3’ cyclic phosphates, it is likely that this metal is required
for stabilization of the hypercharged transition state ra-
ther than the actual phosphoesterase activity.
Interestingly, we observed that one RNase of the BECR
fold related to the colicin E5/D clade is also found con-
sistently associated with the flagellar operon across fir-
micutes (e.g. gi: 28211324 from Clostridium tetani;
Additional file 1). It would be of interest to investigate if
this RNase is delivered by the flagellar system or alterna-
tively functions to regulate flagellar gene expression as a
RNA-processing enzyme. RNases of the Ntox50 clade
have also been acquired by bacteriophages such as Clos-
tridium phage phiC2 (gi: 134287339) and might be used
in conflicts with the host or other phages. Likewise
Ntox19 has been acquired by the giant Acanthamoeba-
infecting mimivirus and is also found in potential effec-
tors secreted by the Acanthamoeba endosymbionts
Parachlamydia and Odyssella.
Novel toxin domains which are likely to function as
nucleases
Our systematic analysis of the polymorphic toxin sys-
tems recovered a total 50 distinct novel toxin domains
that could not be unified with any previously known
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domain (Table 2; Additional file 1). Only a small minor-
ity of these domains contain at least one experimentally
characterized member. Their sequence conservation pat-
terns, together with the preponderance of nucleases
among polymorphic toxins, suggest that most of these
novel toxin domains are likely to be nucleases. Indeed,
their conservation patterns suggest that these novel
toxin domains include both potential metal-dependent
and independent enzymes (Table 2; Additional file 1).
The C-terminal toxin domain of the originally character-
ized contact-dependent inhibitor protein CdiA from
Escherichia coli was demonstrated to possess RNase ac-
tivity [44]. We observed that the E.coli CdiA-C domain
is widely distributed across polymorphic toxins from di-
verse bacteria. We also uncovered this domain in the
Photorhabdus PalA protein, which lacks an associated
immunity protein but is encoded in a pathogenicity is-
land adjacent to the Mcf gene whose product is a toxin
directed against the caterpillar host [87]. In light of this,
it is possible that E.coli-CdiA-C domain in PalA might
be directed against the host as an accessory toxin. Exam-
ination of the E.coli-CdiA-C domain shows that it pos-
sesses an all β fold that lacks any conserved residues
typical of metal-dependent nucleases. Hence, it is likely
to be a metal-independent RNase and probably defines a
novel structural theme among them.
We uncovered an uncharacterized toxin domain that
is found in polymorphic toxin systems from a wide
range of bacteria and several potential effectors delivered
by endo-symbiotic/parasitic bacteria (e.g. Wolbachia,
Ehrlichia, Odyssella, Rickettsia and Legionella). It is also
found at the C-terminus of a group of eukaryotic pro-
teins typified by the plant protein EDA39 and we ac-
cordingly call it the Tox-EDA39C domain (Additional
File 1). This domain is characterized by two highly con-
served histidines respectively in the N- and C-terminal
halves of the proteins that are likely to comprise its ac-
tive site. This conservation pattern is reminiscent of the
catalytic residues seen in the RNase A domain [136],
and might represent a novel metal-independent RNase
that catalyzes a reaction similar to that of RNase A. The
presence of this domain in several eukaryotic lineages,
such as plants, fungi, oomycetes and Dictyostelium, sug-
gests that it might have been acquired by eukaryotes
from bacterial endosymbionts and could have been
recruited as a potential RNase used in anti-pathogen
defense. Ntox43 is typified by the toxin domain of the
recently described RhsT from Pseudomonas aeruginosa,
which has been shown to translocate to the host cyto-
plasm and mediate an inflammatory response [46]. This
toxin, like Tox-EDA39C, has two conserved histidines
suggesting that it might also function as a RNase A-like
metal-independent nuclease (Additional File 1). Hence,
we predict that RhsT is likely to activate the
inflammosome via cleavage of specific RNAs. Although
proteins with Ntox43 display architectures are similar to
classical polymorphic toxins, none of them are asso-
ciated with adjacent genes for immunity proteins. This
suggests that they are likely to be used primarily against
eukaryotic hosts. At least four other toxin domains iden-
tified by us (Ntox18, Ntox19, Ntox22, Ntox26, Ntox30)
are likely to be novel metal-independent endo-RNases
that utilize a two histidine-dependent mechanism to
catalyze transestrification and formation of a 2’-3’ cyclic
phosphate like RNase A (Table 2).
We observed that the RES domain (PFAM: PF08808),
whose function was previously unknown, is another toxin
domain that is found in polymorphic toxin systems.
Interestingly, it is also found in classical toxin-antioxin
systems, where it is typically paired with a distinctive
antitoxin (previously labeled as a domain of unknown
function, DUF2384 in the PFAM database). Hence, we
predict that the RES domain is likely to be a novel RNase
domain shared by different toxin systems. Examination
of the alignment of the RES domain revealed two con-
served arginines, a glutamate and a serine – this config-
uration does not appear likely to support a metal-binding
active site; however, these residues are suitable for
catalyzing a distinct metal-independent RNase reaction.
Ntox24 is characterized by a single conserved histidine,
and, like the RES domain, versions of this toxin do-
main are additionally found in what appear to be novel
type-II toxin-antitoxin systems associated with a previously
uncharacterized family of antitoxins (e.g. gi: 139439131).
The toxin domain from the CdiA protein from Entero-
bacter cloacae (Ntox21) shows universally conserved
residues, including a single histidine and two aspartates,
but could not be unified with any other known domain.
It is conceivable that Ntox24 and Ntox21 act as metal-
independent endoRNases comparable to the Colicin E3
nuclease domain [137], which is also found in poly-
morphic toxin systems (Tox-ColE3)[17]. Our detection
of Tox-ColE3 in these systems also helped in emending
the proposed active site of these RNases. Based on struc-
tural analysis it was previously proposed that the active
site of these enzymes corresponds to D55, H58 and E62
in the structure of colicin E3 (PDB:2xfz) [137]. However,
our analysis indicated that H58 is not conserved across
all members; instead we found that a second histidine,
corresponding to H72 in Colicin E3, is conserved
throughout the fold. Thus, it is possible that the above
types of RNases use a single histidine in conjunction
with an acidic residue that initiates cleavage by inducing
the 2’OH to attack the phosphodiester backbone of
RNA [137]. In contrast, examination of the multiple
alignments of the novel toxins revealed potential metal-
chelating sites in Ntox29 (conserved histidines and aspar-
tates); hence, it could potentially function as a novel
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metal-dependent nuclease. For the remaining Ntox
domains, while the active site residues could be identified
based on conservation, the nature of catalysis remains
unclear.
Deaminases
Other than the nuclease domains, deaminases are the
most common toxin domains that operate on nucleic
acids in polymorphic toxin systems. As we had exten-
sively characterized the toxin deaminases form these sys-
tems in our earlier study [18], we do not consider them
in detail here. However, in this study we recovered two
additional clades of deaminases that were not previously
detected (Figure 10A). The first of these was found in
giant proteins with a toxin-like architecture from the
alphaproteobacterial endosymbionts of the genus Wol-
bachia, which reside in the cells of two dipterans,
namely Culex (gi: 190571717; WPa_1346) and Drosoph-
ila (gi: 42520377, WD0512). These proteins contain two
toxins at their C-termini, of which the Latrotoxin-CTD
(see below) is the terminal toxin and the deaminase N-
terminal to it (Figure 10). An examination of their gene
neighborhoods revealed that they lacked accompanying
genes encoding immunity proteins. Hence, it appears
that these proteins, while resembling the classical poly-
morphic toxins, are primarily directed against host nu-
cleic acids. The deaminase domains from these proteins
are extremely divergent, but structure prediction based
on a multiple alignment with a comprehensive set of dea-
minase domains showed that they belong to the “Helix-4
Figure 10 Domain architectures of polymorphic toxins containing (A) Two novel deaminase families reported in this study, (B)
Cytotoxic necrotizing factor (Tox-CNF), (C) several families of ADP-ribosyltransferases (Tox-ART), (D) Phospholipase A2 toxin (Tox-PLA2)
and toxin RelE (Tox-RelE), (E) three novel α/β hydrolase families, (F) Tox-W-TIP, (G) Ntox38, (H) novel Latrotoxin C-terminal domain
(LatrotoxinCTD), and (I) MafBN secretion related domain. Also shown in (F) and (G) are the multiple sequence alignments of the Tox-W-TIP
and Ntox38 domains respectively. The labeling scheme for domain architectures and alignments, and the coloring scheme and consensus
abbreviations are as in Figure 3.
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division” of the deaminase superfamily in which the
5intervening 4th helix of the core domain causes strands
4 and 5 to be parallel to each other [18]. Thus, they are
united with other deaminases of this division such as
TadA/Tad2, ADAR/TAD1 and the AID/APOBEC-like
deaminases. However, unlike most members of this div-
ision the newly characterized deaminase domains have a
CXE signature in their first active site motif, as opposed
to usual HXE seen in this division (Additional File 1).
These newly detected versions add to the earlier iden-
tified deaminases belonging to the Helix-4 division
among host-directed toxins of alphaproteobacterial endo-
symbionts/parasites, such as those from the Wolbachia
endosymbiont of the lepidopteran Cadre cautella and
from the Orientia and Rickettsia species infecting diverse
eukaryotes[18]. This suggests that modification of nucleic
acids by these fast-evolving deaminase toxins related to
the eukaryotic AID/APOBEC-like proteins might be a
widely used strategy by endosymbionts to alter host
physiology. In particular, the presence of such highly
divergent versions of deaminases in Wolbachia infecting
diverse arthropods hints that they could be attractive
candidates for mediating failure of paternal chromosome
condensation via its mutagenic action [138]. The second
novel clade of deaminases are toxin domains of classical
polymorphic toxins from proteobacteria and actinobac-
teria, which might be delivered via diverse secretory
mechanisms such the T2SS, T5SS, T6SS, T7SS and the
TcdB/TcaC system (prototyped by gi: 162451789,
sce3516 from Sorangium cellulosum; Figure 10A and
Additional File 1). These deaminases usually have a
HAE signature in their first active site motif but belong
to the “C-terminal hairpin” division of the deaminase
superfamily, which is characterized by a C-terminal β-
hairpin following the 3rd-helix of the conserved core.
Given their predominance in free-living bacteria, unlike
the former deaminases, they are likely to be deployed in
intraspecific conflict rather than against eukaryotic
hosts.
Other catalytic toxin domains in polymorphic toxin
systems
Other than the peptidase and nucleic acid cleaving or
modifying toxins we uncovered several other less fre-
quent catalytic domains that function as toxins in poly-
morphic and related secreted toxin systems (Table 2).
These display a wide range of activities and are likely to
elicit their cytotoxic activity by attacking several inde-
pendent aspects of cellular function. We briefly outline
these toxin domains and their possible modes of action.
Domains catalyzing modifications of proteins
The previously characterized DOC domain, which has
been observed in several host-directed effectors (e.g.
Xanthomonas AvrAC), is found in several polymorphic
toxins [22,139,140] (Figure 2D). This is a protein-
modifying toxin domain, which transfers AMP or UMP
from nucleotide triphosphates to serines or threonines
on target proteins [139,140]. Another toxin domain that
we recovered in polymorphic-toxin- related systems util-
izing the PVC-SS showed a specific relationship to the
serine/threonine kinase domain found in lantibiotic
synthetases [141] (Figure 4C). The “eukaryote-type” kin-
ase domain in the lantibiotic synthetases phosphorylates
serine/threonine residues in the lantibiotic precursors
to prime them for the generation of the thioether lin-
kages. Lantibiotic synthetase-type kinase domains have
been shown to possess generic S/T kinase activity
[142], suggesting that the toxin versions might carry
out their action by phosphorylation of proteins on S/T
residues in target cells. A comparable protein-modifying
toxin domain (gi: 291451822, from Streptomyces albus,
Figure 4C) is a glycosyltransferase, related to the Clos-
tridium difficile toxin B, which has been shown to gly-
cosylate the hydroxyl group of threonine 37 in the
switch I region of the small GTPase RhoA [143]. Given
the conservation of the Mg2+−binding DXD signature,
which is critical for catalyzing the transfer of UDP-
linked sugars, in versions of this domain found in toxin
polypeptides detected in our study, it is likely that it
functions in a similar fashion by glycosylating serines or
threonines in specific proteins in target cells. In
addition to its presence in classical polymorphic toxins
with N-terminal RHS repeats and PVC-SS delivered
toxins, we observed that related glycosyltransferase
domains are also found in effector proteins delivered by
various intracellular bacteria. In the endoparasite Le-
gionella pneumophila it is present in a toxin delivered
via the T4SS (gi: 307610704) and in the aphid endo-
symbiont Hamiltonella defensa (gi: 238899322) it might
be deployed as a toxin against the parasitoid wasps that
attack the host aphids [144]. A distinct protein-
modifying toxin domain is typified by the CNF domain
of the uropathogenic E. coli cytotoxic necrotizing factors
1 and 2 and the dermonecrotic toxins of Bordetella.
These domains display a 4-layered sandwich fold, with
an active site histidine and cysteine, and catalyze the
deamidation or transglutamination of a specific active
site glutamine in the small GTPases, like RhoA, Rac and
CDC42, in the cells of their eukaryotic host [140]. We
recovered CNF domains in potential proteobacterial
polymorphic toxins (Figure 10B) with N-terminal fila-
mentous regions (Yersinia sp. yenC1, gi: 109391485) as
well as those fused to phage-tail VgrG domains of the
T6SS (e.g. 345371919 from E.coli).
We also encountered several distinct clades of ADP
ribosyltransferases (ARTs) among the toxin domains of
polymorphic and related toxin systems (Figure 10C)
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[145]. The ART superfamily can be divided into two
major clades depending on the conservation pattern of
the three key active site residues associated with the three
conserved motifs, respectively from the N-terminus, cen-
tral region and C-terminus of the domain. These are the
R-S-E clade and the H-Y-E clade, named after their re-
spective conserved active site residues [146-148]. Protein-
modifying ART domains have been extensively studied in
the context of the host-directed toxins of diverse bacteria.
Members from the R-S-E clade include the cholera toxin,
which modifies a specific arginine in a mammalian Gα
subunit, the Bordetella pertussis toxin which modifies
cysteine, the Clostridium botulinum C3 toxin that modi-
fies asparagine, and the Photobacterium luminescence
toxin which modifies glutamine in target proteins
[145,148]. The H-Y-E clade includes the Corynebacterium
diphtheria, Vibrio cholix and Pseudomonas aeruginosa
exotoxin A toxins, which modify diphthamide in the
translation GTPase eEF-2, and the polyADP ribsosyl
transferases (PARP/PARTs) [146,149,150]. We found
multiple R-S-E clade ART domains in classical poly-
morphic toxin systems. One type of R-S-E clade ART
toxin domains, observed in certain polymorphic toxins
(e.g. gi: 221200352 from Burkholderia multivorans), is
also seen in the T3SS effectors of Pseudomonas syringae,
namely hopO1-1/2/3, a Legionella pneumophila T4SS ef-
fector (gi: 307611385), a novel Protochlamydia amoebo-
phila effector (pc1346; gi: 46446980), and Pseudomonas
aeruginosa exoT (gi: 347302423). Such ART toxin
domains are also found in a remarkable group of giant
proteins from actinobacteria (e.g. 345002682; Strepto-
myces sp.; Figure 10), which combine several toxin
domains such as two anthrax lethal factor-like metallo-
peptidase, two caspase, three ART and one MCF1-SHE
domains (Figure 10). A second distinct type of R-S-E
clade ART domains, which is found in similar actinobac-
terial toxins (e.g., gi: 320008023 from Streptomyces flavo-
griseus), is closely related to the lepidopteran ARTs, such
as pierisin, which ADP-ribosylates the N2 atom of guan-
ine in DNA to induce apoptosis and the insecticidal
toxin of Bacillus sphaericus [151]. Interestingly, the close
relationship of the lepidopteran pierisin-like ARTs to the
bacterial insecticidal toxins suggests that they were prob-
ably a late lateral transfer into these insects from a bac-
terial symbiont or parasite, followed by their reuse as an
apoptotic effector. In this study we found novel toxins of
the H-Y-E clade from actinobacteria, which are closely
related to the eukaryotic PARPs (Tox-ART-PARP), and
are associated with the PVC-SS from (e.g. gi: 291451874
from Streptomyces albus). We also identified related
toxin domain among the toxins secreted by the intracel-
lular pathogen Legionella drancourtii (e.g. LDG_5757; gi:
374260808). Additionally, we also found three distinct
families of toxin ARTs belonging to the H-Y-E clade. The
first of these is an extremely divergent version, which is
typified by a protein with an architecture similar to a
classical polymorphic toxin from Shewanella baltica (gi:
152999126), but without associated immunity proteins
and might be directed against eukaryotic hosts. The two
other families (Tox-ART-HYD1 and 2 prototyped by gi:
336178949 and gi: 238064042 respectively) are widely
distributed in free-living bacteria and are associated with
distinct immunity proteins suggesting that they might
be mainly deployed in intraspecific conflict like the clas-
sical polymorphic toxins. Nevertheless, versions of Tox-
ART-HYD2 appear to have been transferred to several
eukaryotes such as fungi and choanoflagellates (e.g. gi:
331216471 from Puccinia graminis). The above observa-
tions suggest that the use of ARTs to modify proteins,
and in some cases DNA, appears to be yet another strat-
egy that is common to effectors deployed in both intra-
bacterial and bacterio-eukaryotic conflicts.
Lipid-modifying toxin domains
Three distinct lipid-modifying enzymes are represented
among the toxin domains of classical polymorphic toxins
and related PVC-SS-delivered toxins. Two of these
namely the glycerophosphoryldiester phosphodiesterase
(GPDase, gi: 218438711 from Cyanothece) and the CDP-
alcohol phosphatidyltransferase (CAPTase, gi: 317401091
from Neisseria mucosa) domains are found exclusively in
PVC-SS toxins (Figure 4C). In contrast, phospholipase
A2 (PLA2) is found in classical polymorphic toxins with
filamentous N-terminal regions (e.g. gi: 118578532 from
Pelobacter propionicus), which might be secreted via dif-
ferent mechanisms, including the T6SS (Figure 10D). Of
these the GPDase can catalyze the hydrolysis of glycero-
phospholipid head groups by releasing alcohols linked to
glycerol 3-phosphate via a phosphodiester linkage [152].
On the other hand, phospholipase A2 can hydrolyze
lipids by releasing of one of the fatty acid tails from gly-
cerol 3-phosphate [153]. Closely related homologs of the
Tox-phospholipase A2 domains (Tox-PLA2) are also
found in secreted proteins from fungi and oomycetes
(Table 2, Additional File 1). More generally, phospholip-
ase A2 domains are also found in animal toxins from
reptilian venom and from mammalian immune systems
[152], suggesting that the use of this domain as a toxin is
a prevalent strategy throughout evolution. Intriguingly,
members of the CAPTase superfamily are membrane-
embedded enzymes catalyzing the reverse reaction (lipid
synthesis) using cytidine-diphosphate-linked alcohols as
substrates, e.g. phosphatidylserine, phosphatidylcholine,
phosphatidylglycerolphosphate, phosphatidylinositol and
cardiolipin synthetases [154]. It is conceivable that a
novel lipid synthesized by this toxin domain creates dis-
continuities in lipid bilayers, as has been observed with
cardiolipin [155]. Thus, all three of these enzymes could
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potentially mediate their cytotoxicity by damaging the
cell membrane of target cells, either through hydrolysis
of lipids or disruption of the bilayer.
A toxin domain was uncovered in several classical
polymorphic toxins (e.g. Tmz1t_2699 from Thauera sp.;
gi: 237653364) that partly overlapped with a “domain of
unknown function” (DUF2235 in the PFAM database).
Sequence profile searches with the PSI-BLAST program
recovered significant hits to α/β hydrolases (e = 10-5-10-7;
iteration 3 in a search initiated with the domain from
the above Thauera protein). While α/β hydrolase super-
family encompasses hydrolases with several distinct ac-
tivities, such as lipases, peptidases and thioesterases,
profile-profile comparisons with the HHpred program
suggested that these α/β hydrolases (Tox-ABhydrolase-1)
are closest to lipases (e.g. the recovery of triacylglycerol
lipases; PDB: 1tgl). In most cases this α/β hydrolase do-
main is either found fused to N-terminal phage base-
plate modules (e.g. gi: 77461818 from Pseudomonas
fluorescens) or encoded by a gene adjacent to a gene
coding for such modules (Figure 10E). This suggests
that Tox-ABhydrolase-1 might be a toxin that is mainly
delivered via T6SS. These α/β hydrolase domains also
appear to have been transferred to fungi prior to the di-
vergence of the ascomycetes and the basidiomycetes and
are present in most fungal lineages. We recovered two
more distinct, previously uncharacterized α/β hydrolase
families that are potential toxin domains that are asso-
ciated with numerous classical polymorphic toxins
(Tox-ABhydrolase-2 and 3, Figure 10E). Profile-profile
searches with ABhydrolase-3 recovers the lipases (e.g.
pdb: 1lgy; p = 10-12; probability 95%) as the best hit to
the exclusion of other ABhydrolases. Hence, it is con-
ceivable that Tox-ABhydrolase-1 and Tox-ABhydrolase-
3 are further toxins that might disrupt cell-membranes
of target cells via their action on lipids. ABhydrolase-2
is primarily present in proteobacteria and has also been
transferred to ascomycete fungi. It is also found in the
endosymbiont Parachlamydia amoebophilus independ-
ently of an immunity protein and might be deployed
against host molecules. However, Tox-ABhydrolase-2 did
not show any specific relationship to previously charac-
terized lipases. Given, that the ABhydrolase superfamily
includes hydrolases with a very diverse array of activities,
it is not clear if Tox-ABhydrolase-2 might also act on
lipids or target some other cellular component.
Carbohydrate-related toxin domains
We detected two enzymatic domains, which are pre-
dicted to act on carbohydrate substrates, as toxin
domains of polymorphic and PVC-SS-delivered toxins.
The first of these belongs to a superfamily of glycohy-
drolases, typified by bacterial proteins, such as FlgJ and
the N-acetylmuramoyl-L-alanine amidase (gi: 220928985
from Clostridium cellulolyticum), which cleave the gly-
copeptide linkages in peptidoglycan or endo-glycosidic
linkages in oligosaccharides [156,157]. Hence, it is likely
that these toxin domains act by hydrolyzing linkages in
the peptidoglycan of the target cells. These might be
compared to the recently described amidase toxins from
Pseudomonas aeruginosa that are believed to act on pep-
tidoglycan [15]. The second toxin domain in this group
is an oxidoreductase with a TIM barrel fold catalytic do-
main (gi: 158339325 from Acaryochloris marina) [158].
Within this superfamily, the toxin domains are most
closely related to the aldo-keto reductases, such as 2,5-
didehydrogluconate reductase, suggesting that they are
likely to act on sugar substrates. However, the exact
mode of action of this toxin remains unclear – it could
either act on carbohydrates in the peptidoglycan or
within target cells.
Toxin domains related to nucleotide signaling
The RelA/SpoT-like toxin domain is found in classical
polymorphic toxins from Gram-positive bacteria deliv-
ered by the ESX/T7SS (e.g. 302865491; Micau_0989
from Micromonospora aurantiaca; Figure 10D). A
related toxin domain is also found in the T3SS-delivered
effectors directed against plant hosts by several plant
pathogens, such as Xanthomonas (e.g. gi: 353464269; the
XopAD effector), Ralstonia solanacearum and Pseudo-
monas syringae. These proteins typically contain two
copies of the RelA/SpoT domain. Further, in several bac-
teria (e.g. gi: 149004362 from Streptococcus pneumoniae
and gi: 254362874 from Mannheimia haemolytica) the
RelA/SpoT toxin domain is found fused to the MuF do-
main of prophages and is thereby predicted to be deliv-
ered via this distinct phage-derived system. The RelA/
SpoT is a nucleotide-binding domain related to the
DNA polymerase β-type nucleotidyltransferase fold
[159] that synthesizes the alarmone (p)ppGpp [160]. It
has been observed that high levels of (p)ppGpp in non-
starvation conditions rapidly inhibits growth and protein
synthesis [160]. Hence, it is conceivable that this toxin
acts as an unregulated alarmone synthetase in target
cells to shut down their protein synthesis. Its widespread
presence in several phylogenetically distant plant patho-
gens is consistent with the presence of a (p)ppGpp-
dependent signaling pathway in plants, similar to that
seen in bacteria [160]. In light of this, it appears likely
that the MuF-fused versions found in the animal patho-
gens such as Streptococcus pneumoniae and Mannhei-
mia haemolytica might be deployed in intra-bacterial
conflict similar to the classical polymorphic toxins, ra-
ther than against the animal hosts.
Another distinct nucleotide generating enzymatic do-
main, which we found in several polymorphic toxins
from several major bacterial lineages (Figure 10C), is the
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ADP-ribosyl cyclase (Tox-ARC) domain. These toxins
are coupled to various delivery systems including T5SS,
T6SS and T7SS. This domain has previously only been
characterized in animals and generates two distinct
metabolites, namely cyclic ADP ribose (cADPr) and
nicotinic acid adenine dinucleotide phosphate (NAADP),
respectively from NAD and NADP [161]. The former two
nucleotides have been shown to function as potent indu-
cers of calcium influx via the ryanodine receptors [162].
At the same time by channeling NAD it can also affect
protein deacylation by Sirtuins and other processes re-
quiring NAD [163]. Given that polymorphic toxins with
Tox-ARC domains occur in free-living bacteria, and are
typically coupled with the genes for the immunity protein
Imm74, it is likely that they are used in intra-specific con-
flict rather than against eukaryotes. Their mode of action
in the bacterial context is not entirely clear – it is possible
that they deplete NAD or NADP and interfere with vari-
ous metabolic processes dependent on them. Alterna-
tively, the cADPr or NAADP generated by them could
have toxin consequences for the target cell, for example
by interfering with NAD-utilizing process such as RNA
metabolism or DNA ligation. The bacterial Tox-ARC
domains show considerably more sequence diversity than
the eukaryotic counterparts and appear to have been the
progenitors of two independent sets of eukaryotic repre-
sentatives in animals and fungi respectively.
Non-catalytic toxins: Pore-forming and peptidoglycan-
binding domains
Several classical polymorphic and PVC-SS delivered
toxin proteins display unusual C-terminal predicted
toxin domains that do not show any indications of being
enzymes. Further analysis of these predicted toxin
domains suggested that they are likely to operate via
non-catalytic mechanisms. One of these, which is thus
far restricted to proteobacteria is the W-TIP domain that
was named after a conserved tryptophan and TIP tripep-
tide motif (Figure 10F). This small toxin domain is
highly hydrophobic in composition and is predicted to
form two membrane spanning-helices. The first of these
helices bears two absolutely conserved positively charged
residues (RxxR signature), while the second bears the
W-TIP motif. These features suggest that the W-TIP
toxin domain might effect its cytoxicity by forming a
transmembrane pore similar to pore-forming toxins
from diverse organisms [164,165]. Several PVC-SS deliv-
ered toxins also display a single annexin domain
(Figure 4C); however, this domain is unlikely to be a
stand-alone toxin domain as it is always followed by a
further C-terminal bona fide enzymatic toxin domain
(e.g. the anthrax lethal factor-like metallopeptidase and
Ntox3 domains; Figure 4C). The eukaryotic annexins
typically contain four tandem annexin domains and bind
both phospholipids, such as phosphatidylinositol (4,5)-
bisphosphate (Annexin A2) and phosphatidylserine
(Annexin A5), or components of lipid rafts such as chol-
esterol (Annexin A2) [166]. The eukaryotic annexins
also have the unusual capability of apparently traversing
cell membranes despite lacking signal peptides. Hence, it
is conceivable that the annexin domains in bacterial tox-
ins act as accessory domains that aid in the breaching of
target cell membranes to facilitate the delivery of the C-
terminal toxin domain.
One of the most enigmatic toxins is Ntox38
(Figure 10G), which is currently restricted to actinobac-
teria, and might be found in several paralogous copies
per genome (e.g. 7 copies in Actinosynnema mirum and
9 copies in Saccharopolyspora spinosa). This toxin do-
main is usually linked to a N-terminal WXG domain by
a low-complexity glycine-rich linker, suggesting that it is
secreted via the T7SS. This is further supported by the
frequent presence in their gene neighborhoods of a gene
encoding a subtlisin-like serine peptidase associated with
processing of proteins secreted via the T7SS [126]. The
Ntox38 domain is just 33–43 residues in length and is
predicted to adopt a simple three-stranded fold
(Figure 10G). Its size and lack of potential conserved
catalytic residues suggest that it is unlikely to be an en-
zymatic domain. It shows several, conserved hydropho-
bic residues and an invariant C-terminal PXhhG
signature (where h is a hydrophobic residue). It is one of
the few toxin domains whose mode of action remains ra-
ther elusive, but is likely to involve a physical interaction
with a key cellular component rather than catalytic
modification. It shows a strong association with a single
immunity protein, Imm56.
We uncovered an unusual toxin domain at the C-
termini of giant toxin proteins from arthropod alphapro-
teobacterial and gammaproteobacterial endosymbionts
such as Wolbachia and Rickettsiella grylli (Figure 10H).
Homologous domains are also found at the C-termini of
the latrotoxins (latrotoxin-CTD) of the black widow
spider (Latrodectus species) [167]. The latrotoxins also
display other architectural similarities with the above
bacterial toxins in sharing N-terminal ankyrin repeats.
Interestingly, the latrotoxins are not secreted in a con-
ventional fashion, but released upon disintegration of
the producing cell [167]. Upon release the latrotoxin-
CTD is proteolytically cleaved off to form the mature
latrotoxin [168]. Given that the latrotoxin-CTD is shared
by distantly related bacterial endosymbionts, which
colonize a wide range of arthropods, it appears likely
that the spider latrotoxins were acquired via lateral
transfer from a bacterial endosymbiont. The latrotoxin-
CTD is characterized by a conserved, hydrophobic helix;
hence, it is possible that it associates with the membrane
and might facilitate disintegration of the producing cells
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in spiders. Bacterial toxins with latrotoxin-CTDs do not
display any neighboring immunity protein genes; hence,
it is likely that they are primarily used against the
eukaryotic hosts. In this regard, it is interesting to note
that the salivary gland proteins of mosquitoes have been
suggested as being laterally transferred from Wolbachia
[169,170]. We found that such proteins are more widely
distributed across arthropods (e.g. the crustacean Daph-
nia pulex), and that they are related to endosymbiont
toxin proteins, such as those reported above. However,
in place of a C-terminal toxin domain they contain a
conserved domain termed the SGS domain (for salivary
gland secreted protein), which is not found in any bac-
terial toxin, but only in arthropods (Figure 10H, Add-
itional File 1). Thus, it appears that following lateral
transfer of a bacterial toxin protein, the toxin domain
was displaced by an arthropod-specific domain. Hence,
the latrotoxin and SGS proteins could represent different
examples of toxins of endosymbiotic bacteria being
coopted for arthropod-specific functions.
Several toxins delivered via the PVC-SS displayed a pu-
tative toxin domain belonging to the OmpA superfamily
of peptidoglycan-binding domains [171-173] (e.g. gi:
171059731 from Leptothrix cholodnii; Figure 4C). While
several toxin polypeptides contain domains that might
facilitate extracellular adhesion, including peptidoglycan-
binding domains such a PGB1 and the LysM domains,
the OmpA domain, unlike those, always occurred at the
extreme C-terminus. This supports the inference that in
these cases the OmpA domain might have a toxin func-
tion. The OmpA domains have been shown to anchor
porins and the T6SS to the peptidoglycan [172-174].
Given that OmpA domains can bind peptide precursors
for peptidoglycan biosynthesis [172], it is possible that
such toxin domains might act by interfering with pep-
tidoglycan synthesis through binding of such peptides.
Lineage-specific expansion of N-terminal domains in toxin
proteins: Novel secretion/anchoring mechanisms?
The N-terminal domains of the full length polymorphic
toxins are usually good predictors of their trafficking
pathways because they contain domains that are specific
to a given secretory pathway (Table 1). We found another
interesting feature in the N-terminal regions of certain
polymorphic toxins and related proteins from endo-
symbionts/parasites secreted via the T2SS, which is thus
far restricted to a few bacteria. This feature is character-
ized by the presence of lineage-specific domains that
occurs downstream of a N-terminal signal peptide in full-
length toxins from certain organisms. The best example
of this is provided by the MAFB group of polymorphic
toxins found in Neisseria species (Figure 10I). Here all the
full-length toxin proteins display a globular domain, the
MAFB-N domain (Additional file 1; overlapping but not
identical to the model defined as the domain of unknown
function DUF1020 in the PFAM database), just after their
signal peptide. Across different full length toxins the
MAFB-N domain is highly conserved, which is in sharp
contrast to the C-terminal polymorphism in their toxin
domains (Figure 10I). Furthermore, though the MAFB-N
domain is strongly conserved in the genus Neisseria, the
MAFB-N domain is not found outside of it. In terms of
operonic organization, all full-length genes encoding
MAFB-N type polymorphic toxins are accompanied by an
upstream gene which encodes MAFA, a secreted protein
with a lipobox, indicating that it is a lipid anchored sur-
face protein [175]. Like the MAFB domain, the MAFA
domain is restricted to Neisseria and shows no poly-
morphism. This suggests that the conserved MAFB do-
main of these polymorphic toxins is likely to interact with
the surface-anchored MAFA protein, thereby anchoring
them to the cell surface. This hinted that certain lineage-
specific N-terminal domains might serve as a surface an-
chor for toxins. A comparable situation was observed in a
group of seven polymorphic toxins in Microscilla marina,
which are typified by a conserved N-terminal domain up-
stream of their signal peptides (Microscilla-N). This con-
served globular domain is currently not observed outside
of this species and might again play a specific anchoring
function for these polymorphic toxins. It is also conceiv-
able that homotypic interaction between these “constant”
N-terminal domains help spatial clustering of different
toxins on the cell surface.
Like Microscilla, yet another member of the bacteroi-
detes clade, i.e. the Acanthamoeba endosymbiont Amoe-
bophilus asiaticus displays a variety of effectors, which
are predicted to be directed against its eukaryotic host,
that are united by shared conserved N-terminal
domains. We were able to identify two distinct types of
such N-terminal domains that occur immediately down-
stream of a signal peptide and a lipobox, that we termed
Amoebo philus-prodomain 1 (APD1) and 2 (APD2) re-
spectively (Additional File 1). The presence of the lipo-
box prior to APD1 and APD2 suggests that these
effectors do not diffuse into the host cytoplasm, but are
likely to be anchored on the surface of endosymbiont.
The proteins bearing the APD1 and APD2 domains show
highly conserved N-termini but extremely polymorphic
C-termini, with several distinct effector domains – thus,
they appear to represent a mechanistic principle similar
to the MAFB-N and Microscilla toxin N-terminal
domains. However, unlike the classical polymorphic tox-
ins, where the C-terminal domains are serially variable
due to displacement by alternative toxin domain cas-
settes, the Amoebophilus effectors with diverse C-termini
are likely to be deployed in parallel at the same time [79].
Among the variable C-terminal domains of these effectors
are several domains shared with the toxin domains of
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polymorphic toxin systems, such as: 1) papain-like pepti-
dases of the Otu family; 2) lipase-like α/β hydrolases; 3)
The EDA39C-like nucleases. Additionally, these effectors
also display diverse C-terminal domains that are specifically
related to the ubiquitin system, such as the F-box and
U-box subunits of ubiquitin E3 ligases, SMT4/Ulp1-like
desumoylating and UBCH-like deubquitinating peptidases,
and other regulatory modules such as the GIMAP-type
GTPase domains, STAND NTPase domains, SecA-like
helicase-related domains and SbcC-like ATPase domains
[79,176,177]. This suggests that over and beyond typical
toxin-like effectors, the Amoebophilus effectors also inter-
face with the host via a wide range of catalytic activities
that are typically not encountered in the polymorphic
toxin systems. Indeed, the deployment of effectors inter-
acting with the eukaryotic Ub-system is a common
strategy used by several endo-symbiotic/parasitic bac-
teria as well as exoparasitic bacteria that deliver effec-
tors via different secretory systems [80]. On the other
hand deployment of STAND NTPases and GIMAP-type
GTPases is a strategy limited to endo-symbiotic/parasitic
forms. Nevertheless, the presence of the lineage-specific
APD1 and APD2 domains suggests that, as in the case
of the polymorphic toxin systems, these N-terminal
domains might mediate surface anchoring or homotypic
interactions that allow clustering of effectors to certain
locations on the cell surface. Given the lineage-specific
nature of this feature, it might turn out to be more wide-
spread upon more careful analysis.
Immunity proteins
Our earlier studies had revealed that two major immun-
ity protein superfamilies, namely SUKH and SuFu, dom-
inate the polymorphic toxin systems [17]. The current
study further corroborated this observation – systematic
comparisons revealed that members of the SUKH super-
family act as immunity proteins across the greatest
mechanistic and structural range of toxins. They were
found as immunity proteins for toxin domains belonging
to 18 distinct families of nucleases displaying eight dis-
tinct folds, three families of deaminases, DOC-like pro-
tein AMP/UMPylating enzymes, TIM-barrel aldo-keto
reductase, two types of α/β hydrolases and two mechan-
istically distinct peptidases (Table 3). We extended the
diversity of the SuFu superfamily by identifying a second,
previously unknown clade of SuFu domains (Table 3,
Additional File 1). These domains are extremely diver-
gent with respect to the classical SuFu domain but could
be unified with them by means of profile-profile com-
parisons (p = 10-6; probability 86% for matching the clas-
sical SuFu superfamily profile). Together, the two clades
of SuFu domains are immunity proteins for toxins with
six families of nuclease domains of the HNH/EndoVII
fold, the ParB domain, Ntox7 nuclease domain, peptid-
ase domains belonging to two unrelated folds and the
glycerophosphodiester phosphodiesterase domain. Thus,
the extended SuFu superfamily is only next to the SUKH
superfamily in terms of the mechanistic and structural
range of toxins that it can neutralize (Table 3). A key
point to note is that these two superfamilies of immunity
proteins work across toxins, which utilize entirely unre-
lated biochemical mechanisms and target very distinct
types of macromolecules (RNA, DNA, proteins, lipids
and carbohydrates; Table 3). This observation supports
our earlier proposal that the SUKH and the SuFu super-
families primarily function by being able to bind diverse
target proteins by means of sequence variability in their
respective versatile binding interfaces [17]. Thus, in a
Figure 11 (A) Representative examples of poly-immunity gene loci. (B) Representative examples of poly-immunity proteins. (C) Domain
architecture network of immunity domains in poly-immunity proteins. (D) Frequency of immunity protein families that neutralize a given number
of toxin domains.
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sense they parallel the use of certain highly variable but
versatile binding interfaces found in domains from
eukaryotic antigen receptors such as the leucine rich
repeats and the immunoglobulin domain [178]. Beyond
the SUKH and SuFu superfamilies, we recovered over 85
different superfamilies of immunity proteins associated
with polymorphic toxin systems (Table 3). In contrast to
the SUKH and the SuFu superfamilies, majority of these
are specific to only one or a few types of toxin domains
(Table3, Figure 11). For example, the Imm-barstar is spe-
cifically associated with toxins containing the barnase-
like nuclease domain, and Imm39 with URI domain
nucleases across practically all major bacterial lineages.
Likewise, Imm35 is specifically associated only with the
papain-like peptide Tox-PL1, suggesting that it functions
specifically as a peptidase inhibitor. The strong associ-
ation with a single family of toxin domains indicates that
several of the immunity proteins have evolved to counter
only a single type of toxin. Unlike the versatile immunity
proteins, these tend to strongly conserve an interface
that facilitates a very specific interaction with their cog-
nate type of toxin. Thus, we observe opposing evolution-
ary trajectories among the immunity proteins: few
versatile immunity proteins are selected for sequence di-
versification at binding interface to cope with a structur-
ally diverse range of the toxin domains, whereas a large
number of immunity proteins are selected to retain the
ability to specifically interact with a single type of toxin
domain across a wide phylogenetic range.
All but few of the currently identified immunity pro-
teins are cytoplasmic globular proteins and typically do
not show relationships to any known enzymatic
domains. This implies that they primarily act in the
cytoplasm by directly binding to the toxin domains. Two
immunity proteins (Imm-CdiI and Imm17) show a com-
parable architecture in being comprised of two TM heli-
ces. Unlike the other immunity proteins these might act
by preventing uptake of the toxin at the cell membrane.
Likewise, a subset of the immunity proteins associated
with the L,D peptidase, which is predicted to function
on the cell-surface, are secreted or TM proteins, consist-
ent with the localization of the active toxin. Imm65,
which shows a strict association with Tox-JAB-1 is also
exceptional in being the only immunity protein in our
collection that appears to be a lipoprotein anchored via
its N-terminal lipobox. Imm-ARG is also exceptional in
that it is the only currently known enzymatic immunity
protein – it contains a catalytically active ADP-
ribosylglycohydrolase domain (ARG)[148]. Given that it
strictly associates with toxin ARTs of the R-S-E clade, it
is likely that Imm-ARG neutralizes these toxins by re-
versing the ADP-ribosylation catalyzed by them.
Secondary structure analysis indicates that on the
whole the majority of immunity proteins are α+ β
domains (64%) followed by all-α domains (25%). Inter-
estingly, while there are over 50 different types of im-
munity proteins, with α+ β domains being
preponderant, only a few of them belong to previously
characterized superfamilies of domains mediating
protein-protein interactions in other sub-cellular con-
texts. Among these are Imm-NTF2 and Imm-NTF2-2
(NTF2 fold domain), Imm-MyosinCBD (related to the
cargo-binding domain of the type VI myosins of ani-
mals), Imm-LRR (leucine-rich repeats), Imm-Ank
(Ankyrin repeats) and Imm-HEAT (HEAT repeats),
which display domains that are widely used in protein-
protein interactions across several cellular systems
(Table 3). However, unlike the SUKH or SuFu superfam-
ilies, none of these immunity proteins with versions of
previously characterized interaction domains are widely
used across different toxin types in the polymorphic
toxin systems. Some otherwise common protein-protein
interaction domains used in other biological systems,
such as the immunoglobulin or β-propeller domains,
have not yet been found among immunity proteins. This
suggests that, rather than widely coopting common
protein-protein interaction domains that are prominent
in other sub-cellular systems, the polymorphic toxin sys-
tems have selected for their own unique set of proteins
specializing in protein-protein interactions (Table 3). In
the case of the SUKH and the SuFu superfamilies, evi-
dence from gene neighborhoods and phyletic patterns
suggests that they primarily function in the context of
the polymorphic toxin systems and were on several
occasions secondarily adapted for other protein-protein
interaction functions, especially in eukaryotes and
viruses [17]. Interestingly, most immunity protein super-
families are entirely absent in archaea (Table 3). This is
consistent with the general paucity of classical poly-
morphic toxin systems in most archaea; though
haloarchaea display functionally related PVC-SS deliv-
ered toxin systems (See below for further discussion).
These observations also indicate that the polymorphic
toxin systems have provided a unique niche in bacteria
for the innovation of a great variety of domains mediat-
ing distinctive protein-protein interactions, majority of
which are not utilized elsewhere. Nevertheless, at least
13 distinct types of immunity proteins have been trans-
ferred on different occasions to eukaryotes (Table 3).
While some of these transfers to eukaryotes are ancient,
the majority of these transfers are to fungi and diverse
amoeboid eukaryotes which share micro-environments
with bacteria. It would be of interest to investigate if
these have been adapted for eukaryote-specific functions
as observed in the case of the SUKH and SuFu super-
families [17]. In conclusion, we suggest that a systematic
structural investigation of the toxin-immunity protein
interactions might offer a unique opportunity to study
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the evolutionary constraints acting on protein-protein
interaction interfaces.
Polyimmunity loci and polyimmunity proteins
Our earlier analysis had indicated the presence of tan-
dem arrays of genes encoding several distinct paralogous
immunity proteins of the SUKH superfamily, many of
which are often only distantly related to each other [17].
We term these “polyimmunity loci”. Such polyimmunity
loci were suggested to function as potential backups that
allow organisms to survive not only their own toxins but
also neutralize a range of toxins that might be delivered
by non-kin strains that are present in the environment
[17]. Further, they might provide reservoirs of immunity
proteins that allow an organism to potentially “cover”
any new toxin it might evolve or acquire through lateral
transfer. In this study we systematically identified several
new polyimmunity loci and further extended this con-
cept to include homogeneous and heterogeneous poly-
immunity loci (Figure 11A): The homogeneous
polyimmunity loci are defined as those which are domi-
nated by a single type of immunity protein e.g. several
tandem paralogs of the SUKH superfamily [18]. The
most frequently found homogeneous polyimmunity loci
are those containing tandem SUKH superfamily genes.
In addition, Imm6, Imm11 Imm28, Imm33, Imm36 and
Imm 41 also form prominent homogeneous polyimmu-
nity loci (Additional File 1). In contrast, the heteroge-
neous polyimmunity loci contain a wide range of
structurally unrelated immunity proteins. For example, a
heterogeneous polyimmunity locus from Bacteroides sp.
D22 encodes 19 different immunity proteins belonging
to 13 distinct superfamilies, of which the SUKH super-
family alone is represented by 6 distinct versions in this
locus (Figure 11A). As such these polyimmunity loci
represent a unique type of prokaryotic gene cluster –
they differ from other large prokaryotic gene clusters in
concentrating genes that are effectively functionally
equivalent in a certain sense rather than encoding mul-
tiple subunits of a protein complex (e.g. ribosomal or
CRISPR operons) or enzymes catalyzing successive steps
of a complex pathway (e.g. the antibiotic and siderphore
biosynthetic operons) [179,180].
Examination of both polyimmunity loci reveals several
interesting features (Figure 11A and Additional File 1):
1) The immunity genes in a polyimmunity locus are
never interrupted by intervening toxin genes or toxin
cassettes. Thus, they are distinct from regular poly-
morphic toxin loci, which typically display arrays of tox-
ins or toxin cassettes, often with an adjacent immunity
protein. 2) The intergenic distance between two immun-
ity genes in a polyimmunity locus is typically small and
they are arranged in the same orientation. This implies
that they might be transcribed into a single polycistronic
message, from which multiple immunity proteins are
synthesized at once. This appears to distinguish them
from the immunity proteins located within a regular
polymorphic toxin locus in which only the complete
toxin gene and its adjacent immunity protein are
expressed [181]. 3) The polyimmunity loci show consid-
erable differences in terms of the number and type of
included immunity genes, even between strains of the
same species (Figure 11A). 4) In several cases the poly-
immunity loci are adjacent to genes encoding recombi-
nases, such as the XerC/D recombinase (Additional File
1). It is conceivable that the recombination mediated by
these adjacent elements might play a role in accumula-
tion of immunity genes at polyimmunity loci. 5) Usually
organisms possess only a single polyimmunity locus. A
minority of the organisms possess more than one poly-
immunity locus (~13% of the organisms with polyimmu-
nity loci). 6) Extended polyimmunity loci (i.e. those with
four or more tandem immunity genes) are not found in
all bacterial lineages – thus far, they are only found in
certain lineages of proteobacteria, bacteroidetes, firmi-
cutes and actinobacteria. This suggests that extended
polyimmunity loci are probably selected for only in cer-
tain ecological settings (see below). Some of the above
features indeed suggest that these loci are probably
under selection to provide a preemptive defensive
backup against a constantly changing profile of deployed
toxins in context of frequent, recurrent organismal con-
flicts (see below for further details).
Comparable to the polyimmunity loci, are the polyim-
munity proteins, which combine multiple immunity protein
domains into a single polypeptide (Figure 11B). Thus, they
may be viewed as polyvalent immunity proteins that have
the ability to neutralize more than one toxin simultaneously
or serially. We first observed such polyimmunity proteins
in the SUKH superfamily, wherein the same protein con-
tains multiple tandem repeats of the SUKH domain [17].
Similarly, we observed that the SUKH domain might also
be fused to SuFu and Imm33 (DUF2185) domains indicat-
ing that there are polyimmunity proteins, which combine
structurally unrelated immunity domains in the same poly-
peptide. A systematic search for polyimmunity proteins
revealed several additional architectures (Figure 11B). Some
of the largest polyimmunity proteins combine up to 10 dis-
tinct immunity domains in a single polypeptide (e.g., gi:
160893617 from Clostridium sp. L2-50; Figure 11B). Given
its prevalence as an immunity domain, not surprisingly, the
SUKH domain is a common denominator in several of
these polyimmunity proteins – it is combined with at least
8 structurally unrelated immunity domains in different
polypeptides (Figure 11C). The other prominent domains
in polyimmunity proteins are SuFu (combined with five
other domains), Imm13, Imm33 and Imm-Ank (combined
with four other domains) and, Imm11 and Imm34 (each
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with combinations to three other domains) (Figure 11C).
The most frequently found domain combinations in poly-
immunity proteins with more than one type of immunity
domain involve combinations between one or more of the
following immunity domains: SUKH, SuFu (including
SuFu- family 2), Imm-Ank, Imm5, Imm33, Imm34,
Imm36, Imm66, Imm67, Imm68 and Imm69. Like the
polyimmunity loci, the polyimmunity proteins are encoded
in operons, which usually do not contain associated toxin
genes or cassettes. Interestingly, while polyimmunity pro-
teins tend to be coded by small polyimmunity loci with two
or three tandem immunity genes, they might not be found
in the same bacteria with extended polyimmunity loci (see
above) suggesting that the two are functionally related but
Figure 12 Network derived from the domain architectures of toxins. The central panel shows the network for all toxins in all species,
whereas the lower panels show networks derived for major bacterial clades. The network is a directional graph with edges connecting
neighboring domains in a polypeptide, in which the N-terminal domain is the source node, whereas the C-terminal domain is the target node.
Edges are colored to match the source node color to illustrate the main direction of flow in the graph. Domains with similar properties are
grouped together as shown.
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distinct adaptations. Interestingly, some polyimmunity pro-
teins have also been transferred to amoebozoan eukaryotes
(Table 3, Additional File 1).
Contextual features: Functional implications of gene-
neighborhoods and domain architectures
To better understand the functional aspects of the gen-
omic organization of the polymorphic toxins and related
toxin systems in terms of genomic organization, recom-
bination, secretion and interactions with immunity pro-
teins, we resorted to a systematic analysis of their gene
neighborhoods and domain architectures of toxins. For
the sake of visualization, we represented the connections
emerging from both these types of analysis as directed
graphs: In the case of domain architectures, the nodes in
the graph are the individual domains and the edges are
connections between two adjacent domains in a poly-
peptide in the N- to C-terminal orientation. Each of the
repetitive structures such as RHS and filamentous
hemagglutinin repeats were treated as a single node
(Figure 12). In the case of gene neighborhoods the nodes
are individual genes or toxin cassettes and the edges
indicate their neighborhood relationship in the 5’-> 3’
orientation (Additional File 1).
Inferences from the gene neighborhoods
The one pervasive feature of polymorphic toxins across
most gene neighborhoods was the predominance of the
Figure 13 Length distribution for predicted complete active toxins in different bacterial clades. Complete active toxins, as against
cassettes, were identified based on characteristic marker domains for each of the distinct secretory systems associated with the toxin either in the
same polypeptide or in gene neighborhoods (Table 1). The topmost row shows the combined statistics for all active toxins while other panels
present the breakdown of these distributions based on secretory bacterial clades. The toxin length distribution is represented as beanplot[182]
(e.g. left panel in the first row) and a raw histogram (top row, central panel) and clearly indicates the multimodal nature of toxin length. The
barplot on the first row (rightmost panel) shows the frequencies of consecutive toxin and/or immunity gene pairs in theses genomes. Only pairs
of gene encoded by the same strand where considered. The labels indicate whether an immunity protein (I) or a toxin (T) is encoded upstream
or downstream of its neighbor in putative operons, e.g. TI corresponds to a pair where an immunity gene is preceded by a toxin gene. Note that
the TI (toxin -> immunity) architecture is the most frequent pair observed in all graphs except for bacteroidetes/chlorobi and firmicutes, where
the presence of polyimmunity loci inflates the II category. Dashed vertical lines correspond to the median protein length for the data on each
panel, and the solid vertical lines over each beanplot correspond to the median length in that secretory system alone. The axes at the right of
each panel contain the number of active toxins per secretory system.
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toxin-immunity gene (TI) order, wherein the toxin gene
is to the 5’end, while the immunity gene is to the 3’ end
of the operon (Figure 13). This tendency holds good for
both complete toxin genes encoding all the N-terminal
domains, as well as individual toxin cassettes which only
encode toxin domains. There are several implications of
this gene organization: 1) The toxin is synthesized prior
to the immunity protein during translation. As the toxin
protein is targeted to one of the many secretion systems
for delivery to the cell surface, it is unlikely to cause im-
mediate “self-intoxication”, thereby obviating the need
for a premade immunity protein. This is supported in
experiments with toxins exported by the T5SS, where the
toxin is only activated in the target cell [183]. 2) Because
polymorphism is achieved by recombining different toxin
cassettes to a constant 5’ gene body coding for trafficking
and presentation domains, there is the need for the re-
combination event to not only replace the 3’ toxin cas-
sette [17,45], but also bring in its cognate immunity
gene. This feature explains why cassettes also occur as TI
pairs: On account of the TI organization of cassettes, a
single recombination event at the 3’ tip of the complete
toxin gene can replace the existing toxin coding region
with a new toxin cassette and simultaneously bring in the
new immunity gene. Evidence for multiple such recom-
bination events is presented by the genomic organization
of the full toxin genes. They often have a string of mul-
tiple immunity genes at the 3’ end [17]: each of these im-
munity genes is likely to represent a remnant of a former
recombination even that replaced the tip toxin region
while inserting a new immunity gene ahead of it. Thus,
the lack of the need for a premade immunity protein due
to outward trafficking of the toxin appears to have
allowed the emergence of the TI gene order. The TI gene
order in turn seems to have facilitated the emergence of
polymorphism in these systems. Indeed the widely dis-
tributed simple barnase-barstar gene pairs might repre-
sent an incipient TI gene order without notable
polymorphism, whereas the barnase cassette within lar-
ger polymorphic systems represents its incorporation
into the fully developed versions of these systems.
The gene-neighborhood graph also contains the im-
print of some of the secretory systems utilized for the
outward trafficking of toxins by the producing cells
(Additional File 1, Table 1)[18]. The complete toxin
genes trafficked via the T5SS, T6SS, T7SS and PVC-SS
often contain neighboring genes whose products medi-
ate their trafficking. In the case of the T5SS the adjacent
gene typically codes for CdiB-like proteins belonging to
the TpsB class of outer-membrane trafficking proteins
[37]. Such gene neighborhoods are only found in proteo-
bacteria, bacteroidetes, fusobacteria and the negativicute
clade of firmicutes (e.g. Veillonella and Selenomonas)
and are strong markers indicative of the use of the two-
partner system (T5SS) for the extrusion of toxins. The
phyletic pattern of this system suggests that it might
have emerged in the proteobacteria-bacteroidetes assem-
blage (members of the group I bacterial division [184])
followed by transfer to a subset of group II lineages such
as negativicutes and fusobacteria. This supports the hy-
pothesis that the negativicutes have secondarily acquired
a “proteobacterial”-type cell wall through lateral transfer
of specific components, and not as a by-product of the
sporulation system as recently proposed [185]. The
T6SS, PVC-SS, and MuF-SS utilizing toxins are typically
marked by the presence of genes for the injection or
capsid packaging apparatus, and a recycling AAA+ATP
in the case of the former two systems [38,39,75,82]. Sev-
eral T6SS operons additionally encode a PsbP/MOG1-
like protein. The gene coding for the latter protein is
often adjacent to the toxin gene and is related to the
photosynthetic oxygen-evolving complex protein PsbP
(p = 10-17; probability 98% in profile-profile searches)
and might represent a novel subunit of the T6SS that
acts as an adaptor between the secreted toxin and the
injection apparatus. The genes of toxins secreted via the
T7SS are occasionally characterized by gene neighbor-
hoods that encode additional T7SS components such as
the YueA-like FtsK/HerA ATPase (the motor driving
T7SS), and EsaC, which contains a bacterial version of
the PH-like fold [33,186]. Toxins associated with T7SS
neighborhoods are found only in firmicutes, actinobac-
teria and chloroflexi, suggesting that toxins with this
secretory mode possibly emerged early in the diversifica-
tion of the group II bacteria (Table 1).
Inferences from domain architectures
Comprehensive analysis of domain architectures of
complete toxins reaffirms the results from the more
restricted studies regarding the generally “tripartite
organization” of the polymorphic toxins (Figure 1B): The
N-terminal-most domains are related to trafficking of
the toxin to the cell surface in the producing cell. The
central domains, typically forming filamentous struc-
tures, are related to presentation of the toxin on the cell
surface, and processing and release for delivery into the
host cell. The C-terminal-most domains are the toxin
domains. This architectural blue print might be violated
in certain toxins that lack the central filamentous ele-
ments – these are usually shorter secreted proteins. N-
terminal modules are usually associated with the
secretory pathway taken by the toxin, with specific
domains uniquely characterizing different secretory
pathways (Table 1; Figures 12, 13): 1) The TpsA-like se-
cretion domain (TPSASD) defines the T5SS [37]; 2) the
PVC metallopeptidase is determinant of the PVC-SS; 3)
The WXG-like helical bundle (including LXG and
LDXD) domains are strictly associated with the T7SS
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[187]; 4) the SpvB domain with integrin-like β-propeller
domains are the determinants of the TcdB/TcaC export
pathway [42]; 5) the PrsW peptidase domain defines
the eponymous export system. In the case of the T6SS,
the VgrG module, which form the tip of the injection
apparatus [39], might be fused in certain cases to the
N-terminus of the toxin protein. Although the VgrG
module might be also found in the PVC-SS gene neigh-
borhoods it is never fused to toxins secreted via this
pathway. Additionally, our current analysis indicated
that the conserved PAAR motifs (named after the
eponymous signature found in a subset of these
domains; PFAM: PF05488) with an associated TM helix
is found in toxins strictly associated with T6SS gene
contexts. This suggests that the PAAR motif is a deter-
minant for T6SS-driven export. The PAAR motifs typic-
ally occur as pairs and each motif is predicted to form a
3-stranded element, with the second copy usually dis-
playing conserved cysteines, histidines and an aspartate
that might constitute a stabilizing metal-binding site
(See Additional file 1 for alignment). Given their fixed
N-terminal location in the complete toxins and their
specific gene-context association with components of
the T6SS, it is likely that the PAAR motif represents a
signal recognized by this secretory pathway. The T2SS
(general secretory pathway) is the most prevalent
secretory system for polymorphic toxins (Figure 12, 13).
Of the dedicated secretory systems (i.e. those other than
T2SS) we found that T7SS, T6SS and T5SS are the dom-
inant ones, accounting for 12, 11 and 10 percent re-
spectively of the complete toxins in our collection
(Figure 13). The remaining dedicated secretory systems
accounted for lower numbers of the total number of
complete toxins. With respect to the ~150 distinct types
of toxin domains we identified among polymorphic tox-
ins and related systems, other than the general secretory
pathway, the T7SS, T6SS and T5SS again dominate in
terms of diversity of the C-terminal toxin domains with
which they are associated (Figure 12). They are respect-
ively being combined with 45, 43 and 43 percent of the
total number of different types of toxins. Though the
total number of toxin proteins delivered via the PVC-SS
is much lower than that delivered by the three previ-
ously named systems, it is combined with a considerable
diversity of distinct types of C-terminal toxin domains
(31.5% of the total number of toxin types).
As discussed above, the two distinct positions of the
processing peptidases, i.e., just prior to the toxin domain
(e.g. HINT, papain-like peptidase, caspase) or at the N-
terminus of the toxin protein (e.g. ZU5 and PrsW) ap-
pear to reflect two distinct functional themes in terms
of autoproteolytic cleavage of the toxin protein. The
HINT peptidase is found in association with T2SS,
T5SS, T7SS and the TcdB/TcaC export pathway but
never with the T6SS and PVC-SS (Table 1, Figure 12).
This suggests that proteolytic processing by HINT and
the PVC-metallopeptidase are mutually exclusive. This
supports our above-stated inference that the PVC-
metallopeptidase and the HINT peptidase are function-
ally equivalent. It also suggests that the injection process
of the T6SS probably obviates the need for autoproteo-
lytic action in toxin release. Of the repeats constituting
the central filamentous regions, the filamentous
hemagglutinin repeats are found only in toxins delivered
via the T5SS. In contrast, the RHS repeats are found in
toxins delivered by all the different secretory systems,
except the T5SS. The less-common, central filamentous
modules, which are also promiscuous in terms of secre-
tion systems, include the phage tail-fiber and the alpha-
helical ALF repeats. The HINT peptidase domain is
found in association with representatives of all these dif-
ferent repeat types in classical polymorphic toxins sug-
gesting that autoproteolytic processing to release the
C-terminal toxin is a phenomenon that is independent
of the type of the N-terminal stalk on which it is borne.
A subset of toxin proteins from firmicutes, actinobac-
teria, proteobacteria and bacteroidetes are characterized
by the presence of additional adhesion-related domains in
their architectures (Figure 12). Most are carbohydrate or
peptidoglycan binding and include the LysM, discoidin,
Laminin-G, RicinB, bulb-lectin, PGB (peptidoglycan
binding), CWB (cell wall binding) and SH3 domains
[188-190]. The SH3 and laminin-G domains are usually
found at the N-termini of the complete toxin proteins
delivered by the T2SS and are likely to help in anchor-
ing the toxin to the cell wall of the producing cell by
binding components of the peptidoglycan or cell-surface
carbohydrates. In contrast, RicinB, discoidin and bulb
lectin domains might be found either at the N-termini
or embedded among the RHS repeats or close to the
C-terminal toxin module. This suggests that certain
versions of these domains might also be used to enhance
contact with target cells. Indeed, previously the RHS
repeats have also been proposed to possess carbohydrate
binding ability – hence, the RHS repeats might also dir-
ectly participate in the adhesive action of the long toxins
with such stalks [115,191]. The architecture graph also
makes it clear that the nucleic acid-targeting toxins are
the most prevalent type of toxin, far exceeding the
peptide- and lipid- targeting toxins by a large margin
(Figure 12). This is likely to be a reflection of the fact
that a cell can be killed most effectively by disrupting
the two key junctions in the flow of biological informa-
tion, namely by disrupting the genome and by blocking
translation.
Examination of the length distribution of the complete
toxins reveals a multimodal distribution with peaks of de-
creasing magnitude (Figure 13). The first peak is around
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400, the second is between 1400–1600, the third is be-
tween 2200–2400 and the fourth is between 3000–3400
residues in length. The longest toxin recorded in our set is
SACTE_5178 (gi: 345002682), with multiple toxin
domains, from Streptomyces sp. SirexAA-E, and 13652
amino acids in length. This suggests that while the
complete toxins cover a wide length range there are cer-
tain preferred lengths. In general terms it suggests that the
polymorphic toxins are of two types: 1) stalked – those
with long N-termini with multiple repetitive elements,
which are likely to be used primarily in the contact
dependent mode as described for the original CDI sys-
tems [17,36]. 2) Unstalked – these toxins lack a sub-
stantial N-terminal extension and are like to be
secreted toxins that possibly act through diffusion into
the environment or through directed delivery into the
target cell [17]. The peaks of the distributions of the
toxins delivered via the PVC-SS, T7SS and phage MuF-
terminase system, are in the short range and these con-
tribute in a major way to the first peak in the overall
length distribution curve (Figure 13). In the case of the
T7SS, while the majority of toxins are short and likely to
be unstalked, there is a smaller set of longer stalked toxins
which are also delivered by this system (Figure 13). The
T6SS delivered toxins show a clear bimodal length distri-
bution, with a shorter variety lacking stalks or fused to N-
terminal HCP1 domains (Figure 13). This type contri-
butes to the first peak seen in the overall length distribu-
tion curve. The second peak is around 1400–1500
amino acids in length (matching the second peak in the
overall length distribution curve) and consists of stalked
toxins with RHS repeats. This suggests that the T6SS
delivers both unstalked and stalked toxins. The former
are probably directly delivered into the target cell, whereas
the latter are merely placed on the cell surface and might
act through the contact-dependent mode. TcdB/TcaC-
delivered toxins show a peak at around 2200 amino acids
and contribute to the third peak observed in the overall
distribution. The T5SS-delivered toxins show a peak a
little after 3000 residues and contribute to the 4th peak
in the overall distribution (Figure 13). The toxins with
RHS repeats show a peak in their length distribution
around 1400–1600 amino acids (second peak in the over-
all distribution), while for the filamentous hemagglutinin
repeats the peak length distribution is 3000–3400 amino
acids (the fourth peak in the overall distribution) (Fig-
ure 13). This indicates that the major types of stalked tox-
ins with different kinds of repeats, each have their own
preferred lengths. This suggests that contact via such
stalked toxins happens at a relatively constant distance
from the cell surface. This in turn probably points to an
optimal approach distance between neighboring cells in
colonial aggregates, such as biofilms, where intra-specific
competition would be expected.
Comparisons with other toxin systems
The polymorphic toxin systems show several similarities
and differences with other well-studied toxin systems of
bacteria involved in different levels of intra-genomic,
intra-species and inter-species conflicts. We compare
below the polymorphic toxin systems with several of
these systems and discuss the potential importance of
significance of the similarities and differences:
1) Effectors directed at hosts and distantly related com-
petitors: Mechanistically the polymorphic toxins and the
effectors directed against hosts and distantly related
competitors are closely related. These effectors are usu-
ally chromosomally encoded like classic polymorphic
toxins. As seen from the above discussion (Tables 1, 2),
both these systems share a large number of toxin
domains, processing peptidases, and also common
secretory pathways including T2SS, T5SS, T6SS, T7SS,
PVC-SS and TcdB/TcaC-like export. However, the T3SS
and T4SS do not appear to be used by classical poly-
morphic toxins, even though they are common export
pathways for effectors in specific bacterial lineages
[34,192]. Some of them also have a structure closely re-
sembling conventional polymorphic toxins and are only
distinguished by the lack of associated genes for immun-
ity proteins. Neighboring cassettes for standalone toxin
domains are rare in these systems. However, the
organization of other effector proteins sharing toxin
domains with conventional polymorphic toxins might be
different – the toxin domain is not necessarily located at
the C-terminus and might occur internally or as a stan-
dalone protein. Additionally, these effectors also display
certain toxin domains, such as those pertaining to the
eukaryotic Ub-systems that are not deployed in classical
polymorphic toxin systems used in intraspecific conflict.
This reflects the relative rarity or the relatively limited
functional penetration of sub-cellular systems by the
prokaryotic cognates of the Ub-system [126], making
them less effective targets for interference.
2) Plasmid-encoded bacteriocins: The plasmid-encoded
bacteriocins, such as colicins, pyocins and cloacins con-
ceptually resemble the classical polymorphic toxins in
being deployed against closely related target cells. They
also share the general architectural organization with
classical polymorphic toxins – the N-terminal and cen-
tral domains being deployed in trafficking with a toxin
domain at the extreme C-terminus. Likewise, these sys-
tems are also characterized by immunity proteins that
help protect the producing cells [20]. Not only do their
toxin domains share several mechanistic themes, such as
cleaving of DNA, RNA and perforating of membranes,
with the toxin domains of polymorphic toxins, but they
also share certain homologous toxin domains such as
the HNH, ColE3 and BECR-fold nucleases such as the
colicinD and ColicinE5 domains (Table 2). However,
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being on plasmids their primary function is to enhance
the fitness of the carrying plasmid. Hence, they usually
do not have dedicated systems for their export and de-
pend on inducing lysis of a subset of the producing cells
[20].
3) Toxin-Antitoxin systems (Type I, II and III TA-
systems): These systems might be encoded either on the
chromosome or on a plasmid, and resemble the poly-
morphic toxin systems in comprising of a pair of ele-
ments with opposing activities. In the type II systems
both the toxin and antitoxin are proteinaceous and
interact physically with each other, thus being analogs of
the polymorphic systems [22,24,28,193]. In contrast to
the above described TI order of the polymorphic toxin
systems with a 3’ immunity gene, in TA systems the
antitoxin is typically the 5’ gene [22]. These elements are
primarily intra-genomic selfish elements that are
selected for maintaining themselves, and on occasions
providing incidental advantage to the host cell [24,28].
Thus, they do not have a need for any kind of export
trafficking and delivery apparatus that are encountered
in the other systems. As a consequence both the toxin
and antitoxin from these systems are small proteins, typ-
ically comprised of a single domain [22]. Nevertheless,
certain toxin domains from the TA systems are homolo-
gous to toxin domains of polymorphic toxins. The chief
examples of these are the RNases belonging to the BECR
fold (see above), the RES domain, Ntox24 and DOC-like
protein AMP/UMPylating enzymes. However, we cur-
rently do not have evidence for sharing of any of the
metal-dependent nucleases between these two systems –
the PIN domain nucleases are thus far only known from
TA systems [108], whereas the REase, HNH and URI
fold nucleases of the polymorphic toxin systems are not
seen in the TA systems. On the whole, toxins of TA sys-
tems tend to predominantly target the genome and the
RNAs of the translation apparatus [193], but those from
the polymorphic toxin systems appear to have a much
wider range, though even among them there is prepon-
derance of nucleic acid-targeting activities that target the
above functions (Figure 12). Peptidases are relatively rare
in classical TA systems in comparison to the poly-
morphic toxins and their PVC-dependent relatives.
However, in course of this study we uncovered a previ-
ously unknown TA system, which combines a toxin pep-
tidase of the YabG family with a distinctive antitoxin
which was previously annotated as a “domain of un-
known function” (DUF1021). This adds to the pool of
toxin domains that are shared by these systems. Another
enzymatic domain shared by the toxins of type II TA
systems and polymorphic toxins is the ART domain
[148]. Interestingly, in this case the immunity protein or
the antitoxin in both these systems might be an enzyme
that removes the ADP-ribose modification, such as the
ADP-ribosyl glycohydrolase. The immunity proteins
from the type II TA systems, in addition to physically
binding their cognate toxins, also usually act as tran-
scription factors that regulate the expression of the TA
gene-pair via their common promoter [22]. There is cur-
rently no evidence for any immunity proteins with a
transcription factor function in the polymorphic toxin
systems. In the case of the type I and type III TA sys-
tems the antitoxin is a small RNA that respectively inter-
acts with the toxin transcript or the toxin protein
[24,133]. Currently, there are no known polymorphic
toxin systems with RNA regulators. It appears that the
need for specific physical interactions between the toxin
and antitoxin in most type II and III TA systems places
certain restrictions on the types of toxin domains that
can be incorporated into them – they typically are small
domains that are not vastly different in size from the
antitoxins.
4) Restriction-Modification systems: Like the TA sys-
tems, the R-M systems are mobile, intra-genomic selfish
elements that operate in prokaryotic genomes [21].
Comparable to the cell-killing mediated by TA systems
they have means of enforcing addiction by launching
restriction attacks on cell if they are disrupted [194].
They resemble both classical polymorphic toxins and
TA systems in combining a toxin (the restriction en-
zyme) with an antidote (the modification enzyme, typic-
ally a cytosine or adenine DNA methylase). However,
unlike those systems the physical interaction between
the modification enzyme and the restriction enzyme is
not central to the counteraction of the latter’s toxic
properties. Rather, since they operate on DNA, the anti-
dote action of the modification enzyme is mediated by
rendering the genome resistant to the restriction en-
zyme by preemptively modifying it. Being purely intra-
genomic selfish elements, like TA systems, but unlike
polymorphic toxin systems, they do not have any fea-
tures related to trafficking or delivery. Instead, R-M sys-
tems display elaborate adaptations that enhance their
target specificity and DNA-binding and manipulation
capabilities in the form of specialized DNA-binding
domains and accessory subunits such as helicases and
MORC ATPases [120,195,196]. Nevertheless, as noticed
above, R-M systems and polymorphic toxin systems ap-
pear to share several enzymatic toxin domains such as
the REase, HNH, URI and ParB domains.
In conclusion, polymorphic toxin systems share certain
key features with each of the other well-characterized
prokaryotic toxin systems. The distinctions appear to
arise from the differences in selective forces shaping each
of these systems. On the whole the greatest mechanistic
diversity of toxin and immunity domains are seen in the
polymorphic toxin systems, which is reflective of the rela-
tively few constraints faced by them in terms of their
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Figure 14 (See legend on next page.)
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targets. However, certain types of catalytic domains are
preponderant across several of these systems due to dis-
ruption of the genome or the translation machinery being
apparently the easiest means of killing a cell.
Genome-wide distribution of polymorphic toxin systems
and ecological implications
Differences in distributions and structure of toxins and
immunity protein: Phylogenetic and ecological tendencies
To better understand the ecological significance of poly-
morphic toxins and related systems we systematically
compared their genome-wide prevalence to organismal
phylogeny. Our analysis revealed that all the major
lineages of bacteria with sufficient genomic data had at
least one representative coding for polymorphic toxin
systems. However, the distribution of these systems be-
tween different bacterial lineages shows pronounced dif-
ferences (Figures 13, 14). Among the group-I bacteria
[184], polymorphic toxin systems are abundant in the
proteobacteria-like clade (including acidobacteria), bac-
teroidetes, and the clade unifying chlamydiae, verruco-
microbia and planctomycetes, but are relatively rare in
aquificae and spirochaetes. Among the group-II bacteria
[184], such systems are abundant in firmicutes, actino-
bacteria and chloroflexi but are relatively rare in cyano-
bacteria and thermotogae. They are generally absent in
most archaeal lineages, with the rare exception of certain
methanoarchaea and haloarchaea. Of these, Methanosar-
cina acetivorans displays classical stalked polymorphic
toxins with RHS repeats and cassettes for toxin modules
and immunity proteins, just as in the cognate bacterial
systems. A few other methanoarchaea display simple
barnase-barstar-like systems, whereas haloarchaea like
Halogeometricum borinquense display several PVC-SS
delivered toxins with variable C-terminal toxins modules
(Additional File 1). This general rarity of the poly-
morphic toxin systems is in striking contrast to the gen-
eral prevalence of the toxin-antitoxin systems across
archaea [22]. This distribution, with a dominant pres-
ence in most major clades of both group-I and group-II
bacteria, suggests that polymorphic toxin systems could
have been present in the ancestral bacterium. However,
it should be noted that these genes and cassettes are
highly prone to lateral transfer as suggested by the spor-
adic phyletic distribution of both toxin domains and im-
munity proteins [17]. Hence, the distribution of these
systems might also reflect in part the secondary
dispersion of such systems across diverse bacteria by lat-
eral transfer. In support of this it may be noted that in
many organisms the polymorphic toxins are situated on
hypervariable chromosomal islands that are prone to lat-
eral transfer [197]. Nevertheless, distributions of the asso-
ciated specialized secretory systems that deliver these
toxins usually follow stricter phylogenetic boundaries, i.e.
T5SS and T6SS occur primarily in group-I bacteria and
T7SS in group-II bacteria. This suggests that indeed there
might have been an ancestral presence of such poly-
morphic toxin systems in bacteria that selected for differ-
ent dedicated delivery systems in each lineage and
diversified further as these delivery system were fixed.
Certain patterns of distribution of polymorphic
toxin systems appear to transcend phyletic boundaries
(Figure 14): 1) the hyperthermophiles, which are often
chemoautotrophs, from both bacteria and archaea show
a strong tendency to lack such systems. 2) Likewise, the
photosynthetic bacteria across different bacterial clades
have a dearth of such systems (Figures 12, 14; Add-
itional File 1). The relative underrepresentation of such
systems in both these groups of organisms is not related
to their genome sizes because organisms with similar sized
genome with other lifestyles do possess such systems. In
particular, the relative rarity of such systems in cyanobac-
teria is striking when they are compared to other bacteria
with multicellular tendencies and similar complex signal-
ing mechanisms [65], such as deltaproteobacteria and acti-
nobacteria, which in contrast possess abundant arrays of
polymorphic toxin systems (Figures 12, 14). While in the
case of archaea it is possible that the rarity of these sys-
tems is related to their lack of bacterial-type protein up-
take systems [20], it should be noted that bacterial
hyperthermophiles show a similar pattern. The only ex-
ception is the firmicute Geobacillus thermoglucosidasius,
which, unlike the rest, is not a classical hyperthermo-
phile, and can survive across a wide temperature range
[198]. It appears that the relative rarity of such systems
might be more related to their phototrophic or chemo-
lithotrophic tendencies. It is possible that that their
relative independence with respect to energy, reducing
equivalents and/or carbon dioxide results in lower levels
of intra-specific competition for resources.
Finally, we also observed strong phylogenetic signals
in the length distributions of complete toxins: 1) The
group- I bacteria with Gram-negative cell walls with
outer membranes (proteobacteria and bacteroidetes) had
(See figure on previous page.)
Figure 14 Scatterplots of the number of toxins versus number of immunity proteins per genome. In scatter plots, black or gray dots in
the background represent all taxa, and red or blue dots correspond to taxa belonging to the clade or ecological properties described on each
plot’s title. The dashed line corresponds to the diagonal (x = y) and the ellipses encircle taxa that are characterized by an excess of immunity
proteins as discussed in the text.
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a multimodal distribution of complete toxins, showing
both unstalked toxins and stalked toxins of various
modal lengths (Figure 13). This suggested that they are
likely to engage in both contact-dependent inhibition as
well as inhibition via secreted toxins. 2) Firmicutes with
the exception of the negativicute clade showed a largely
unimodal distribution of complete toxin lengths with a
median value of 492 residues. This suggests that the fir-
micutes deploy their toxins either mainly via secretion
or through much closer contact than in the previous
group. 3) The actinobacteria show a bimodal distribution
of toxin lengths (Figure 13). The first peak is around
400–500 amino acids in length and the second is around
1400–1500 amino acids. This suggests that, like proteo-
bacteria, they use both distant contact and secretion or
close contact. The use of both short secreted toxins and
longer contact-dependent toxins suggest that intra-
specific conflict might play out both in the context of
biofilms, where contact is critical, and also in motile
phases and swarming growth, where contact might be
less intense. The distinction in this regard between fir-
micutes and the two other groups raises question as to
whether certain bacterial groups might resort to such
forms of conflict only under specific circumstances.
Differences in the relative numbers of toxins and immunity
proteins: Implications of intra- and inter-specific conflicts
The median number of toxin domains found in organ-
isms that possess such systems is 3, which is the same as
the median number of immunity proteins found per gen-
ome (Additional File 1). The difference in the number of
immunity proteins and toxin domains per organism is
normally distributed with a sharp peak at 0 (Additional
File 1). Furthermore, there is a positive correlation be-
tween the number of toxin domains and number of im-
munity proteins with an approximately linear increase in
the number of immunity proteins with increasing num-
ber of toxin cassettes (Figure 14). These observations in-
dicate that on the whole there is a balance between the
number of toxin cassettes and immunity proteins, which
is consistent with the genomic organization of the poly-
morphic toxin loci and the principle of approximately
one-to-one mapping of immunity proteins with toxins.
The number of active toxins is positively correlated with
the total number of toxin cassettes, suggesting that with
an increase in the number of individual polymorphic
toxin loci the number of toxin cassettes associated with
them increase more or less linearly (Additional File 1).
The median number of active cassettes per organism is 1,
indicating a median 1:3 ratio between active toxins and
associated toxin cassettes.
We then studied the patterns of relative numbers of
active toxins, cassettes and immunity proteins and their
correlations, if any, with life-style and preferred
ecosystems of the organisms. With exceptions discussed
in the preceding subsection, bacteria across most well-
sampled ecosystems display polymorphic toxin systems.
However, we observed that a subset of organisms show
strong anomalies in terms of the relative distribution of
toxin domains to immunity proteins (Figure 14). We
measured this anomaly using the difference between the
number of immunity proteins and toxin domains and
uncovered some striking ecological correlations. In gen-
eral, in aquatic ecosystems we observed a strong propor-
tionality in the number of toxins domains and immunity
proteins, with roughly equal number of both (Figure 14).
This suggests that in these niches there is a tendency for
“honest” intra-specific conflict, with the polymorphic
toxin systems primarily geared towards discrimination of
non-kin conspecifics. Those organisms that showed sig-
nificantly greater number of toxins than immunity pro-
teins could be grouped into two general ecological
niches: 1) pathogens- Both extracellular and intracellu-
lar pathogens of animals, plants and microbial eukar-
yotes. We interpret the relative abundance of toxins to
immunity proteins in the former group as an adaptation
for pathogenesis – the toxins are primarily used against
hosts, rather than for intra-specific conflict; hence, many
of their toxins do not have corresponding immunity pro-
teins. This situation is especially prominent in intracellu-
lar bacteria such as Waddlia chondrophila, Legionella
and Amoebophilus asiaticus, which have a large number
of toxins but hardly any immunity proteins (Additional
File 1). In general, the notable absence of immunity pro-
teins in intracellular pathogens suggests that in most
cases (baring exceptions like Odyssella) they do not en-
gage in competition with conspecifics in their distinctive
niche. In contrast, other pathogens of animals (e.g. Neis-
seria species), plants (e.g. Ralstonia and Pseudomonas
syringae) and microbial eukaryotes (e.g. Odyssella), while
showing a large number of toxins, also have comparable
number of immunity proteins. This suggests that they
are likely to compete actively with conspecific rivals in
course of colonizing niches on or within their hosts. 2)
Slow growing, heterotrophic bacteria with a degree of
“multicellular” organization, mainly actinobacteria and
deltaproteobacteria [65]. Organisms of this group are
also well-known for their production of diverse non-
proteinaceous antibiotics and maintain their slow-
growing life-style by inhibiting competing faster-growing
bacteria [5]. Thus, we see the over-representation of tox-
ins relative to immunity proteins in this group as being
part of their weaponry deployed in inter-specific compe-
tition. Importantly, both these groups are also enriched
in organisms coding for the greatest number of toxin
domains in their genomes. The greatest number of tox-
ins is seen in different Photorhabdus species, which are
nematode symbionts that aid nematodes in killing their
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insect prey [84]. Indeed, this bacterium is not only
known to kill insects with their toxins, but also com-
petes intra- and inter-specifically with other bacteria
[199]. Thus, a large number of toxins domains might be
a predictor for not just pathogen-host and inter-specific
conflict but also intense intra-specific competition in
certain niches.
On the other end of the spectrum we found several
bacteria with an overrepresentation of immunity proteins
relative to toxins. Especially striking were bacteria which
showed a marked paucity of toxins but had a large num-
ber of immunity proteins, typically occurring in polyim-
munity loci or as polyimmunity proteins. This group of
bacteria is enriched in taxa belonging to the human oral
microbiome (Figure 14; Additional File 1). Interestingly,
this phenomenon was observed across bacteria belonging
to phylogenetically distinct clades in the human oral
microbiome: this group includes representatives of bac-
teroidetes (Capnocytophaga gingivalis), betaproteobac-
teria (Eikenella corrodens), spirochetes (Treponema
denticola), actinobacteria (Actinomyces sp.) and firmi-
cutes (Streptococcus oralis) (Figure 14; Additional File 1).
This indicates that the oral environment has repeatedly
favored proliferation of immunity proteins relative to tox-
ins in a subset of bacteria across different clades. We in-
terpret this imbalance in terms of the ecology of
microfilms formed in the oral environment, where several
bacteria are often packed in close proximity [200]. In this
situation, non-kin “cheaters” which can invade micro-
films to benefit from cooperative associations with prox-
imal organisms can accrue an increase in fitness. Hence,
we propose that the excess of immunity proteins in these
organisms, particularly in the form of polyimmunity loci
and polyimmunity proteins, is an adaptation to evade at-
tack from a diverse array of toxins while invading non-
kin bacterial assemblages. In support of this, we observed
that there is a second group of taxa from the human oral
microbiome that display relatively balanced ratios of tox-
ins and immunity proteins (Figure 14; Additional File 1).
It is likely that these organisms are the targets for inva-
sion by the lineages with excess immunity proteins. Gen-
eralizing, this observation we propose that the presence
of a large excess of immunity proteins over toxins might
be a predictor for cheating behavior in invading non-kin
bacterial assemblages.
A distinct second group of bacteria with a large excess
of immunity protein differed from the above group in
having a median or above median number of toxins.
This group was greatly enriched in bacilli from soil such
as Bacillus cereus, B. mycoides, B. thuringiensis, Breviba-
cillus brevis and Paenibacillus polymyxa and representa-
tives of the human colonic microflora (Figure 14;
Additional File 1). Even in this case, the excess of im-
munity proteins were typically associated with the
presence of polyimmunity loci and polyimmunity pro-
teins. Remarkably, we found that even within the same
species (e.g. B. cereus and B. thuringiensis) different
strains widely differed in the relative number of toxin
domains to immunity proteins – some isolates had a
considerable excess of immunity proteins, while other
had a balanced ratio to toxin domains and immunity
proteins (Figure 14; Additional File 1). This suggests that
the different strains in a given species adopt two general
strategies during intra-specific competition: 1) those
which participate in “honest” cooperation between kin
and discrimination against non-kin. These have similar
numbers of immunity proteins and toxins because they
possess only as many immunity proteins as required to
balance their own toxins. 2) Those which adopt the
strategy of cheating by invading non-kin assemblages.
These varieties could potentially shift to the second
strategy, by expressing their polyimmunity loci or pro-
teins, when there is an excess of “honest players”, be-
cause in these situations cheating might become
profitable. Notably, not all soil bacilli present an excess
of immunity proteins over toxins, e.g. B.subtilis does not
show the marked imbalance we observed in the above
species. This predicts that there are likely to be differ-
ences in the social behavior of different soil bacilli, with
species like B.cereus possibly engaging in greater degree
of colonial or cooperative behavior throughout their life
history. Further, the observation that the soil bacilli with
an excess of immunity proteins have multiple toxins, un-
like several of the above-described oral taxa which lack
toxins, indicates that the context in which these groups
might adopt a cheating strategy might differ. Among the
oral taxa that lack toxins, it is conceivable that they have
a phase in their life history where they do not engage in
interactions with other bacteria. However, when they en-
counter target bacteria that can be invaded, they prob-
ably express their polyimmunity loci to interact with
them while evading their toxins. In general terms, our
findings might also explain how these organisms might
escape collapse of the cheating strategy, which would
happen when the numbers of cooperators are dimin-
ished. By facultatively expressing polyimmunity proteins
or loci only when target cooperators are abundant and
switching them off when they are absent, the deploy-
ment of the cheating strategy might be limited to advan-
tageous circumstances.
Transfer of components of polymorphic toxins and
related systems to eukaryotes and their viruses
While eukaryotes deploy a wide-range of toxins, some of
which share homologous domains with the polymorphic
toxins and related systems, most of them do not seem to
represent direct counterparts of the bacterial systems.
The eukaryotic systems that come closest to the
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bacterial systems described herein are the fungal killer
toxins such as the Kluyveromyces lactis γ-toxin and PaT
secreted by Millerozyma acacia and Debaryomyces
robertsiae [201-203]. Like the bacterial polymorphic tox-
ins, these secreted fungal toxins are primarily used in
conflict with closely related non-self strains and act as
endo-tRNases. However, it should be noted that they are
coded by linear plasmids, which makes them similar to
the classical colicin-like bacteriocins, though, unlike
them, release of the fungal toxins does not entail lysis of
the producing cells. These endo-tRNases currently do
not have any homologs outside of fungi and were not
detected in any bacterial toxin system. Nevertheless, in
this study we observed that at least 13 toxin domains
from polymorphic toxin systems and their relatives have
been laterally transferred to fungi (Table 2). This sug-
gests at least a subset of these toxin domains of bacterial
provenance might also be used by fungi in intra-specific
conflict in a manner comparable to the above-
mentioned, fungi-specific tRNases. Our earlier study of
the deaminase toxins revealed that at least a subset of
these, which were acquired by fungi, are probably used
in intra-specific conflict, counter-selfish element defense
or in phenomena related to heteroincompatibility [18].
Indeed, a major effector in the apoptosis-like heteroin-
compatibility process of several fungi, namely Het-C,
appears to have originated from a bacterial toxin domain
found in polymorphic toxin systems (see above).
The toxin domains from the bacterial systems also ap-
pear to have been acquired by animals and several other
eukaryotes. At least 14 toxin domains observed in poly-
morphic toxin systems are also present in metazoans,
whereas at least six are present in amoeboid eukaryotes
belonging to the amoebozoan and heterolobosean
lineages (Table 2). Experimental evidence in animals
suggests that at least a subset of these, are deployed in
antiviral defense and apoptosis. The AID/APOBEC dea-
minases are notable in the former context, though it
appears that their role has further expanded in animals
to encompass genome mutagenesis for generating anti-
gen receptor diversity [204]. Like the fungal Het-C, on at
least two occasions in metazoans, executers of apoptosis
have emerged from toxin domains derived from poly-
morphic toxin systems – the DNA-fragmenting nuclease
CIDE (a HNH fold endonuclease domain) [114] and the
pierisin-like ARTs which ADP-ribosylate DNA [205,206].
The phyletic patterns indicate that the lateral transfer of
these two toxin domains happened at very different
points in animal evolution – the CIDE-like nuclease was
transferred close to the base of the metazoa, whereas the
pierisin appears to have been transferred only into the
lepidopteran insects. Indeed, several of the toxin
domains that have been sporadically transferred to
eukaryotes could have been incorporated as lineage-
specific components of apoptosis or antiviral defense
systems. Of particular interest is the animal version of
the Het-C domain which is currently known from chor-
dates and the rotifer Adineta vaga. Like bacterial poly-
morphic toxins, it occurs in a cell-surface protein, which
in vertebrates is encoded by the MHC class III region
[207,208]. Given this architecture it is conceivable that it
is deployed as a defensive toxin against fungal or bacter-
ial pathogens. However, in certain cases, such as the
GHH domain, which was acquired by animals, the toxin
is no longer retained in its catalytic form; instead the
catalytically inactive form is used as an extracellular sig-
naling molecule (i.e. Od-Oz or teneurin). As noted
above, the ADP-ribosyl cyclase appears to have been
acquired by both metazoa and fungi from bacterial poly-
morphic toxin systems. In metazoa this enzyme was
recruited as a signaling enzyme (prototyped by human
CD38 and CD157), which generates two nucleotide mes-
sengers cADPr and NAADP that in turn regulate the in-
flux of calcium via the ryanodine receptor [162,163].
Thus, the origin of multiple metazoan signaling messen-
gers can be traced back to the polymorphic toxin.
Of note is the observation that several toxin domains of
the polymorphic toxin systems are shared with effectors
delivered by endo- parasitic or symbiotic bacteria. Given
the widespread presence of such resident bacteria in cells
of animals, amoeboid eukaryotes and ciliates [78,79,209],
it is probable that such effectors are a major source of
several of the toxin domains transferred to eukaryotes
and their viruses (which might share the host cell with
the intracellular bacterial residents; Tables 2). Indeed the
toxin-like domains of effectors and polymorphic toxins
deployed by several intracellular bacteria, such as Wolba-
chia, Orientia, Rickettsia, Rickettsiella, Legionella, Odys-
sella, Amoebophilus, Protochlamydia and Hamiltonella
might affect the host evolution at various levels. In a very
direct sense, their action might play a major role in the
manipulation of host behavior, reproduction, sex ratio
and fitness (e.g. defense against parasitoid wasps in
aphids by Hamiltonella [100,101,144]). In certain animal
lineages, such as the arthropods, the pervasive presence
of endosymbiotic bacteria might facilitate the routine
transfer of certain toxin genes, and appears to have con-
tributed to the toxins of the arthropods themselves, as
suggested by the latrotoxins of spiders. The acquisition of
certain toxin domains by the mimiviruses (Tox-MCF1-
SHE and Ntox19), iridoviruses (Tox-Otu domain), and
several NCLDVs (Tox-JAB-2) suggests that they might be
used by these viruses to manipulate host behavior in a
manner comparable to the intracellular bacteria. Simi-
larly, several toxin domains are also encountered in bac-
teriophages (Table 2), suggesting these viruses might also
utilize toxin domains as a strategy to interfere with host
physiology.
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Certain endosymbiotic bacteria like Odyssella also con-
tain full-fledged polymorphic toxin systems with both
toxins and immunity proteins. Such endosymbionts could
possibly explain the occasional acquisition of immunity
protein domains by eukaryotes and their viruses (which
might share the host cell with the resident bacteria;
Tables 2, 3). As previously noted, the SUKH domain pro-
teins observed in several lineages of DNA viruses appear
to have originated from immunity proteins of the poly-
morphic toxin systems [17]. Likewise, we had shown that
the SuFu immunity protein has given rise to an intracel-
lular component of the metazoan-specific hedgehog sig-
naling pathway [17]. Our current analysis indicated that
the C-terminal cargo-binding domain that is unique to
animal type VI myosins is evolutionarily related to the
immunity protein Imm-MyosinVICBD [210] (p = 10-7 in
iteration 4 with JACKHMMER in a search initiated with
an immunity protein gi: 332655030) that is predicted to
counter certain ADP-ribosyltransferase toxins. Given that
in eukaryotes the MyosinVICBD is only found in the ani-
mal lineage and in a single association, i.e. with myosin
VI, it is likely it was acquired from bacteria through
transfer of a gene encoding an immunity protein. Trans-
port of cargo by the myosin VI is unique in that it is
directed toward the minus ends of the actin filaments
and is required for several key cellular differentiation
events in eukaryotes [210]. Other than toxin domains and
immunity proteins, processing components such as the
HINT peptidase domain, have been acquired by eukar-
yotes and incorporated into several distinct eukaryote- or
even animal-specific regulatory systems such as the
hedgehog pathway [17]. Another example of a processing
peptidase from polymorphic toxin-like proteins, the ZU5
autopeptidase domain, might have also contributed to the
evolution of the animal apoptosis system – the two ZU5
domains are observed in PIDD, the core protein of the
PIDDosome, which provides a platform for recognizing
molecular patterns that are associated with loss of gen-
omic integrity and genotoxic stress [211]. We observed
that related ZU5 domains are also observed in a lineage-
specifically expanded group of proteins from sponges,
which might have a role in defense against pathogens
(Additional File 1).
On a more general note, several endosymbiotic alpha-
proteobacteria such as Wolbachia, Rickettsia and Odys-
sella closely resemble the progenitor of the
mitochondrion [212]. Thus, such endosymbiotic associa-
tions point back to the very origin of the eukaryotes.
Similarly, other endosymbiotic associations, such as
those with chlamydiae might have played an important
role in the origin of the photosynthetic plant lineage
[213,214]. Hence, it is conceivable that the origin of
some of the eukaryotic systems might be related to ac-
quisition of genes from the toxin systems of these early
bacterial symbionts. We had earlier proposed that the
PIN domain RNases of the eukaryotic nonsense-
mediated mRNA decay system might have emerged
from the prokaryotic toxin-antitoxin systems [22]. Simi-
larly, the SUKH, Tad1/ADAR-like deaminase, the SuFu-
associated HNH fold nuclease, ADP-ribosyltransferase
and the ParBL1 domains might be early acquisitions
from polymorphic or related secreted toxin systems of
endosymbiotic bacteria, which were incorporated into
various core function systems of eukaryotes [17,18]. In
this context, it is tempting to suggest that the deubiqui-
tinating peptidases such as those of the Otu clade, the
Zu5 peptidase domain in the nuclear membrane protein
Nup96/98, and the polyADP-ribose transferases (PARPs)
might also be early acquisitions from polymorphic toxins
or related effectors of the earliest endosymbionts in the
associations leading to eukaryogenesis. Hence, it is con-
ceivable that the very origin of certain features of the
eukaryotic cell, and pan-eukaryotic regulatory systems
such as ubiquitination and polyADP-ribosylation might
have depended on domains derived from systems used
in intra- and inter- specific conflict among prokaryotes.
Thus, components derived from polymorphic toxins and
related systems in symbiotic or pathogenic bacteria
might have been critical for more than one major evolu-
tionary transition in eukaryotes.
Conclusions
The current work is the first comprehensive analysis of
the recently discovered polymorphic toxin systems. It
builds upon our two earlier studies [17,18] that first
uncovered these systems and revealed that their diversity
was much greater than what was suspected in initial ex-
perimental studies [44]. In this work we have systematic-
ally identified the most prevalent toxin and immunity
protein domains and have classified them based on sen-
sitive sequence and structure analysis. This work thereby
provides a framework for future studies on this exciting
class of toxin systems. By creating an annotated inven-
tory of toxins and immunity proteins it allows for fur-
ther biochemical characterization of these proteins. In
this regard, we offer a number of clear biochemical pre-
dictions in terms of the secretory mechanisms, the mode
and site of action, enzymatic activities, active sites and
possible catalytic mechanisms of toxins and immunity
proteins. The systematic collection of toxins also aids
their investigation as potential biotechnological and
therapeutic reagents – a possibility underscored by the
precedent presented by several other related toxins [4,7].
The pervasive relationship of toxins involved in intra-
specific conflict to those used by bacteria in inter-
specific conflict, such as toxins directed against hosts, is
highlighted in this study. Thus, the results presented
here also help in understanding the pathogenesis of
Zhang et al. Biology Direct 2012, 7:18 Page 65 of 76
http://www.biology-direct.com/content/7/1/18
numerous plant and animal pathogens, as also the inter-
action between unicellular eukaryotes and their abun-
dant intracellular bacterial residents. These findings
might have considerable significance for our future
understanding of the virulence of key pathogens, such as
Pseudomonas aeruginosa, Legionella, and rickettsiae
among other animal pathogens, and Pseudomonas syrin-
gae, Xanthomonas and Ralstonia among plant patho-
gens. The toxins characterized here also provide insights
regarding the biochemical basis for complex multi-
organism interactions, such as the role for Hamiltonella
in defense against parasitoid wasps and Photorhabdus in
nematode predation of insects[84,100,101,144,199].
This study offers a platform for understanding certain
key ecological aspects of bacterial interactions. Systems
characterized here suggest, for the first time, possible mo-
lecular determinants for phenomena such as kin versus
non-kin discrimination, cooperation and cheating both in
the context of biofilms and motile growth. The ideas pre-
sented here allow for several testable microbiological hy-
potheses regarding bacterial conflicts. For example, the
proposal regarding cheating in diverse taxa from the oral
microbiome and certain soil bacilli can be tested via rela-
tively straight-forward competition experiments. Indeed,
such experiments can test our proposal if the polyimmu-
nity loci and proteins facilitate a facultative cheating strat-
egy in interactions between conspecifics. The systematic
characterization of these loci also allow for further explor-
ation of the rates of polymorphic transitions of toxins
under different conditions and in different ecosystems.
Some of these studies might have considerable bearing in
human, non-human animal and plant health, because
they might help explaining the preferential colonization
of bodily niches by certain strains as opposed to others
[15,199]. This might be of considerable value in facilita-
tion of processes such as wound healing and appropriate
re-colonization of bodily niches after antibiotic therapy.
The immunity proteins from these systems also offer a
means for understanding the two contrasting aspects of
the evolution of protein-protein interfaces. Our earlier
study had shown the versatility of the SUKH and SuFu
domain immunity proteins in interacting with a diverse
array of structurally and mechanistically distinct toxin
domains [17]. Thus, they join the previously studied
scaffolds such as the immunoglobulin domain and LRRs
in vertebrate antigen receptors as models to understand
how a single structural scaffold can diversify to accom-
modate an enormous variety in protein-protein interac-
tions [178]. On the other hand, we have also uncovered
numerous immunity proteins that are specific in terms
of the toxins they counter. Furthermore, a notable ma-
jority of these immunity proteins are apparently unique
to these systems. This presents them as models for the
converse aspect of the evolution of interactions, i.e. how
a large number of distinct domains with very specific
interfaces for interaction have emerged apparently de
novo in these systems. Further investigation of immunity
proteins through a combination of structure determin-
ation studies and biochemical analysis would be of great-
est interest in regard to the evolution of these specific
protein-protein interaction capabilities.
Finally, the analysis of the diversification of compo-
nents from polymorphic toxins and related systems
points to a previously underappreciated evolutionary
principle. Several toxin, immunity protein, structural
modules and secretory components from these systems
have a distinct life beyond their locus of provenance, es-
pecially in eukaryotic regulatory and defense systems. We
have documented that on numerous occasions compo-
nents from these systems were incorporated into regula-
tory systems of eukaryotes, and in many cases might have
played a major role in the very origin of some of these
systems [17,18]. Thus, these systems appear to be par-
ticularly rich sources to draw from for new functional
innovation. We attribute this to the consequences of nat-
ural selection in systems related to inter-organismal or
intra-genomic conflicts. Not surprisingly, such toxin-
immunity systems have a large effect on the fitness of
organisms [15,44], thereby escalating an arms race situ-
ation. This has resulted in a strong selective pressure for
constant diversification of polymorphic toxins and their
immunity proteins. Thus, such systems have acted as a
“nursery” for innovations in the protein world. Given that
such conflicts often extend to the sphere of symbiotic
and parasitic interactions with eukaryotes, the latter have
access to a “readymade” set of molecular innovations
from such systems, which can be recruited to spur the
emergence of new interactions in eukaryotic systems. This
is consistent with the similar diversification seen in other
systems involved in intra-genomic or inter-organismal
conflict [5,127,196,215,216]. These include antibiotic bio-
synthesis systems which are used in inter-specific conflict,
siderophore biosynthesis systems whose diversification
helps prevent siderophore-stealing by “cheaters”, R-M
and TA systems involved in intra-genomic conflict
[5,21,194,217]. Indeed, our earlier studies indicated that
components from each of these conflict systems have
played a major role in contributing components to di-
verse eukaryotic regulatory systems [127,196,215,216].
Thus, organismal and genomic conflicts being the basis
for major molecular innovations, which in turn might
facilitate major evolutionary transitions, can be consid-
ered a general evolutionary principle.
Methods
As described in the search strategy, protein sequences
corresponding to predicted toxins, trafficking, presenta-
tion, processing and immunity domains were isolated
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using diagnostic domain architectures and gene-
neighborhood templates, that were initially identified in
previous studies [17,18] (Figure 1). The sequences of
representatives of each of the domains from toxins, im-
munity proteins and associated trafficking components
were then used as seeds in iterative profile searches with
the PSI-BLAST [218] and JACKHMMER [219] programs
that run against the non-redundant (NR) protein data-
base of National Center for Biotechnology Information
(NCBI), to identify further homologs. A list of these
search-seeds and the residue ranges for each domain is
provided in Additional file 1. For most searches, which
were used to report the relationships presented in this
work, a cut-off e-value of .01 was used to assess signifi-
cance. In each iteration the newly detected sequences
that had e-values lower than the above cutoff were exam-
ined for being false positives and the search was contin-
ued with the same e-value threshold only if the profile
was uncorrupted. The postulated relationships recovered
using such iterative searches were further confirmed with
other aids such as secondary structure prediction and
superposition on known structures, if available. This
resulted in the identification of over 250 toxin and im-
munity domains. Search results for these domains are
provided in Additional file 1.
For each toxin or immunity gene, the gene neighbor-
hood was also comprehensively analyzed using a custom
Perl script of the inhouse TASS package. This script uses
either the PTT file (downloadable from the NCBI ftp site)
or the Genbank file in the case of whole genome shot
gun sequences to extract the neighbors of a given query
gene. Usually we used a cutoff of 5 genes on either side of
the query. The protein sequences of all neighbors were
clustered using the BLASTCLUST program (ftp://ftp.
ncbi.nih.gov/blast/documents/blastclust.html) to identify
related sequences in gene neighborhoods. Each cluster of
homologous proteins were then assigned an annotation
based on the domain architecture or conserved shared
domain. This allowed an initial annotation of gene neig-
borhoods and their grouping based on conservation of
neighborhood associations. The remaining gene neigh-
borhoods were examined for specific template patterns
typical of toxin-immunity systems. In this analysis care
was taken to ensure that genes are unidirectional on the
same strand of DNA and shared a putative common pro-
moter to be counted as a single operon. If they were head
to head on opposite strands they were examined for po-
tential bidirection promoter sharing patterns.
Multiple sequence alignments of all domains were
built by the Kalign [220], Muscle [221] and PCMA [222]
programs, followed by manual adjustments on the basis
of profile-profile and structural alignments. Secondary
structures were predicted using the JPred [223] and
PSIPred [224] programs. A comprehensive database of
profiles was then constructed using these multiple align-
ments and was used extensively in the annotation and
analysis of protein domain architectures and gene neigh-
borhoods. For other known domains, the Pfam database
database [189] was used as a guide, though the profiles
were augmented in several cases by addition of newly
detected divergent members that were not detected by
the original Pfam models. Clustering with BLASTCLUST
followed by multiple sequence alignment and further
sequence profile searches were used to identify other
domains that were not present in the Pfam database. Sig-
nal peptides and transmembrane segments were detected
using the TMHMM [225] and Phobius [226] programs.
The HHpred program [227] was used for profile-profile
comparisons to either unify poorly characterized families
to proteins with a known structure in the PDB database
or to group related families of toxins or immunity
domains. Structure similarity searches were performed
using the DaliLite program [228]. Phylogenetic ana-
lysis was conducted using an approximately-maximum-
likelihood method implemented in the FastTree 2.1
program under default parameters [229]. Predicted lat-
eral transfers to eukaryotes were further evaluated for
false positives by ensuring they were embedded in contigs
or complete chromosome sequences with other genes
typical of eukaryotes, comparing exon-intron structure of
the genes, studying their phyletic distribution within
eukaryotes and comparing the protein distances of the
predicted eukaryotic proteins (as measured by bit scores)
with bacterial homologs. Structural visualization and
manipulations were performed using the VMD [230]
and PyMol (http://www.pymol.org) programs. Auto-
matic aspects of large-scale analysis of sequences,
structures and genome context were perfomed by
using the in-house TASS package, which comprises a
collection of Perl scripts. Supplementary material can
also be accessed at ftp://ftp.ncbi.nih.gov/pub/aravind/
TOXIMM/toximDBsupplementary.html.
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Reviewers’ comments
Reviewer 1: Dr. Igor Zhulin (Oak Ridge National Laboratory, USA)
I have conflicting views on this paper. On one hand, I have read
Introduction, the beginning of Results & Discussion (the authors lost me half
through this section though as it become very descriptive and I had a hard
time connecting the pieces), and Conclusions with a great interest. The topic
is fascinating and the amount of work that has been done is unbelievable.
The authors analyzed an enormous amount of data, both published and
results of their computational research, and presented not only a catalog of
proteinaceous toxin systems, but a multi-scale picture of their roles in
various biological processes. On the other hand, it all came at a high price of
lacking necessary details regarding computational analyses and focus. I
perfectly understand that presenting such a huge amount of information
requires sacrifices in some areas, but I do not think that it should be in
describing “experimental procedures”. It is a generally accepted policy in
science that procedures must be presented in a sufficient detail, so
experiments can be independently reproduced. This paper, in my opinion,
does not fulfill this requirement. The section “Search strategy to identify new
toxins and immunity proteins”, which serves the purpose of providing such
details, gives only a very general description.
Authors’ response: We have altered the Material and Methods to provide more
extensive details regarding the procedures we followed with respect to sequence
and structure analysis. We do not agree with the referee’s statement that
experimental procedures have been sacrificed. In essence all the sequence and
structure analysis was performed using publically available programs, which
have been published and are well-known in the computational biology
community, if not more widely. In the current version of the Material and
Methods we describe these without omission and any reader with access to
appropriate computer resources can use the same. We also disagree with the
referee’s allegation of the lack of sufficient information for independent
reproducibility – see below for further details in this regard.
Finally, the length and overall organization of this paper makes it very
difficult to follow it through and the lack of page numbers is inexcusable for
a manuscript that has 130 of them. Nearly each of the 38 subchapters of this
paper has its own introduction and reads as a separate story. As a result, we
do have an encyclopedia of polymorphic toxin systems, but its true scientific
quality is hard to estimate.
Personally, I would rather see much smaller pieces of this work presented in
a concise way with all details of searches and analyses clearly shown. The
global view that authors aimed at presenting is much better suited for
review papers. Here we have a lot of original work mixed up with a review
of literature: the number of references in this paper is higher than in many
comprehensive reviews on similar topics. I think the quality of both original
work and review suffers from this mix.
The bottom line is that to me this is a paper that reaches very interesting
conclusions, but which is very difficult to comprehend in its entirety and
some (if not many) of its results cannot be verified (or are very difficult to
verify) independently.
Authors’ response: We regret the inconvenience caused by the lack of page
numbers, which stems from using a PDF reader which provides the page
numbers as against a print version. The referee raises three basic issues which
we address below-
(i) Length of the article – single long versus multiple short papers: Short articles
are useful when a single domain or computational observation needs to be
succinctly presented. Indeed, upon our initial discovery of these systems we
published two shorter articles outlining just the details of specific aspects of
them. However, upon further investigation it became clear that neither those
two works nor subsequent experimental studies on these systems really do
justice to the magnitude of domain diversity seen in these systems. Unlike many
other systems, despite these proteins being around and accumulating in the
non-redundant protein database for now more than a decade, there has been
hardly any comprehensive study on them. This is testified by the rather
rudimentary annotation borne by most of them in protein databases. This
being the first such treatment on a long-neglected class of highly represented
proteins meant a particularly long paper. Furthermore, the practical aspects of
publication meant it was quite infeasible to prepare numerous separate small
papers and submit each for peer-review. We realized in course of our study that
splitting the individual discoveries into multiple manuscripts would dilute the
big picture emerging from these systems. With respect to shorter works being
easier to read than a comprehensive manuscript as this we opine that it is
largely a matter of taste. It may be noted that referee two, despite finding the
length remarkable, commented regarding its easy readability. The apparent self-
sufficiency of the sub-sections is primarily to help readers who might be more
interested in one or few of toxin or immunity domain families but the text has
been edited to minimize redundancy. Hence there is no repetition of material
between sections.
(ii) Review versus original paper admixture: We disagree with the referee in
saying that it is a mixture of review and original research. The “review” aspect is
limited to the introduction and general conclusions, as is typical of any research
paper. It should be kept in mind that any kind computational analysis work
based on sequence/structure analysis needs to place newly identified domains in
the context of what is already known in order to make new functional
predictions. This is exactly what we do – this necessitates the mention of
previous studies and also precedence of biochemical activities for functional
inference. We do not see this as being a mixture of review with new results but
merely an aspect of building a functional argument. While there are several
domains and ideas presented in this study, we were particular in only
emphasizing those that are novel and discovered in this study. In our
calculation, ~ 85% of our dataset (that has about 250 toxin and immunity
domains) is not found in any domain database. Those that are already present
in protein domain databases like PFAM, they are typically listed as domains of
unknown function (DUFs) and are need of functional annotation.
(iii) Reproducibility: As noted above, we do not accept the claim that our results
are not reproducible. Of course, the ease of reproducibility depends entirely on
the time available to one attempting it. We should emphasize that all the
computational discoveries reported here use standard sequence/structure
analysis techniques laid out in the Material and Methods, as is typical of a
paper in this field. Those cases involving more difficult detections we explicitly
mention in the paper program used and statistical support for the particular
relationship or the Z score cutoffs used by DALIlite for structural relationships.
Since we have provided Genbank identifiers (gis) for the prototypical proteins of
every group, all the remaining relationships can be reproduced by running
profile searches with PSI-BLAST, HMMsearch3, JACKHmmer or HHpred on the
Web or locally, either in a unidirectional or transitive fashion. Most importantly
we have provided one of the most extensive supplements for a sequence/
structure analysis paper -- alignments for each toxin and immunity domain
have been provided; hence, obtaining starting points for reproducing searches
should not pose any difficulty. The gis of all proteins under consideration are
also provided along with an appropriate classification. This allows for
independent verification of architectures and operonic associations. In addition
to the extensive tables in the body of the article which provide details regarding
active sites and phyletic patterns, the data is also provided in the supplement as
searchable tables, where readers can browse the data by species, domain,
operons, and pathway of secretion. We fear the referee did not peruse the
extensive supplement that provides all the material for reproducing the
presented analysis. In the revised version we have further improved the
presentation of the supplement to improve ease of access to the alignments.
We will also upload all the new alignments to protein databases such as Pfam
making the material available upon publication to facilitate easy reproduction
and use of the presented results.
Reviewer’s reponse to above:
I am not persuaded with authors’ arguments regarding their description of
“experimental procedures”.
Let me consider just the first paragraph of Materials and Methods, which is
shown below (in italics) in its entirety and is fragmented only by my
interjections.
As described in the search strategy, protein sequences corresponding to
predicted toxins, trafficking, presentation, processing and immunity domains
were isolated using diagnostic domain architectures and gene-neighborhood
templates, that were initially identified in previous studies [17,18] (Figure 1).
These domains were then used as seeds in iterative profile searches with the PSI-
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BLAST [217] and JACKHMMER [218] programs that run against the non-
redundant (NR) protein database of National Center for Biotechnology
Information (NCBI), to identify further homologs.
This is a very general statement, which provides very little detail. Cleary, each
PSI-BLAST and JACKHMMER search is carried out not with “domains”, but
with one concrete protein sequence, which has a name and coordinates of
the region that was used as a query.
Authors’ response: We concede that the word domain in this context might be
confusing for some readers. However, it is should be noted that in this context
we obviously imply the amino acid sequence corresponding to a given domain.
This point has been emended.
A search is performed against a specific database of a certain size and
content. The size of NR database has doubled in less than 3 years and is
changing every day. Thus, it is important either to work with a fixed version
of NR or to report which version was used in a given search. Here is the
excerpt from the authors’ own work, which provides a good example of
how “experimental procedure” should be described:
“A PSI-BLAST search was initiated with the conserved N-terminal extension of
the SGC (human SGC1β, gi: 4504215, region 1–360), using an inclusion
threshold of .01, and compositional bias based statistics to eliminate false
positives arising due to peculiarities of sequence composition. Both the N-
and the C-terminal parts of this extension gave several distinct hits to
different bacterial proteins, supporting the presence of two distinct globular
domains in this extension. Based on these hits we divided the extension into
N- and C-terminal parts and initiated separate PSI-BLAST searches with them.
Searches with the N-terminal part of the extension gave significant hits to
bacterial proteins of the length 180–195 residues within the first 3 iterations
(eg. Mdge1313 from Microbulbifer degradans is detected with an expect-
value (e) of 10–4 in the first iteration). . .” (LM Iyer, V Anantharaman and L
Aravind 2003 BMC Genomics 2003 4:5)”. Although some details are still
lacking and the NR version was not specified (not that critical for the year
2003), this description is thorough enough to reproduce the steps that were
taken during the domain identification process. I regret that ten years later
authors think that providing search details is no longer necessary. Once
again, I understand the reason for not providing details for numerous
searches that they have carried out, and once again I disagree with this
position.
Authors’ response: We appreciate the referee quoting from a former work of
ours. Obviously we have neither forgotten nor changed our philosophy to
domain discovery or analysis in the past 8 years. We note that the referee states
that he understands why we do not give these details in the same manner as it
is done when reporting the discovery of a single/few domains. We should
reiterate that when such an analysis is scaled up to hundreds of domainsf
providing descriptions as that pasted by the referee would result in an
extraordinary and tedious prolixity for most readers (users) of the article. Hence,
the report in the actual manuscript focuses on the points of biochemical/
biological interest with only a general description of the search strategy for
most cases. This does not mean that the issues raised by the referee are
inaccessible. They are simply provided in the supplementary material. Herein a
reader might find a collection of the actual saved PSI-BLAST searches for all the
notable domains described herein. The same files should supply the specifics of
the nr database at the point of the run. Furthermore, another file in the
supplement provides the query gi with sequence coordinates of all seeds used
for the domain-specific searches. Yet another file provides the searches with all
the profiles, which we created for this work (either PSI-BLAST or HMM) against
the NR database from May 23rd 2012. The links have been made explicit in the
additional file.
Referee’s comment resumes: For most searches in which were used to report
the relationships presented in this work a cut-off e-value of .01 was used to
assess significance.
Let us leave alone the fact that something is missing from this sentence
(what were used?) and focus on the main point. This statement means that
for some searches a cut-off E value other than 0.01 was used.
Authors’ response: This sentence had a typo which we have now corrected and
appreciate the referee pointing the same.
FOR WHICH ONES? WHY? No details provided. Furthermore, 0.01 is already a
“dangerous” level, when it comes to false positives. The description provided
by authors leaves a possibility that some searches were carried out even
with a worse E value. It does not automatically mean the results are
incorrect, but it does mean that a special care must be taken when
considering such relationships and description must be provided.
Authors’ response: The .01 cutoff is dangerous only in the hands of the
untrained sequence analyst. Obviously we took special care to manually
examine every iteration of searches with every domain reported in this study.
Thus, we ensured that the new sequences being included are unlikely to be false
positives.
Referee’s comment resumes: This was further confirmed with other aids such
as secondary structure prediction and superposition on known structures, if
available. For each toxin or immunity gene, the gene neighborhood was also
comprehensively analyzed using a custom Perl script of the inhouse TASS
package. The process was carried out iteratively and exhaustively and resulted in
the identification of over 250 toxin and immunity domains.
I am guessing that the first sentence refers to assessing the validity of
multiple sequence alignments (which is described in the next paragraph).
This indeed is a common technical element, which requires no further
description. However, the next sentence makes quite a difference. What is
meant by “comprehensive analysis of the gene neighborhood”? How many
genes in the vicinity of the gene of interest were analyzed? How were they
analyzed: by their RefSeq annotation? COGs? Best BLAST hit? Gene
neighborhood analysis is a very important element of computational
genomics of prokaryotes; however, there is no publically available, published
program or even a single, commonly accepted approach on how to do this
analysis. Thus, it is important to provide details.
Authors’ response: The Material and Methods have emended to include further
details on neighborhood analysis.
“The process was carried out iteratively and exhaustively. . .” Which process?
The entire process of domain identification or only the PSI-BLAST searches? I
understand how the latter can be done iteratively and exhaustively, but I can
only guess what it means with respect to the entire process, and certainly
cannot distinguish between these possibilities.
Authors’ response: The Material and Methods have emended to remove the
potential confusion arising from this statement.
In response to my original critique authors replied that they “do not agree
with the referee’s statement that experimental procedures have been
sacrificed. In essence all the sequence and structure analysis was performed
using publically available programs, which have been published and are
well-known in the computational biology community, if not more widely”. In
essence, yes, but in some cases, obviously, no: a custom Perl script of the in-
house package. . . Custom scripts execute specific actions. We do not need
to know what the script is, but we certainly do need to know what the
action was. “Comprehensive analysis of gene neighborhoods” to me is a
prototype example of sacrificing the description of “experimental
procedures”. Even when it comes to publicly available and published tools,
procedure details should be provided. In experimental biology, it is not
enough to state that PCR was used to amplify a given gene – exact primers
must be provided. Perhaps, this is not the best analogy, but it illustrates the
point.
Authors’ response: The Material and Methods have been emended to describe
the action of the script which in essence provides the details pertaining to the
gene-neighborhood analysis raised above.
On the final note, I would like to emphasize that I have an utmost respect
for the authors, who have been leaders in the field for many years now, and
who produced a series of groundbreaking papers in computational
genomics. Without doubts, their results and conclusions are both correct
and important. Furthermore, I applaud their decision to submit all domain
models to the public repository (Pfam). However, I do disagree with their
position on attention to detail in describing “experimental procedures”. I can
expand on this point substantially; however, this is not the place for such a
debate.
Authors’ response: We too believe that this is not the place for a general
debate on methodology.
Reviewer 2: Dr. Arcady Mushegian (Stowers Institute for Medical
Research, USA)
The manuscript by Zhang et al. is a magisterial treatment of a large and
heterogeneous group of bacterial complex toxin proteins as well as the
immunity proteins that countervail the action of these toxins. It is a
comprehensive collection of old and new protein families, genome contexts
and phyletic distributions of these important functional modules in
prokaryotes, which also crosses over to partially analyze the sequence
relationships of secretion systems in bacteria. I have no concerns about the
quality of sequence comparison, domain definition and genome context
analysis. This is a catalog of novel predicted functions, which can guide the
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work of experimentalists for years to come. I do have, however, several small
concerns about data presentation and some comments that have to do with
the broader discussion of bacterial evolution. More specifically:
Authors’ response: We thank the reviewer for his positive comments and
suggestions.
p. 21–22: a few homologs of multidomain polymorphic bacterial toxins are
purported to be present in eukaryotes (e.g. gi 321474287 in Daphnia and
Tox-REase-8 in a subset of insects), and it is surmised that they have been
horizontally transferred from bacteria. How do we know that these genes
are indeed found in the genomes of these eukaryotes, and do not
represent endosymbiont DNA or other contamination? Have the genomic
contigs been assembled, do these genes display eukaryotic features - e.g.,
introns?
Authors’ response: In our analysis, we were particularly careful in eliminating
false assignments of lateral transfer to eukaryotes and used several parameters
to decide if the laterally transferred genes were indeed encoded by the
eukaryotic species. In the simplest scenario, the presence of introns was
indicative of their eukaryotic presence. For example, the gene for gi 321474287
in Daphnia contains 11 introns, whereas most Tox-REase-8 genes in insects at
least contain one intron, eliminating the possibility of these genes being
contaminants. Other parameters that were considered include: 1) Elimination of
sequences that were identical or almost identical to bacterial sequences. In our
dataset, none of the proteins assigned as laterally transferred showed any
identities or near identities to bacterial sequences; 2) Most proteins assigned as
laterally transferred to eukaryotes also showed a presence in more than one
eukaryotic species, which further helps in eliminating false lateral transfer
assignments. For e.g. Tox-REase-8 is present in crustaceans, insects and
placozoans. Similarly, Tox-GHH domains are present in five major lineages of
bacteria, while in the eukaryotes they are only found in multiple metazoan
species (TCAP domains of teneurins). In response to this comment and to that
made by Reviewer 3, we have explained this procedure in more detail in the
Materials and Methods.
p. 44–45. The gene neighborhood network shown in Figure 12: I am not
sure what it is supposed to visualize. The authors state that the direction of
the edges is important, i.e., it shows the 5' to 3' order of genes or protein
domains; but the arrowheads are barely visible even in the pdf at
magnification 250%, and will not be seen online. In any case, the edge
density is so high that the main message seems to be 'anything can link to
anything'. The graphs become more sparse when clade-specific connections
are shown - this is more interesting, but perhaps visualization would be
better if the density of connections is modeled by the edges of different
thickness.
Authors’ response: We agree with the reviewer that the full view of the domain
architectural network was too dense for a detailed view. We have now added a
simplified graph next to the central graph that further combines all nodes into
metanodes based on their functional type. This simplified graph gives a better
view of the follow on connectivities across all toxin polypeptides. For example, it
clearly shows that toxin domains detected in this study are almost always at
the C-terminus of the protein.
The next several comments have to do with somewhat superficial and
inconsistent discussion of relative plausibility of various evolutionary
scenarios.
To wit:
p. 46 "The phyletic pattern of this system suggests that it might have
emerged inthe proteobacteria-bacteroidetes assemblage (members of the
group I bacterial division [183]) followed by transfer to a subset of group II
lineages such as negativicutes and fusobacteria." --- Why not the other
direction, or ancestral origin followed by gene losses (especially given that
these scenarios are discussed later for essentially the same phyletic vectors)?
Authors’ response: The above argument is based on parsimony. In this study,
we notice a strict correlation between the occurrence of T5SS and the presence
of an outer membrane. Most lineages from Group I bacteria (including all
proteobacteria and bacteroidetes) contain an outer membrane and also
components of T5SS. In contrast, most lineages of Group II bacteria contain
only one membrane layer around the cell further encapsulated by a cell wall.
Some exceptions include the negativicutes which are a subset of firmicutes that
have an outer membrane. Since the ancestral state of the Group I and Group II
bacteria can be generally reconstructed as possessing an outer membrane in
the former and containing a single membrane layer in the latter, we propose
that the T5SS were laterally transferred to the negativicutes and fusobacteria .
We have added an additional remarks in this regard in the revised manuscript.
Referee’s further response: The explanation is fine in this case, but compare it
to the following point-counterpoint.
p. 52–53: "This general rarity of the polymorphic toxin systems is in striking
contrast to the general prevalence of the toxin-antitoxin systems across
archaea [22]. This distribution, with a dominant presence in most major
clades of both group-I and group-II bacteria, suggests that polymorphic
toxin systems could have been present in the ancestral bacterium." --- First,
what is meant by "this distribution"? My understanding is that "this
distribution" includes "general rarity" of polymorphic toxins in archaea. How
can rarity of a system in archaea suggest its presence in bacterial stem, as
opposed to later invention in bacteria? I suspect that this is mostly
unfortunate wording that should be edited. In contrast, my second concern
is more fundamental: essentially, any phyletic distribution may be interpreted
as 1. ancestral presence of a gene followed by gene losses, or 2. later
invention in one clade followed by horizontal transfers to to the other
clades; or else 3. some combination of ancestral presence, losses and HGT.
To turn these scenarios from mere hand waving to something supported by
the evidence, one has to specify the model of gene gain and gene loss
more explicitly, or to bring in some auxiliary evidence that favors one of the
explanations. I do not see much of this here.
Authors’ response: We agree that this section was a bit unclear and we have
now revised it. Similar to the previous point, the polymorphic toxin systems that
we report in this study are present in all major lineages of bacteria. While there
is no denial that extensive lateral transfer of these systems occurs, the presence
in the ancestral bacterium with divergence mirroring the evolution of different
secretion systems within the bacterial superkingdom is a parsimonious
argument. In contrast only a few archaeal “species” contain these systems
suggesting that they were probably not present in the ancestral archaeon.
Parsimoniously, this suggests that the few archaeal polymorphic toxin systems
were acquired from bacterial versions, because alternatively it would require a
large number of gene losses in different archaeal linaeges.
Referee’s further response: In the previous exchange, the presence of a gene at
the root of group I only, but not at the root of group II nor at joint root of I + II,
was called “parsimonious”. Now, presence at the root of all bacteria is believed
to be parsimonious, when the same set of taxa is examined. What kind of
parsimony is invoked in each case? (I think I can discern the answer from the
next two sentences, but please correct me if I am wrong). The authors appear
to understand parsimony as the explanation that requires the smaller number
of events. I cannot accept this as an always-preferable explanation, when it
does not matter what these events are and how are they counted; in a
moderate form, however, we can use parsimony as a criterion of selecting the
null hypothesis, i.e., “choose the scenario with the smallest number of events,
unless the additional evidence suggests that a more complex scenario has to be
considered”. I think that, in this case, however, precisely such additional evidence
is available in the form of evolutionary estimates of the relative rate of gene
gain and gene loss: almost every estimate suggests that on average gene losses
are moderately to highly more frequent than gene gains. So, unweighted
parsimony will not work in these cases – a scenario with 1:1 gain-to-loss ratio
will be actually making an additional assumption of a relative loss rate that is
constrained to be lower than what is observed in nature. Everything is then
hanging on the word “large” – how large the excess of losses in archaea is, so
that this makes the scenario so unlikely?
Authors’ response: We agree that the general frequencies of gene loss tend to
exceed those of gains. However, with respect to the toxin systems in archaea we
are dealing with the following situation: The non-redundant database has
representatives from over 225 completely sequenced WGS sequences. Classical
polymorphic toxin-like systems are found only in about 15 of them. Thus, there
are approximately 15 times the archaeal genomes which lack these as those
which have these systems. Approximately more 1/3rd of the bacterial genomes
have at least one such system. Hence, although the referee is right in pointing
to the differences in the rates of loss exceeding gain, we believe our original
reasoning based on the parsimony argument is a valid one.
Referee’s further response:
This is also supported in phylogenetic trees, where the archaeal toxins or
immunity domains group with particular bacterial versions.
Is this true for the trees of all families, or only some?
Authors’ response: Baring the barnases where the relationship is difficult to
ascertain one way or another, consistently the other toxin domains shows the
archaeal branches embedded within the bacterial radiation.
p. 53, the following sentence: "However, it should be noted that these genes
and cassettes are highly prone to lateral transfer as suggested by the
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sporadic phyletic distribution of both toxin domains and immunity proteins
[17]. Hence, the distribution of these systems might also reflect in part the
secondary dispersion of such systems across diverse bacteria by lateral
transfer." --- Essentially, this is the same as to say that inheritance of any
genetic element may be either vertical or horizontal. So?
Authors’ response: While the sentence might on the surface appear trivial but
needs to be seen in light of the earlier comment on the polymorphic toxins
being inferred present in the stem of the bacterial superkingdom. While that
inference can be made based on the distribution of the toxins and their
corresponding secretion systems, we intended to provide a more realistic picture
(the above sentences), lest it be taken that their evolutionary history was
predominantly vertical since their emergence early in bacterial evolution.
Referee’s further response: Once again, in the exchange regarding the
statement on p. 46, the inference was that certain toxin was present in the step
of proteobacteria + Bactoroidetes, but not in the stem of all bacteria. I suppose
the scenarios are really different for different toxins – can this be made more
explicit?
Authors’ response: The toxin distributions in bacteria are certainly affected by
lateral transfer so we cannot be certain of the inference of particular toxin in
the common ancestor. Nevertheless, based on the differential distributions, we
can tentatively propose that some of the widespread versions, such as the
barnase, HNH and deaminase domain toxins might have been present in the
stems of the major bacterial clades such as those uniting the group-I bacteria
or group-II bacteria.
p. 53: "Certain patterns of distribution of polymorphic toxin systems appear
to transcend phyletic boundaries. . . 1) the hyperthermophiles, which are
often chemoautotrophs, from both bacteria and archaea show a strong
tendency to lack such systems." --- this seems to be the case of multiple
losses in bacteria, possibly favored by similarity in the habitats, and possibly
ancestral absence in archaea. Ecological adaptations like this 'transcend
phyletic boundaries' more or less by definition - is this the point?
Authors’ response: While adaptations directly related to an ecological niche are
indeed obvious in terms of transcending phyletic boundaries, this is not
necessarily the case with inter-organismal conflict systems, which do not directly
relate to the ecological niche. Since we nevertheless found correlations between
these systems and ecology, we felt it would be useful to point them out. This
would help understanding the more subtle effects of ecology of a species on
their interactions with conspecifics and other organisms.
Referee’s further response: The correlation has been observed between
hyperthermophily and lack of polymorphic toxins. As the authors imply, this
may in fact be the correlation between chemoautotrophy and lack of toxins –
or is it? Which effects here are gross, and which are subtle? Could it be, for
example, that hyperthermophily is generally correlated with reduced repertoire
of all kinds of secreted proteins, which would be more easily destabilized and
inactivated by adverse environment outside the cell?
Authors’ response: We agree that the point raised by the referee regarding
temperature affecting protein stability and thereby placing a selective constraint
on the number of toxins could be in principle a valid alternative explanation.
However, beyond certain compositional and length distribution differences the
total number of secreted and membrane proteins in hyperthermophiles do not
appear to be significantly different from other organisms (e.g. Nilson et al.
Proteins. 2005 Sep 1;60(4):606–16.) Hence, we are not certain if this explanation
might be more relevant than autotrophy, which additionally accounts for the
comparable situation in photosynthetic autotrophs.
p. 56: in the case of oral microbiomes, I am not sure how some species were
assigned to 'biofilm-forming' category and others to 'cheaters' - I think that
at least some species in the latter category are biofilm-forming in their own
right.
Authors’ response: As pure cultures, all these species are likely to form biofilms,
but the oral environment is a mixed population of diverse bacterial species, and
it is well known that oral biofilms are comprised of mixed bacterial species
(Paster BJ et al. Bacterial diversity in human subgingival plaque, ref 198). In this
context, we hypothesize that the number of toxin and immunity domains
predicts how a species will interact with another one during the formation of a
mixed biofilm.
Reviewer 3: Dr Frank Eisenhaber (Bioinformatics Institute, Singapore)
I agreed to be a reviewer when reading the author list only to find out that
MS is by far the longest that I have ever seen as reviewer in my life. Despite
of the initial horror and of the impressive length, the text is a fine reading -
both as a research paper and as a review of this specific field. One would
not think to shorten it by a page. The thoughts and results are plausible
(there is no hope to repeat the calculations even partially). There is
considerable care for the detail throughout the text, figures and additional
files (except for very minor things such as ref. 144 appearing incomplete).
I find the generous addition of supplementary information especially
notable.
Possibly, this will be of greatest benefit for people creating annotation
pipelines and sequence databases. For practical purposes, the authors might
think to add archives with all the individual alignments in single files and
domain models in several formats such as the HMMR2, HMMER3, etc. ready
made.
I think that the work is a welcome addition to the scientific literature.
Authors’ response: We thank the reviewer for his positive comments and
suggestions. A more user-friendly supplementary file is now provided with the
alignments of the toxins and immunity domains as separate files in a zipped
format. We will additionally upload all alignments to protein domain databases
such as Pfam, so that researchers can access them more easily. Ref. 144 has
been updated in the revision.
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